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ABSTRACT 
Harnessing Saccharomyces cerevisiae Genetics for Cell Engineering 
Laura Michele Wingler 
 
 Cell engineering holds the promise of creating designer microorganisms that can 
address some of society’s most pressing needs, ranging from the production of biofuels 
and drugs to the detection of disease states or environmental contaminants.  Realizing 
these goals will require the extensive reengineering of cells, which will be a formidable 
task due both to our incomplete understanding of the cell at the systems level and to the 
technical difficulty of manipulating the genome on a large scale.  In Chapter 1, we begin 
by discussing the potential of directed evolution approaches to overcome the challenges 
of cell engineering.  We then cover the methodologies that are emerging to adapt the 
mutagenesis and selection steps of directed evolution for in vivo, multi-component 
systems.   
 Yeast hybrid assays provide versatile systems for coupling a function of interest 
to a high-throughput growth selection for directed evolution.  In Chapter 2, we develop 
an experimental framework to characterize and optimize the performance of yeast two- 
and three-hybrid growth selections.  Using the LEU2 reporter gene as a model selectable 
marker, we show that quantitative characterization of these assay systems allows us to 
identify key junctures for optimization.  In Chapter 3, we apply the same systematic 
characterization to the yeast three-hybrid counter selection, beginning with our 
previously reported URA3 reporter.  We further develop a screening approach to identify 
effective new yeast three-hybrid counter selection reporters. 
 Installing customized multi-gene pathways in the cell is arguably the first step of 
any cell engineering endeavor.  Chapter 4 describes the design, construction, and initial 
validation of Reiterative Recombination, a robust in vivo DNA assembly method relying 
on homing endonuclease-stimulated homologous recombination.  Reiterative 
Recombination elongates constructs of interest in a stepwise manner by employing pairs 
of alternating, orthogonal endonucleases and selectable markers.  We anticipate that 
Reiterative Recombination will be a valuable tool for a variety of cell engineering 
endeavors because it is both highly efficient and technically straightforward.  As an initial 
application, we illustrate Reiterative Recombination’s utility in the area of metabolic 
engineering in Chapter 5.  Specifically, we demonstrate that we can build functional 
biosynthetic pathways and generate large libraries of pathways in vivo.  The facility of 
pathway construction by Reiterative Recombination should expedite strain optimization 
for metabolic engineering. 
i 
 
Table of Contents 
Table of Contents         i 
List of Figures          vi 
List of Tables          x 
List of Abbreviations         xii 
Acknowledgements         xvi  
Dedication          xviii 
Chapter 1 Directed Evolution Strategies for Cell Engineering  1 
 1.0 Chapter outlook       2 
 1.1 Directed evolution for in vivo systems    3 
 1.2  Approaches to the engineering of in vivo systems   5 
  1.2.1 Rational design      5 
  1.2.2 Library approaches      6 
 1.3 Mutagenesis technologies for systems-level directed evolution 10 
  1.3.1 In vitro mutagenesis of DNA     12 
  1.3.2 In vivo mutagenesis of DNA     14 
 1.4 Assay methods for systems-level directed evolution   17 
  1.4.1 Assays for defined output patterns    18 
  1.4.2 Assays for defined outputs     18 
  1.4.3 Achieving throughput and sensitivity in in vivo assays  20 
 1.5 Continuous in vivo directed evolution    23 
 1.6 Conclusions        25 
1.7 References        26 
ii 
 
Chapter 2 An Experimental Framework for the Characterization and 
Optimization of Yeast Hybrid Selections    35 
 2.0 Chapter outlook       36 
 2.1 Introduction         37 
 2.2 Results        39 
2.2.1 An experimental framework for characterizing yeast  
hybrid LEU2 growth selections    39 
  2.2.2 Characterization of enrichment in LEU2 selection  
systems       41 
  2.2.3 Characterization of strains’ growth in LEU2 selection  
systems       43 
2.2.4 Optimization of enrichment in the yeast two-hybrid  
LEU2 selection      45 
 2.3 Discussion        47 
 2.4 Experimental methods      49 
 2.5 Strains, plasmids, and oligonucleotides    55 
 2.6 References        56 
Chapter 3 Characterization and Discovery of Yeast Three-Hybrid  
Counter Selections       59  
 3.0 Chapter outlook       60 
 3.1 Introduction        61 
 3.2 Results        64 
  3.2.1 Model of the cellulase chemical complementation system 64 
iii 
 
  3.2.2 Characterization of the 8LexAop-pSPO13-URA3  
reporter gene       66 
  3.2.3 Efforts to optimize the URA3 yeast-three hybrid reporter  
gene        70 
  3.2.4 A library approach for the discovery of yeast-three  
hybrid counter selection reporter genes   70 
  3.2.5 Characterization of the GIS1 counter selection reporter 76  
  3.2.6 Efforts to optimize the GIS1 counter selection reporter 78 
 3.3 Discussion        79 
 3.4 Experimental methods      81 
 3.5 Strains, plasmids, and oligonucleotides    89 
 3.6 References        91 
Chapter 4 Reiterative Recombination for the In Vivo Assembly of  
Multi-Gene Pathways      95 
 4.0 Chapter outlook       96 
 4.1 Introduction        97 
  4.1.1 Methods for assembling multi-gene pathways in vitro 98 
  4.1.2 Methods for assembling multi-gene pathways in vivo 99 
 4.2 Design of Reiterative Recombination     100 
4.3 Results        103 
  4.3.1 Construction of a system for Reiterative Recombination 103 
  4.3.2 Validation of the Reiterative Recombination system  104 
   
iv 
 
4.3.3 Construction of a “pathway” of genes via Reiterative 
Recombination      109 
 4.4 Discussion        114 
 4.5 Experimental methods      115 
 4.6 Strains, plasmids, and oligonucleotides    127 
 4.7 References        129 
Chapter 5 Reiterative Recombination for Metabolic Engineering  134 
 5.0 Chapter outlook       135 
 5.1 Introduction        136 
  5.1.1 Multi-gene pathways for metabolic engineering  136 
  5.1.2 Multi-gene libraries for metabolic engineering  138 
 5.2 Results        141 
  5.2.1 Application of Reiterative Recombination to the  
construction of the lycopene biosynthetic pathway  141 
  5.2.2 Construction of an optimized biosynthetic pathway via  
Reiterative Recombination     142 
  5.2.3 Construction of libraries of biosynthetic pathways via  
Reiterative Recombination     145 
  5.2.4 Transfer of a Reiterative Recombination pathway to a  
heterologous organism     149 
  5.2.5 Design of next-generation Reiterative Recombination  
systems       151 
 5.3  Discussion        154 
v 
 
 5.4 Experimental methods      157 
 5.5 Strains, plasmids, and oligonucleotides    162 
 5.6 References        165 
Appendix Sequences of Pathways Constructed by Reiterative  
Recombination       171 
 A.1 Sequence of the reporter gene pathway    172 
A.2 Sequence of the lycopene biosynthetic pathway   178 


















List of Figures 
Figure 1-1 The directed evolution of biomolecules versus the directed  
  evolution of in vivo systems      3 
Figure 1-2 Mutagenesis strategies for systems-level directed evolution  12 
Figure 1-3 Throughput and sensitivity in in vivo selection systems  18 
Figure 1-4 Yeast n-hybrid systems      20 
Figure 1-5 Continuous in vivo directed evolution incorporating genetic  
exchange        25 
Figure 2-1 Strains for the characterization of yeast hybrid LEU2 selections 41 
Figure 2-2 A colorimetric assay to monitor enrichment    42 
Figure 2-3 Assessment of the throughput of LEU2 selection systems  43 
Figure 2-4 Growth of LEU2 selection system strains under selective  
conditions        44 
Figure 2-5 Growth curve optimization of the yeast two-hybrid selection 45 
Figure 2-6 Optimization of yeast two-hybrid mock selection conditions 46 
Figure 3-1 The chemical complementation counter selection provides a  
growth selection for cellulase catalysts    62 
Figure 3-2 Model of the cellulase chemical complementation system   65 
Figure 3-3 Growth of ura3 and URA3 strains under yeast three-hybrid  
counter selection conditions      67 
Figure 3-4 Enrichment of ura3 strains under yeast three-hybrid counter  




Figure 3-5 Growth of active and inactive yeast three-hybrid strains under  
URA3 counter selection conditions     69 
Figure 3-6 Enrichment of inactive yeast three-hybrid strains in the URA3  
counter selection       69  
Figure 3-7 Screen for alternative reporters for the yeast three-hybrid  
counter selection       73 
Figure 3-8 Characterization of lacZ expression from the promoter library 74 
Figure 3-9 Representation of 200 colonies’ performance in the counter  
selection reporter screen      75 
Figure 3-10 Growth curves for retransformed yeast three-hybrid counter  
selection reporter candidates      76  
Figure 3-11 Characterization of 8LexAop-pTEF1-GIS1 as a yeast three- 
hybrid counter selection reporter     77 
Figure 3-12 GIS1 mock selection results      78 
Figure 4-1 General scheme of Reiterative Recombination   101 
Figure 4-2 Details of Reiterative Recombination     103 
Figure 4-3 Construction of the parental acceptor Reiterative Recombination  
strain         104 
Figure 4-4 Validation of endonuclease-stimulated integration of DNA via  
Reiterative Recombination      105 
Figure 4-5 Marker conversion efficiencies in Reiterative Recombination  
with decreasing lengths of homology     107 
Figure 4-6 Consecutive rounds of Reiterative Recombination   108 
viii 
 
Figure 4-7 Construction of a reporter gene “pathway” by Reiterative  
Recombination       109 
Figure 4-8 Construction of donor plasmids by plasmid gap repair  110 
Figure 4-9 Donor plasmid controls in the reporter gene “pathway” assembly 111 
Figure 4-10 Phenotypic analysis of cured recombinants from the reporter  
gene “pathway” assembly      112 
Figure 4-11 Genotypic analysis of cured recombinants from the reporter  
gene “pathway” assembly      113 
Figure 4-12 Maps of donor plasmids and the acceptor module integration  
fragment for Reiterative Recombination    120 
Figure 4-13 Reiterative Recombination timeline     123 
Figure 4-14 General design of subfragment homology regions for plasmid  
gap repair and Reiterative Recombination    124 
Figure 5-1 Modifying biosynthetic pathways for metabolic engineering 137 
Figure 5-2 Assembly of the lycopene biosynthetic pathway using  
Reiterative Recombination      142 
Figure 5-3 Assembly of an optimized lycopene biosynthetic pathway using 
Reiterative Recombination      145 
Figure 5-4 Construction of mock libraries of lycopene biosynthetic  
pathways via Reiterative Recombination    146 
Figure 5-5 Restriction analysis of cured recombinants from the lycopene  




Figure 5-6 Assembly and shuttling of the E. coli carotenoid biosynthetic  
pathway        150 























List of Tables 
Table 2-1 Strains used in this study      55 
Table 2-2 Plasmids used in this study      55 
Table 2-3 Oligonucleotides used in this study     55 
Table 3-1 Candidate counter selection reporter genes    72 
Table 3-2 Construction of URA3 counter selection strains   83 
Table 3-3 PCR amplification of candidate counter selection reporter genes 85 
Table 3-4 Strains used in this study      89 
Table 3-5 Plasmids used in this study      89 
Table 3-6 Oligonucleotides used in this study     90 
Table 4-1 Marker conversion efficiencies in Reiterative Recombination  
with decreasing lengths of homology     107 
Table 4-2 PCR amplification of subfragments for Reiterative  
Recombination       125 
Table 4-3 Strains used in this study      127 
Table 4-4 Plasmids used in this study      127 
Table 4-5 Oligonucleotides used in this study     128 
Table 5-1 Percentage of cells with the HIS LEU phenotype in cured  
recombinant pools from various rounds of Reiterative  
Recombination       147 
Table 5-2 Mock screen for lycopene-producing strains via Reiterative 




Table 5-3 PCR amplification of subfragments for Reiterative  
Recombination       158 
Table 5-4 Strains used in this study      162 
Table 5-5 Plasmids used in this study      163 





















List of Abbreviations 
(GSG)2 glycine-serine-glycine-glycine-serine-glycine linker 
5-FOA  5-fluoroorotic acid 
A  deoxyadenosine 
AD  transcriptional activation domain 
Amp
R
  ampicillin resistance 
Ax  absorbance at x nm 
bp  base pair 
°C  degrees Celsius 
C  deoxycytoside 
cAMP  adenosine 3′,5′-cyclic monophosphate 
Cm
R
  chloramphenicol resistance 
DBD  DNA-binding domain 
Dex  dexamethasone 
DHFR  dihydrofolate reductase 
DMF  dimethyl formamide 
DNA  deoxyribonucleic acid 
dNTP  deoxynucleotide triphosphate 
DSB  double-strand DNA break 
E. coli   Escherichia coli 
et al.  et alia 
FACS  fluorescence-activated cell sorting 
FPP  farnesyl pyrophosphate 
xiii 
 
g  gram 
G  deoxyguanosine 
G418  geneticin 
gal  galactose 
gDNA  genomic DNA 
GFP  green fluorescent protein 
GR  glucocorticoid receptor 
h  hour 
HRS  heritable recombination system 
IPP  isopentenyl pyrophosphate 
IPTG  isopropyl -D-thiogalactopyranoside 
Kan
R
  kanamycin resistance 
kb  kilobase 
kcat  catalytic turnover number 
Km  Michaelis constant 
L  liter 
LexAop operator binding a dimer of the LexA DNA-binding domain 
M  moles per liter 
MAGE multiplex automated genome engineering 
Magenta-Gal 5‑bromo-6-chloro-3-indolyl-β-D-galactopyranoside 
MAPK  mitogen-activated protein kinase 
Mb  megabase 
MCS  multiple cloning site 
xiv 
 
mg  milligram 
min  minute 
mL  milliliter 
Mtx  methotrexate 
nm  nanometer 
nM  nanomoles per liter 
NRPS  nonribosomal peptide synthase 
ODx  optical density at x nm 
OMP  orotidine-5'-phosphate 
ONPG  ortho-nitrophenyl--galactoside 
ori  origin of replication 
PACE  phage-assisted continuous evolution 
PCR  polymerase chain reaction 
PKS  polyketide synthase 
pM  picomoles per liter 
raf  raffinose 
RNA  ribonucleic acid 
rpm  revolutions per minute 
s  second 
S. cerevisiae Saccharomyces cerevisiae 
SC  synthetic complete 
SDS  sodium dodecyl sulfate 
t  time 
xv 
 
T  deoxythymidine 
UV  ultraviolet 
X-Gal  5-bromo-4-chloro-3-indolyl--D-galactopyranoside 
X-Gluc 5-bromo-4-chloro-3-indolyl--D-glucuronic acid 
Y2H  yeast two-hybrid 
Y3H  yeast three-hybrid 
YPD  yeast peptone dextrose media 
g  microgram 
L  microliter 

















First, let me acknowledge funding from the NIH and the NSF, and the NSF 
Graduate Research Fellowship in particular.  
I would like to thank my advisor, Professor Virginia Cornish, for being a mentor 
in the truest sense of the word.  Thank you for teaching me both the hard and soft skills of 
science, for keeping the big picture up front, and for giving me challenging problems to 
work on and so much freedom in chasing them down.  Thank you most of all for 
believing in my work and in me when I usually did not. 
My thanks also go to Professor Samuel Danishefsky and Professor Ruben 
Gonzalez for serving on my graduate committee, for their encouragement throughout 
graduate school, and for kindly providing recommendation letters as I began preparing 
for the next step of my career.   I am also grateful to Professor Lorraine Symington and 
Dr. George Ellestad for their willingness to serve on my thesis committee. 
Thanks to all the members of the Cornish laboratory, past and present, for making 
this a dynamic and stimulating place to learn and work.  Forgive me if I only call out a 
few of the wonderful people who passed through during my tenure here.  Dr. Pamela 
Peralta-Yahya, who initiated projects that directly or indirectly led to both of my major 
lines of work, was a role model of everything a graduate student should be and taught me 
most of what I know in the lab.  Vanessa Mondol taught me the rest while keeping the lab 
in line.  Dr. Dante Romanini and Nili Ostrov provided many invaluable discussions and 
manuscript critiques.  Nili also initiated the Stephanopoulos collaboration that led to 
much of Chapter 5, is taking ReRec in multiple new directions, and is my partner in 
crime for brainstorming.  One way or another, we will make it through our (top-secret) 
xvii 
 
bucket list of experiments.  Heather Horgan made these past five years happen and 
somehow shares an incredible number of my obscure interests.  I’m saving 8% of my 
love for you.  Undergraduate Chris Sosa and rotation students Cheng Wang and Timothy 
Kernan followed up on various aspects of Chapter 2, and Marie Harton is already doing a 
wonderful job of picking up the work of Chapter 3.  Last but not least, let me thank the ad 
hoc bioethics and gender issues “journal club” for discussions both thought provoking 
and entertaining, for preserving my sanity, and of course, for many excellent meals.    
I cannot thank the members of Calvary Baptist Church enough for adopting me 
into your family even before I was quite ready to be taken in.  In particular, I am so 
grateful to each member of Crossroads for shattering my complacency week after week 
and for sharing the same struggles in so many different corners of this crazy city.  My 
love goes to the Calvary Handbell Choir for getting me to Calvary in the first place and 
for teaching me much about music, worship, and fellowship.  Finally, thank you to the 
vibrant and amazingly talented Youth Handbell Choir for teaching me to lead and putting 
up with me in the meantime, for energizing me with your enthusiasm, and for always 
demanding the next challenge.  I’ve said it before and say it again—y’all are awesome. 
Moving beyond the island of Manhattan, my love and gratitude go out to the 
members of Olive Chapel Baptist Church, the village that raised me and shaped my faith, 
that has continued to support me and my family through some very dark days these past 
five years, and that makes some mighty fine barbecue.  Real barbecue. 
Most of all, my thanks to all of my family for loving me in spite of myself.  Most 
most of all, thank you to my parents, for everything and then some.  I ought to elaborate, 







Not that we are sufficient of ourselves to think of anything as being from ourselves,  
but our sufficiency is from God . . . 








































*The content of this chapter will be published in  




1.0 Chapter outlook 
Synthetic biology holds the promise of creating designer microorganisms that can 
address some of society’s most pressing needs, ranging from the production of biofuels 
and drugs to the detection of disease states or environmental contaminants.  Realizing 
these goals will require the extensive reengineering of cells at the systems level.  
However, the rational design of all but the simplest in vivo systems is difficult or 
impossible, even when extensively characterized systems and components are used.  By 
relying on iterative cycles of mutagenesis and selection rather than complete 
understanding of systems’ behavior, directed evolution has the potential to overcome the 
complexities of cell engineering.  While early examples of directed evolution in the 
context of in vivo systems provide strong evidence for the promise of this approach, the 
scope of these directed evolution experiments has been quite limited due to the technical 
difficulties associated with effecting genome-wide, targeted mutagenesis and assaying for 
any given function of interest.  Here we review existing and emerging methods that will 
allow both the mutagenesis and assay steps of directed evolution to be carried out at the 
systems level inside the cell.  An exciting consequence of performing the entire directed 
evolution cycle in vivo is the fact that we can now creatively harness the cell’s own 
processes and machinery for these tasks.  The novel strategies enabled by these advances 
have the potential to surmount the challenges of cell engineering and bring its enormous 







1.1 Directed evolution for in vivo systems 
Directed evolution has matured into a widely employed technology for 
engineering antibodies and antibody mimics, enzymes, and nucleic acid aptamers for use 
as therapeutics, diagnostics, and research reagents
1
.  The power of directed evolution lies 
in its ability to bypass limitations in our understanding of the relationships among 
biomolecules’ sequences, structures, and functions that make rational redesign difficult or 
impossible.   Instead, large “libraries” of biomolecules are generated using various 
strategies to mutagenize the encoding DNA, and those with the desired function are 
identified through screens or selections (Fig. 1-1A).  The mutagenesis and assay process 
can be iteratively repeated until the function of interest is obtained or optimized. 
 
With the advent of synthetic biology, the next challenge is to leap from 
engineering individual biomolecules in vitro to engineering multi-component systems 
Figure 1-1. (A) The directed evolution of biomolecules versus (B) the directed evolution of in vivo 
systems.  The directed evolution of in vivo systems will require advances in both the mutagenesis 
and assay steps. 
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that function in vivo
2
.  Under various appellations such as synthetic biologists, metabolic 
engineers, and cell engineers, researchers are already taking steps towards repurposing 
microorganisms as biosensors, “smart” therapeutics, and factories for biosynthesizing 
biofuels and drugs
3
.  However, if modifying the function of individual molecules is 
difficult, modifying cells for these sophisticated applications will be orders of magnitude 
more challenging.  Not only must the function of individual biomolecules within the 
system often be altered, but all components must interact productively with each other 
and with the intricate and incompletely understood network of existing cellular 
machinery.  Just as directed evolution impacted the engineering of biomolecules by 
solving problems at the limits of rational design, it now has the potential to overcome the 
complexity of engineering in vivo systems (Fig. 1-1B).   
Directed evolution approaches could help circumvent the intellectual bottlenecks 
impeding cell engineering, but implementing such strategies is hindered by the technical 
challenge of generating and effectively searching large libraries of variants in vivo.  At 
the end of the 20
th
 century, advances in recombinant DNA technology and high-
throughput assays, which exponentially increased the number of variants that could be 
tested at a time, were critical to making directed evolution the robust tool for the 
engineering of individual biomolecules that it is today.  However, most of these 
established directed evolution methods cannot be directly employed in contemporary 
efforts to carry out directed evolution on a larger scale and in the context of the cell.  
New technologies are needed to drive the transition from the engineering of biomolecules 
to the engineering of living cells.  In spite of the associated complications, moving 
directed evolution in vivo presents us with an intriguing opportunity—we can now 
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envision harnessing the power and elegance of natural biological processes to reengineer 
cells for our own purposes. 
In this chapter, we begin by presenting select examples from diverse fields that 
exemplify the rational design, directed evolution, and related library approaches being 
taken as we push the boundaries of our ability to reprogram cells for novel functions.  We 
then discuss the technical advances that will be required to adapt mutagenesis and 
selection for in vivo, multi-component systems and the methodologies that are emerging 
to address these needs.  We limit our discussion to the work that has been done on the 
relatively well-characterized microorganisms Escherichia coli and Saccharomyces 
cerevisiae, the hosts that are and will likely continue to be the workhorses of synthetic 
biology for the foreseeable future. 
1.2 Approaches to the engineering of in vivo systems 
1.2.1 Rational design 
One major thrust of the cell engineering community has been to characterize and 
standardize the behavior of biological “parts” (e.g., promoters, transcription factors, 
ribosome-binding sites), with the goal of being able to computationally design in vivo 
systems with predictable behaviors
4
.  An example where these efforts have borne fruit 
over the past decade is the refinement of artificial “genetic oscillators”5-7.  These circuits 
use series of transcription factors to create positive or negative feedback loops to achieve 
regular temporal undulations in the expression of a reporter gene.  The first-generation 
oscillator was far from ideal, as oscillations persisted for only three cycles and exhibited 
considerable noise in gene expression levels
5
.  After years of refinement, Stricker et al. 
reported highly robust genetic oscillators that continued to function for hours and had 
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periods that could be adjusted by altering growth conditions
7
.  The authors note that the 
key to the dramatic improvements in the oscillator design was modeling the circuit more 
comprehensively—incorporating not only genes’ transcription rates, but also parameters 
such as the translation, folding, and oligomerization of proteins.  They explicitly caution 
against “making simplifying assumptions in the design of engineered gene circuits”7. 
Nevertheless, the high profile of this and other
8-14
 examples of designed in vivo 
systems that are functional, robust, and reliable is evidence that reprogramming cells at 
will has not yet become a routine reality.  Notably, these successes have all been 
achieved for systems that were already exhaustively characterized, that involved only 
small numbers of genes (<10)
15,16
, and that were generally intended to be insulated from 
other cellular processes as much as possible.  As we push synthetic biology forward into 
more sophisticated applications such as metabolic engineering, exogenous components 
will need to be more deeply integrated with the host cells’ endogenous machinery, and 
individual circuits and pathways will need to be productively interwoven into highly 
sophisticated networks.  Given that we are only beginning to be able to design even 
simple systems, the routine design of engineered in vivo systems is not yet feasible.  
1.2.2 Library approaches 
 In light of our inability to build fully descriptive, predictive models of the cell, 
library approaches such as directed evolution are needed to allow researchers to move 
cell engineering efforts forward rapidly.  These strategies are already being implemented 
to optimize and diversify a variety of in vivo systems. 
Optimizing regulatory circuits.  Yokobayashi et al. used directed evolution to 
refine the performance of a genetic circuit
17
.  They began with a very simple framework 
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that looked as though it should be functional on paper—two transcriptional repressors 
placed in series should lead to the transcription of a reporter gene, but when the small 
molecule IPTG is added to inactivate the first repressor (lacI), the reporter’s expression 
should be turned off.  However, due to the noise of biological systems, such as finite 
amounts of transcription from leaky promoters, the original circuit never expressed high 
levels of the GFP reporter under any conditions.  The authors then mutated one of the 
repressors and its binding site to tune the sensitivity of the circuit and screened for cells 
that exhibited the desired change in GFP expression upon addition of IPTG.  This 
strategy led to the identification of a number of functional circuits without requiring any 
biochemical information on the system’s components to guide optimization attempts. 
Peisajovich et al. created a library of pathways by focusing on the level of protein 
rather than transcriptional regulation
18
.  They recombined the regulatory and catalytic 
domains from 11 proteins involved in the MAPK signaling pathway that leads to the 
mating response in S. cerevisiae following pheromone stimulation.  Expressing this 
library of chimeric proteins with the endogenous pathway provided strains that exhibited 
a range of kinetics in the mating response and some strains that had improved mating 
efficiencies. 
 Generating new regulatory topologies.  Guet and coworkers demonstrated that 
they could generate transcriptional regulatory circuits with a variety of topologies by 
combinatorially mixing and matching small sets of regulatable promoters (five) driving 
the expression of three transcriptional regulators
19
.  The resulting networks exhibited 
diverse qualitative and quantitative patterns of reporter expression with or without two 
small-molecule inducers.   
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Mody et al. were able to manipulate the architecture of signaling pathways in 
yeast by creating chimeras of Fus3p and Hog1p, related MAP kinases from the yeast 
mating and osmolarity response pathways, respectively
20
.  They found that when these 
chimeras were expressed in strains in which both endogenous MAP kinases were deleted, 
some chimeras were able to rewire the pathways (e.g., to activate the mating pathway in 
response to the osmolarity signal or to activate both the osmolarity and mating pathways 
in response to a single signal).   
Optimizing metabolic pathways.  The need to incorporate directed evolution 
approaches in to cell engineering efforts is being manifested even more clearly in the 
realm of metabolic engineering
21
.  Recent, high-profile breakthroughs in metabolic 
engineering
22-28
 have raised the tantalizing prospect of, ultimately, routinely 
biosynthesizing any desired biofuel, chemical feedstock, or natural product in tractable 
heterologous microorganisms.  Metabolic engineering poses an additional layer of 
complexity to cell engineering because it inherently perturbs cellular metabolism.  Even 
simply overexpressing a heterologous protein imposes a burden on cells
29,30
; pointedly 
disrupting metabolic flux can have even more profound, unanticipated effects, 
complicating rational optimization efforts
31
.  Without exception, intensive optimization 
of strains has been required to attain high-level production, or often any detectable 
production, of the target compounds.  To date, most of these optimization processes have 
proceeded in a laborious, stepwise fashion.  However, several elegant examples of using 






For example, Ajikumar et al. recently achieved high-yield production of 
taxadiene, the first committed intermediate in the biosynthesis of the potent 
chemotherapeutic taxol (paclitaxel), in E. coli by dividing the biosynthetic pathway into 
two modules and combinatorially varying the expression levels of enzymes in the two 
modules
25
.  This library approach pinpointed a promoter combination that gave a 15,000-
fold increase in taxadiene yield.  Analysis of other strains from the library also revealed 
that there was no simple relationship between expression levels and taxadiene production, 
and the global maximum for taxadiene yield fell within a very limited range of expression 
levels.  When analyzing lower-performing strains, they discovered that a completely 
unexpected metabolic byproduct, indole, accumulated through unknown mechanisms in 
most members of the library, inhibiting taxadiene production.  These results highlight our 
current inability to predict the cascading effects of disrupting delicately balanced cellular 
pathways.  
While most efforts to optimize metabolic pathways’ yields through library 
approaches have focused on tuning the expression levels of relevant genes
25,32,33
, Leonard 
and coworkers also incorporated protein engineering into optimizing biosynthesis of the 
diterpenoid levopimaradiene in E. coli
24
.   After maximizing flux towards universal 
terpenoid precursors by overexpressing genes in the non-mevalonate pathway, the 
authors discovered that geranylgeranyl diphosphate synthase and levopimaradiene 
synthase became the rate-limiting enzymes in the pathway.  Separately, they mutagenized 
both enzymes and identified variants with increased activities.  Replacing the wild-type 
proteins with these two improved variants, together with optimizing the production of 
10 
 
terpenoid precursors, increased levopimaradiene yields by a factor of approximately 
2,600. 
Diversifying metabolic pathways.  In addition to increasing yields of natural 
products, library approaches have also been used to biosynthesize natural product 
analogs
34
.  Perhaps the most impressive example has come from Kosan Biosciences, 
whose researchers placed the three modules of the small polyketide synthase (PKS) gene 
cluster for  6-deoxyerythronolide B on two plasmids for expression in E. coli and then 
replaced two of the modules with over ten variants each
35
.  Co-transforming all possible 
combinations of plasmids led to the production of 154 different pathway variants, almost 
half of which produced detectable levels of the expected triketides.   
While the modularity of assembly-line enzymes such as PKSs and nonribosomal 
peptide synthases (NRPSs) provides enormous potential for combinatorial biosynthesis, 
chimeric enzymes derived from mixing and matching modules often have poor or no 
activity.  Fischbach et al. addressed this problem with directed evolution
36
.  After 
replacing a valine-specific domain of the hybrid NRPS-PKS cluster that produces 
andrimid with a heterologous isoleucine-specific domain, the yield of the andrimid 
analog was only a seventh of andrimid yields from the wild-type pathway.  Mutagenesis 
of the isoleucine domain by error-prone PCR led to the identification of a domain variant 
that increased the analog’s yields 4.5-fold. 
1.3 Mutagenesis technologies for systems-level directed evolution 
Despite the widespread adoption of directed evolution approaches for 
biomolecule engineering, and despite the apparent advantages of analogous strategies for 
cell engineering, examples of carrying out controlled directed evolution experiments for 
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cell engineering applications remain relatively few.  The reticence of the field to fully 
embrace this strategy undoubtedly stems from the technical challenges that accompany 
translating directed evolution approaches for biomolecules to in vivo systems.  It is telling 
that in the small number of systems-level directed evolution experiments reported, such 
as those described above, researchers have typically only interrogated one or two 
components of a more complex system. 
The first technical advance required for systems-level directed evolution will be 
the ability to mutagenize numerous, defined loci.  Efficient methods for mutating 
individual genes have been developed for model organisms such as E. coli and S. 
cerevisiae
37,38
.  However, these techniques are not useful for mutating multiple genes 
because 1) they are too time-consuming for or incompatible with iterative mutagenesis 
and/or 2) their efficiencies drop precipitously when used to mutagenize multiple loci in 
parallel.  It is important to recognize that many cell engineering applications will require 
both modification of heterologous genes that are newly introduced into the host cell and 
of the cell’s genetic background.  The strategies that are emerging to effect mutagenesis 
at the systems level can be divided into two broad categories—in vitro mutagenesis of 
DNA, followed by subsequent introduction into the desired host cell, and in vivo 
mutagenesis of DNA directly in the cell (Fig. 1-2). 
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1.3.1 In vitro mutagenesis of DNA 
The first option, in vitro mutagenesis of DNA, is primarily applicable only to 
exogenous constructs introduced into host cells and not to mutation of the strain’s genetic 
background.  In vitro mutagenesis has the advantage of being able to utilize the wealth 
and wide variety of existing mutagenesis techniques that have been developed for the 
directed evolution of individual biomolecules
39,40
.  A rich spectrum of diversification 
patterns can be achieved through these methods—ranging from entirely random 
mutations to site-specific modifications to the shuffling of fragments from related 
molecules.  Importantly, many of these mutation techniques are very straightforward 
molecular biology protocols that could easily be multiplexed to mutate numerous genes 
in parallel.  As the cost of DNA synthesis continues to drop, high-throughput gene 




Figure 1-2. Mutagenesis strategies for systems-level directed evolution.  DNA can either be (A) 




The main challenge associated with applying in vitro mutagenesis techniques to 
systems directed evolution is moving the mutated DNA into the cell in a manner that is 
efficient enough to cover large library sizes.  As discussed above, the stepwise 
introduction of mutated genes into the cell one at a time using standard genetic 
techniques is arduous and impractical.  To streamline this process, the mutated DNA of 
individual genetic components must somehow be assembled, either in vitro or in vivo. 
A plethora of in vitro enzymatic methods specifically designed to accurately 
assemble multi-gene constructs have been introduced in recent years
35,42-51
.  These 
techniques are typically derivatives of routine molecular biology procedures, but the 
robustness and stringency of assembly have been greatly improved to enforce accurate 
assembly for large constructs.   A number of these protocols have been applied to the 
construction of impressively large DNA molecules from tens to hundreds of kilobases in 
length, and some of them have efficiencies high enough to theoretically be useful for 
making libraries, which we define as being able to generate at least 10
3
, but preferably 
closer to ≥108 variants at a time.  However, the few methods that have actually been 
tested in the context of library construction have only been used to build rather small 
collections of pathways (≤102 variants)52. 
The main drawbacks of these in vitro assembly methods are the technical 
difficulty of manipulating large, fragile DNA pieces in vitro
16
 and the fact that they do 
not inherently solve the problem of moving the assembled DNA into the cell.  Even for 
constructs that are located on plasmids, as the size of DNA constructs increases, there is a 
corresponding decrease in the efficiency with which it can be transformed into cells, and 
thus the achievable in vivo library size
53,54
.  For many applications, it is necessary to 
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integrate constructs into the chromosome to improve strains’ stability and control the 
exogenous genes’ copy number55-57.  Integration protocols proceed with even lower 
efficiencies than plasmid transformations, especially for large DNA constructs
58
. 
The alternative to in vitro assembly is exploiting cells’ endogenous homologous 
recombination machinery to stitch together numerous DNA fragments in vivo
57,59-63
.  In 
vivo assembly is quite straightforward technically, as it only requires transformation of 
DNA pieces into the host cell, and has been used by expert laboratories to build even 
genome-sized (>100-kb) molecules
57,62,63
.  Several methods further allow for the 
integration of large DNA constructs into the chromosome
57,59,60
.  However, even in 
organisms with efficient homologous recombination machinery, such as Bacillus subtilis 
and S. cerevisiae, these assembly methods proceed with very low efficiencies, generating 
only tens to hundreds of recombinants at a time and making them infeasible for the 
generation of in vivo libraries.    Robust and high-yielding methods for assembling DNA 
in vivo will be required before libraries of multiple heterologous genes mutated in vitro 
can installed in the cell efficiently enough to be useful for directed evolution library 
construction (see Chapters 4 and 5). 
1.3.2 In vivo mutagenesis of DNA 
A new wave of technologies is now emerging to mutagenize DNA directly in 
living cells in a targeted manner.  These methods will provide a critical advance for the 
field by enabling mutagenesis not only of DNA newly introduced into the cell but also of 
multiple loci in the host cell’s genome. 
In some respects, in vivo mutagenesis has been utilized for decades.  Chemical 
mutagens, UV radiation, and mutator strains are all classic methods for evolving strains’ 
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phenotypes, but they suffer from obvious issues of toxicity and do not allow mutations to 
be targeted to specific loci
40,64
.  Given that the number of possible combinations of 10 
point mutations in the E. coli genome (~10
72





, these fully random mutagenesis methods are an extremely inefficient way 
to introduce diversity for most applications.  Furthermore, it is difficult to recover 
information on what mutations contributed to improvements in phenotype to guide future 
directed evolution experiments
66
.  Loeb et al. have developed a next-generation mutator 
strain that employs a mutant DNA polymerase to focus enhanced mutagenesis to a 
plasmid of interest
67
.  However, this strain still suffers from toxicity issues and does not 
allow at-will modification of the genome. 
As with in vivo DNA assembly, homologous recombination seems to be 
presenting itself as the most general and broadly applicable solution for targeted in vivo 
mutagenesis.  Wang et al. recently described multiplex automated genome engineering 
(MAGE), a powerful platform for introducing modifications throughout the chromosome 
of E. coli
32
.  MAGE takes advantage of the body of work from the Court laboratory 
showing that expressing the recombination machinery from the -Red bacteriophage in a 
mismatch repair-deficient E. coli strain promotes high-frequency mutagenesis of the 
chromosome by single-stranded oligonucleotides transformed into the cell
68,69
.  Wang et 
al. optimized the conditions for this “recombineering” system so that they could reliably 
introduce deletions, replace sequences, or make short insertions (<~30 bp) with 
efficiencies of up to ~30%.  By then automating the procedure to allow repeated cycles of 
transformation and mutagenesis, they mutagenized the ribosome binding sites of twenty 
genes that were known to affect yields of the terpenoid pigment lycopene in E. coli, 
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calculating that they generated >10
10
 variants in the course of 35 rounds of mutagenesis.  
Screening a small fraction of this diversity (10
5
 colonies) yielded variants with up to a 
~5-fold increase in lycopene production over the parental strain, and sequencing of a 
number of mutants provided insight into key parameters affecting yields. 
As part of a Heritable Recombination System (HRS) (see Section 1.5), our 
laboratory has developed an efficient in vivo mutagenesis method for S. cerevisiae
70
.  We 
place “cassettes,” consisting of a mutagenic region flanked on either side by short (~30 
bp) homology regions targeting the gene of interest, between two homing endonuclease 
recognition sites in a plasmid.  Following induction of endonuclease expression to cleave 
the cassette plasmids, we observe high-efficiency (~5%) homologous recombination with 
the target DNA sequence.  Since not all cassette plasmids are cleaved and yeast can 
undergo sexual reproduction, mutations and cassette plasmids can subsequently be 
exchanged among populations of cells to accumulate mutations in multiple genes.  
Though we initially demonstrated this technology using plasmid-based target genes, this 
same iterative mutagenesis strategy should be extendable to chromosomal modifications 
in subsequent versions of the HRS. 
The breadth of types of genetic modifications that can be accessed via in vivo 
mutagenesis is also beginning to rival that of in vitro mutagenesis.  For example, Bikard 
et al. have harnessed another natural mechanism for diversifying genomes, the integron 
of Vibrio cholera, to shuffle genes within a defined pathway in E. coli
71
.  Integrons 
employ an integrase, a site-specific recombinase enzyme, to excise members of an array 
of DNA cassettes flanked by recombination sites and integrate the cassettes into a 
primary recombination site
72
.  Adapting this system to create a “synthetic integron,” 
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Bikard et al. placed the genes for tryptophan biosynthesis between recombination sites, 
initially preventing their expression by placing transcriptional terminators within the 
pathway.  Expression of the integrase to induce recombination, followed by selection for 
growth in the absence of tryptophan, led to the identification of pathways in which the 
terminators had been excised, some of which also had rearrangements and duplications in 
the biosynthetic genes.  While the frequency of cassette shuffling events (~10
-4
 for a 
single reordering event) is currently too low to be useful as the sole mutagenesis strategy 
in most directed evolution experiments, optimization of recombination or coupling of this 
method to a robust selection strategy capable of searching very large library sizes (see 
Section 1.4) could reach into new areas of genetic diversity. 
1.4 Assay methods for systems-level directed evolution 
 The second broad challenge in systems-level directed evolution will be 
developing suitable high-throughput assays, either screens or selections, to evaluate the 
performance of variants.  In screens, each library member must be assayed individually, 




even with automation techniques.  Selections, by 
contrast, are designed such that only the desired variants survive; much larger libraries 
(≥108) can be tested because the vast majority of variants do not have to be analyzed 
explicitly.  It is worth noting that a screen of 10
5
 would have to be carried out every day 
for over two and a half years to test a library of 10
8
.  Considering the tremendous number 
of variables that need to be interrogated in the context of in vivo directed evolution 
experiments, the use of selections whenever possible will be essential. 
 At their most basic level, the diverse objectives being pursued by cell engineers 
can roughly be divided into two categories: obtaining variants with defined response 
18 
 
patterns and obtaining variants with a defined output.  These manifold applications need 
to be linked to assays that have both high throughput (the ability to identify one cell with 
the desired output from 10
n
 lacking it) and sensitivity (the ability to distinguish n-fold 
differences in the output) (Fig. 1-3).     
 
1.4.1 Assays for defined output patterns 
 The first common scenario is that researchers are trying to create cells that exhibit 
a certain response pattern; examples of this include the creation of regulatory circuits 
(Section 1.2) and the longer-term goal of fashioning cell-based biosensors.  In these 
cases, the actual identity of the output is secondary and a matter of choice, meaning that 
reporters providing the best throughput and sensitivity can be utilized (see Section 1.4.3).  
The challenge for these systems will be customizing and calibrating these reporters to 
ensure that they perform optimally in a given system. 
1.4.2 Assays for defined outputs 
 For other applications, such as metabolic engineering, the objective is to engineer 
cells to provide a specific output, such as the production of a particular chemical 
compound (Section 1.2).  The challenge for these endeavors is finding means to couple 
the output of interest to a high-throughput assay.  Most small molecules, for example, do 
not have chromophores or other distinctive, measurable properties that allow them to be 




detected directly even in medium-throughput microtiter plate assays.  Instead, their 
production must be analyzed using liquid or gas chromatography-mass spectrometry, 
placing an absolute cap of <10
3
 on the number of variants that can be tested
21
.  The 
frustration with this bottleneck in screening throughput has actually altered the course of 
research in the field of metabolic engineering.  Instead of pursuing the highest-impact 
targets, researchers continually re-optimize the production of a few readily assayable 
compounds
31,32,73
, such as the terpenoid pigment lycopene that confers an orange 
phenotype on colonies, hoping that they will at least serve as imperfect surrogates for 
more valuable molecules
24,74
.   
 Linking sundry outputs to robust assays is not a new problem; researchers have 
long struggled with how to assay individual biomolecules both in vitro and in vivo.  Some 
of the many creative solutions developed for biomolecules should be able to translate to 





 conversion of the biosystem’s initial output to create 




 Ideally, these assay strategies should be as general and modular as possible both 
to maximize the scope of their utility and to enable coupling to the readout of choice.  
Yeast hybrid systems (and their derivatives in other organisms) provide elegant examples 
of such versatility in assays for biomolecules (Fig. 1-4).  Based on the artificial coupling 
of a DNA-binding and transcription activation domain to create a transcriptional 












interactions to be coupled to the expression of a reporter gene of choice.  Our laboratory 
further elaborated the yeast three-hybrid assay to permit the detection of enzymatic 
activity via “chemical complementation”84, allowing enzymatic reactions that previously 





, to be coupled to an in vivo growth selection.  Devising equally flexible 
assay methods should be an invigorating pursuit for the cell engineering community. 
 
1.4.3 Achieving throughput and sensitivity in in vivo assays 
 What readouts can provide the throughput and sensitivity needed for systems-
level directed evolution experiments?  The most difficult criterion to satisfy will be 
throughput.  Two assay methods that are compatible with in vivo systems have the 
Figure 1-4. Yeast n-hybrid systems. The yeast one-hybrid (A), two-hybrid (B), three-hybrid (C), 
and chemical complementation (D) systems provide a model for coupling diverse functions to a 




potential to search libraries ≥108 in size—fluorescence activated cell sorting (FACS) and 
growth selections.  
 Though technically a screen rather than a selection, FACS can analyze and sort 
cells at rates of up to 10
7




 are achievable in 
directed evolution experiments
87-89
.  The fluorescence readout that can most readily be 







 of a fluorescent protein such as GFP.  GFP is already commonly used as a 
reporter gene for many cell engineering applications such as the refinement of genetic 
circuits (Section 1.2).  In addition, emulsion techniques have expanded the range of small 
molecule-based fluorescent readouts that are compatible with FACS
89
.  The quantitative 
fluorescence signal measured by FACS means that sensitivity is inherently built into the 
assay.  However, for some applications, the analysis of single cells can be problematic 
since stochastic cell-to-cell variations are not averaged out over a population
21
.  The 
primary drawback of FACS that will limit its utility the most is the high cost of the 




 Growth selections are a second means to achieve very high assay throughputs in 
vivo; the majority of directed evolution experiments that have achieved the most 
impressive functional changes (e.g., large shifts in enzyme substrate specificity) in 
individual molecules have employed such selections
92-94
.  As with GFP, the most 
versatile means to link an arbitrary output of interest to a growth selection is by the 
expression or activation of a protein required for growth under certain conditions, 
typically auxotrophic markers or antibiotic resistance markers. 
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The sheer simplicity and accessibility of growth selections advocates for their 
broader use in directed evolution for cell engineering applications, but there will be 
several challenges associated with appropriating these classic genetic assays.  These 
reporter genes have historically been employed by geneticists as digital “on/off” markers 
for purposes such as plasmid maintenance or gene knockouts.  When placed in the 
context of more sophisticated systems, where issues such as basal reporter gene 
transcription will be present, they may not maintain the throughputs of ≥108 that can be 
achieved in genetic screens (see Chapters 2 and 3).  In addition, the sensitivity of these 
growth selections to intermediate levels of activation is underdetermined.   
The first step towards overcoming these issues will be rigorous characterization 
and optimization of the throughput and sensitivity of these growth selections. The 
collective experience from the biomolecule directed evolution field has drilled home the 
lesson that careful analysis of in vitro assays’ performance parameters is critical, but this 
step has often been neglected in early examples of the application of in vivo growth 
selections.  Second, if growth selections are not sufficiently effective, simple changes to 
the strain background, growth conditions, or the reporter gene itself (e.g., destabilizing 
the protein product) can often drastically improve or modulate growth selections’ 
throughput and sensitivity
95-97
.  Thinking more creatively, our increasing knowledge of 
how to construct simple genetic circuits could be put to use to construct feedback loops 
and other regulatory mechanisms to decrease basal transcription, amplify small 
differentials in transcription, and adjust the threshold of the output required to obtain 
robust growth
11,98,99
.  We have further suggested identifying new selectable markers, 
beyond those traditionally used by geneticists, that might provide throughputs and 
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sensitivities better matched to contemporary needs (Chapter 3).  Here again, directed 
evolution can be an effectual strategy to refine and optimize the performance of these 
selection systems.     
1.5 Continuous in vivo directed evolution 
 The developing technologies to mutagenize and assay living cells at the systems 
level are moving us closer towards the ultimate goal of achieving continuous in vivo 
directed evolution.  Fully integrating in vivo mutagenesis and assay techniques will 
obviate the need to move DNA in and out of the cell at every round of directed evolution, 
eliminating the transformation barrier that is currently the absolute cap on library size, 
while permitting us to retain molecular control over the evolutionary process.  The Liu 
laboratory and our own have recently made strides towards this vision, describing 
frameworks that are compatible with performing multiple consecutive rounds of in vivo 
directed evolution.   
Liu and coworkers’ phage-assisted continuous evolution (PACE) system100 uses 
an automated bioreactor system to evolve a bacteriophage population.  After the phage 
library infects E. coli, expression of a phage-encoded gene with the activity of interest is 
coupled to the expression of a phage coat protein.  This coat protein required for the 
phage to be infectious, but it is encoded only by a gene in the host.  As the phage 
replicate in E. coli, high rates of mutagenesis are achieved using a non-targeted, mutator 
strain-type approach.  Cells continually flow through the reactor; therefore the phage’s 
progeny must receive sufficient coat protein to rapidly infect a new host cell before they 
are “washed out.”  Though the authors evolved only an individual protein, T7 RNA 
polymerase, in their initial report, PACE could conceivably be applied to the directed 
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evolution of pathways.  However, since fresh E. coli cells are infected in each round of 
phage evolution, PACE will be incompatible with mutation of the host’s chromosome. 
Our laboratory has developed a Heritable Recombination System (HRS) in yeast 
permitting continuous in vivo directed evolution that also incorporates genetic exchange 
among evolving populations
70
 (Fig. 1-5A).  As described above (Section 1.3.2), 
mutagenesis is effected by endonuclease cleavage of cassette plasmids.  Since some 
cassette plasmids survive cleavage, cells can exchange cassette plasmids between each 
round of mutagenesis by utilizing yeast’s sexual reproduction cycle, invoking natural 
evolutionary mechanisms.  In our first-generation HRS, we demonstrated that we could 
sequentially mutagenize two selectable markers carried on a plasmid, repairing stop 
codons engineered into the sequence that inactivated the gene products, without ever 
removing the DNA from the cell.  Furthermore, even if we transformed cells with 
libraries of cassette plasmids containing a 10
6
-fold excess of stop codons relative to wild-
type codons, we were able to recover the doubly-repaired plasmid, demonstrating that we 
were generating very large library sizes in vivo.   
Combining in vivo mutagenesis with genetic exchange opens up intriguing 
possibilities for the directed evolution field.  Since libraries of variants can be crossed via 
sexual reproduction after they are initially installed by transformation, library sizes 
exceeding the transformation limit can be accessed.  Perhaps even more significantly, 
winnowing of individual libraries through selection before sexually combining them 
could allow the “virtual search” of exceptionally large libraries that surpass even the 
number of cells that can be grown in high-density culture (Fig. 1-5B).  This winnowing 
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approach would be analogous to the use of pruning algorithms in computational biology 





 By analogy to the directed evolution of biomolecules, the directed evolution of in 
vivo systems can energize the field of cell engineering.  While computational approaches 
have been making steady advances in recent years, the rational design of in vivo systems 
is far from a solved problem even for simple, exhaustively studied systems.  A direct 
parallel can be seen here to the field of computational enzyme design, where after 
decades of work experts are just now finally beginning to be able to design enzymes de 
novo for very well-characterized reactions
103-105
.  Even here, small libraries (~10
2
) of 
designed enzymes must be tested to identify functional catalysts, and the resulting 
Figure 1-5. Continuous in vivo 
directed evolution incorporating 
genetic exchange. (A) Our 
heritable recombination system  
(HRS) allows the crossing of 
beneficial mutations through 
mating and sporulation. (B) 
Winnowing and then crossing 
individual libraries could allow 
the virtual search of extremely 
large library sizes.  Grayed 
cells represent strains never 





enzymes have low activities
106
.  As we now attempt to engineer not only individual but 
also entire systems of biomolecules to function in living cells, it is clear that directed 
evolution approaches that circumvent intellectual bottlenecks will be essential for rapid 
progress. 
Elegant new approaches are already emerging to address many of the technical 
challenges associated with creating and searching large libraries of variants in vivo.  In 
spite of the complications that accompany moving into the cell, this transition offers us 
the opportunity to appropriate and redirect biological mechanisms that directed evolution 
practitioners have long attempted to mimic in vitro, such as mutagenesis based on 
homologous recombination and sexual reproduction.  As technologies for the systems-
level in vivo directed evolution mature, we will be able to weave mutagenesis and assay 
techniques into continuous, streamlined processes.  This combination of faithfully 
recapitulating natural evolution while still retaining molecular control over the process 
will allow us to explore biological diversity in creative new ways and help us realize the 
potential of cell engineering. 
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*The content of this chapter will be published in  
L.M. Wingler, V.W. Cornish. “An Experimental Framework for the Characterization and 
Optimization of Yeast Hybrid Selections,” in preparation.  
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2.0 Chapter outlook 
Growth selections can provide powerful, very high-throughput assays for in vivo 
directed evolution experiments.  Most growth selections used for directed evolution are 
adapted from selectable markers used for conventional genetic applications, but it has 
been underexplored whether these markers retain their high throughputs—their ability to 
search libraries of ≥106—in more complex, engineered systems.  Rigorous 
characterization of the performance of these standard markers in the context of the 
specific application of interest will be imperative for their effective use in directed 
evolution.  In this chapter, we develop an experimental framework to quantitatively 
assess the performance of yeast two- and three-hybrid growth selections and apply it to 
optimization of the throughput of the yeast two-hybrid LEU2 growth selection.   This 
framework is based on 1) comparison of the efficacy of the selectable marker in systems 
of increasing complexity, 2) detailed analysis of strains’ growth, and 3) mock selections 
for enrichment, which are facilitated by a colorimetric enrichment assay that can be 
performed in medium throughput.  For yeast two- and three-hybrid systems utilizing the 
LEU2 reporter, throughputs were found to be comparable to each other but lower than 
when LEU2 was used as a digital “on/off” marker, as it is in conventional genetic 
selections.  Based on information obtained by analyzing the growth of these strains, we 
were able to make very simple modifications to the yeast two-hybrid selection protocol 
that improved its enrichment factor by two orders of magnitude and enabled large 
libraries of up to 10
7
 to be searched.  These results underscore the importance and value 
of quantitatively characterizing and optimizing growth selections as they are harnessed 




 Directed evolution holds promise for creating designer proteins for use as 
reagents and biosensors and for industrial applications such as bioenergy production.  
Progress in the directed evolution field over the past two decades shows that the key to 
achieving ever more dramatic changes in function is library size
1
.  Screens of ~10
5
 
variants can be carried out with miniaturization of traditional assays for protein functions 
in a microtiter plate format.  To test larger numbers of variants, however, selections are 
needed, where only the “winners” survive.   
Yeast two-hybrid (Y2H) and three-hybrid (Y3H) systems represent potential 
methods for linking protein-protein and protein-small molecule interactions, respectively, 
to in vivo growth selections for directed evolution applications (Chapter 1, Fig. 1-4)
2,3
.  
Functional interactions involving the protein of interest reconstitute a transcriptional 
activator that leads to the expression of a reporter gene, which can be a selectable marker.  
Our laboratory’s version of the yeast three-hybrid system uses the chemical dimerizer 
Dexamethasone-Methotrexate (Dex-Mtx) to reconstitute a transcriptional activator from 
LexA-dihydrofolate reductase (DHFR) and B42-glucocorticoid receptor (GR) fusion 
proteins
4
.  By elaborating upon this three-hybrid scaffold, we further developed chemical 
complementation, which provides a general platform for linking enzymatic activity to 
reporter transcription via covalent coupling of Dexamethasone- and Methotrexate-
derivatized substrates
5
.  Using chemical complementation, we can now couple arbitrary 
enzyme activities to an in vivo growth assay for directed evolution
6
.   
For yeast n-hybrid-based selections to be useful for demanding applications in the 
field of directed evolution, they must be able to enrich active variants from a pool of ≥106 
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less active variants.  Selectable markers that complement strains’ auxotrophies or confer 
drug resistance exhibit these very high throughputs in the context of traditional genetic 
applications, such as plasmid maintenance or gene knockouts.  However, it is 
underdetermined whether these markers retain their throughputs when appropriated for 
more complex synthetic biology applications such as yeast hybrid systems.  Typically 
only qualitative analysis of growth selections is performed, and the focus of these studies 
has been on determining the sensitivity (i.e., the correlation between binding affinity and 
growth for yeast two- and three-hybrid systems) rather than the throughput of these 
assays
7,8
.   
Here, we develop an experimental framework to quantitatively monitor 
enrichment in yeast hybrid-based assays and identify key junctures for optimization.  Our 
characterization strategy is based on three principles.  First, using a reductionist 
approach, we evaluate the performance of the growth selection as layers of complexity 
are added in a stepwise manner—testing the performance of the reporter gene when used 
as a digital (“on or off”) selectable marker as in standard genetic applications, then as a 
yeast two-hybrid and finally a yeast three-hybrid reporter.  Second, we collect detailed 
data on the growth of these strains to identify potential ways to optimize enrichment.  
Third, we use mock selections to explicitly determine the throughput of these selections, 
developing a medium-throughput colorimetric assay to easily monitor enrichment.  We 
apply this methodology to characterize and optimize the performance of the LEU2 
reporter gene in the yeast two- and three-hybrid assays, resulting in a >300-fold increase 
in the enrichment factor.  This basic characterization framework should be useful not 
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only for yeast hybrid assays but also more generally for the application of reporter genes 
to directed evolution and synthetic biology. 
2.2 Results 
2.2.1 An experimental framework for characterizing yeast hybrid LEU2 growth 
selections 
We chose the LEU2 reporter gene as a model system to develop our experimental 
framework for characterization of yeast hybrid selections.  The LEU2 gene encodes the 
-isopropylmalate dehydrogenase enzyme required for leucine biosynthesis in 
Saccharomyces cerevisiae
9
 and is a commonly used auxotrophic marker for routine yeast 
manipulations
10
 and for the yeast two-hybrid assay
8
.  We previously used this selectable 
marker to convert our Dex-Mtx yeast three-hybrid system and chemical complementation 
into growth selections, and we demonstrated that we could search small libraries (10
2
) of 
glycosynthase enzyme variants using plate-based growth selections
6
.   
We wanted to adapt yeast hybrid LEU2 selections for liquid culture, which should 
have a number of advantages for more demanding directed evolution experiments.  First, 
larger libraries can be searched in high-density liquid culture selections than in selections 
on plates
11
.  Minimizing selection volumes will be particularly important for the 
expanded use of the yeast three-hybrid and chemical complementation selections, which 
require compounds that can be challenging to synthesize in large quantities
12
.  Second, 
members of the library are forced to directly compete against each other for resources.  






We began by constructing a series of strains to evaluate the performance of LEU2 
as a reporter for the yeast two- and three-hybrid systems.  We also constructed analogous 
strains allowing us to determine the maximum attainable efficacy of the LEU2 selection 
under the conditions of the hybrid assays—that is, when LEU2 is simply used as a marker 
gene that is expressed from its endogenous promoter.  For each system, two strains were 
constructed—a “positive” strain containing all constructs required to activate LEU2 
transcription under selective conditions and a “null” strain lacking one of the requisite 
constructs (i.e., the B42 activation domain (AD) fusion protein for the hybrid systems or 
LEU2 under the control of its endogenous promoter for the LEU2 marker system) (Fig. 
2-1).  Each strain also contained a constitutively expressed colorimetric marker gene, 
either gusA (-glucuronidase), which causes colonies to turn blue in the presence of the 
compound X-Gluc, or lacZ (-galactosidase), which causes colonies to turn red in the 
presence of the compound Magenta-Gal.  These colorimetric markers gave us a medium-




2.2.2 Characterization of enrichment in LEU2 selection systems 
 Next, we characterized the baseline throughput of the LEU2 marker, two-hybrid, 
and three-hybrid systems.  We performed mock selections in which the positive strain for 
each system was diluted with increasing excesses of the null strain and subjected the cell 
mixtures to selective conditions.  We performed these mock selections at relatively high 
cell densities (~3x10
7
 cells/mL) to push the limits of the LEU2 selection and to enable us 
to search large libraries of up to 10
7
 in even in small (<5 mL) culture volumes.  As shown 
in Figure 2-2, the addition of a constitutively expressed colorimetric marker gave us a 
convenient assay to easily track enrichment in these mock selections.  At various time 
points, aliquots of selections were plated on non-selective media, and the proportion of 
positive and null cells in the population could be determined simply by counting the 
number of blue and red colonies.  Importantly, since several hundred colonies from the 
Figure 2-1. Strains for the characterization of yeast hybrid LEU2 selections. In “positive” strains 
for the (A) plasmid-based LEU2 marker (B) the yeast two-hybrid (C), and the yeast three-hybrid 
systems, all constructs required to activate LEU2 transcription were present.  In otherwise 
isogenic “null strains,” the shaded construct for each system was absent so that LEU2 
transcription should not be activated.  In the LEU2 marker system, strains also contained LexA-
DHFR and the DNA-binding domain (DBD) binding site-LEU2 reporter gene to facilitate a more 
direct comparison to the hybrid systems.  For the yeast two-hybrid system, “BAIT” and “TARGET” 





non-selective plates could be counted, this colorimetric assay allowed us to detect when 
the positive strain comprises >~1% of the population.  In a real directed evolution 
experiment, this would be the minimum enrichment required to detect true hits in a 
secondary screen of ~100 colonies, the maximum number it would be feasible to analyze 
with most low-throughput assays.   
 
As shown in Figure 2-3, the ability of positive strains to overtake selections 
decreases in the more complex hybrid systems.  When LEU2 was used as a marker gene 
expressed from its constitutive promoter, the positive strain readily overtook the 
Figure 2-2. A colorimetric assay to monitor enrichment.  As shown for the yeast three-hybrid 
system as an example, null and positive strains constitutively express -galactosidase (lacZ, red) 
and -glucuronidase (gusA, blue), respectively.  To analyze the progress of mock selections, 
aliquots of cells from selections were plated on non-selective media at various time points.  After 
colonies grew, the compounds X-Gluc and Magenta-Gal were used to assay for -glucuronidase 
and -galactosidase, respectively, and red and blue colonies were counted to determine the 




population, representing approximately ~40% of the population after six days of selection 
under these conditions, even when initially diluted by a factor of up to 10
7
.  The yeast 
two-hybrid and three-hybrid positive strains, by contrast, always comprised a lower 
proportion of the population than the LEU2 marker positive strain at the same time points 




2.2.3 Characterization of strains’ growth in LEU2 selection systems 
 We then collected detailed growth curves for the null and positive strains under 
selective conditions to identify potential sources of the observed differences among these 
three systems.  The difference in growth for the three positive strains lies in the length of 
Figure 2-3. Assessment of the throughput of 
LEU2 selection systems.  Mock selections 




) for the 
LEU2 marker, yeast two-hybrid, and yeast 
three-hybrid systems were assayed to 
determine the percentage of null and positive 
cells in the population after (A) 0, (B) 3, (C) 
and 6 days of selection using the colony color 
assay described above.  Mock selections were 
performed in synthetic media containing 2% 
galactose, 2% raffinose, lacking tryptophan, 
histidine, and leucine.  Yeast three-hybrid 
selective media also contained 1 M 
Dexamethasone-Methotrexate.  Error bars are 
the standard error of three replicate selections.  




the lag phase before growth begins (Fig. 2-4).  All positive strains have essentially 
identical growth rates, with doubling times of 3.5-4 hours during the exponential growth 
phase.  This is consistent with previous reports that LEU2 behaves as a “threshold 
reporter”8; a minimum level of transcription is required for growth to begin, but growth 
rates are independent of transcription levels above this threshold.  As expected, none of 
the null strains grew significantly.   
  
The LexA and B42 fusion proteins are driven by the galactose-inducible and 
glucose-repressed GAL1 promoter.  The observed lag phase for the positive hybrid strains 
relative to the LEU2 marker strain could be due to the time required to synthesize the 
fusion proteins after moving cells into galactose-containing media at the beginning of the 
selection, before which LEU2 transcription cannot even begin.  Accordingly, we looked 
at the effect of inducing fusion protein expression before beginning selections.  After 
testing a wide variety of pre-induction conditions, we found that growing the yeast two-
hybrid positive strain in non-selective galactose media for 24 hours before beginning the 
selection essentially eliminated the lag phase (Fig. 2-5).   
Figure 2-4. Growth of LEU2 
selection system strains under 
selective conditions.  Media 
composition was as in Figure 
2-3.  Error bars are the standard 
error of six replicates. Note that 






2.2.4 Optimization of enrichment in the yeast two-hybrid LEU2 selection 
 Finally, we used the information from the growth curves to optimize the 
throughput of the yeast two-hybrid LEU2 selection.  Applying the galactose pre-induction 
of fusion protein expression to mock selections increased the percentage of positive cells 
in the selection population under most conditions (Fig. 2-6).  In particular, the positive 
strain from a 10
5
 library was enriched to a significant proportion of the population 
(>10%) at earlier time points (3 days), and it could be reproducibly enriched to detectable 
levels even from libraries of 10
7
.  This equates to an over 70-fold increase in the 
enrichment factor for the galactose pre-induction as compared to the glucose pre-
induction at the same time point, where the enrichment factor is defined as
14
:  
 nrichment factor   
   positive cells/  negative cells)
final




Figure 2-5. Growth curve 
optimization of the yeast two-
hybrid selection.  The yeast 
two-hybrid positive strain was 
grown in synthetic media 
lacking histidine and 
tryptophan and containing 
either 2% glucose or 2% 
galactose, 2% raffinose for 24 hours prior to beginning the selection at time = 0 hours.  The LEU2 
marker strain was grown in the same way as the yeast two-hybrid glucose sample.  Selective 
media was as in Figure 2-3.  Error bars are the standard error of four replicates.  Note that the y-






Given that the growth curves indicated that the positive strain began growing 
rapidly, within 24 hours of beginning the selection (Fig. 2-5), we also tested the effect of 
performing multiple, shorter rounds of selection rather than a single extended selection 
(Fig. 2-6).  Maintaining selection cultures at a constant cell density and volume allowed 
the positive strain to dominate the population, comprising >95% of cells, at the end of 
nine days of selection for mock libraries of up to 10
5
.  Compared to the original selection 
conditions, this improvement amounts to an over 300-fold increase in the enrichment 
factor for the 10
5
 library.  While this procedural modification did not recover the desired 
Figure 2-6. Optimization of yeast two-hybrid mock selection conditions.  Mock selections from 




) for the LEU2 yeast two-hybrid system were assayed to 
determine the percentage of null and positive cells in the population after (A) 0, (B) 3, (C) 6 , and 
(D) 9 days of selection.  The “original conditions”  were as described in Figure 2-3.  “Pre-
induction of hybrid protein expression” involved a 24-hour induction in non-selective galactose 
media, as described in Figure 2-5.  For “multiple shorter selections,” the OD600 of the selection 
was adjusted to 1.0 once a day, removing cells and adding fresh media to maintain a constant 




strain from libraries of 10
7
, combining multiple rounds of selection with the galactose 





In this work, we have established an experimental framework that enables us to 
rigorously characterize and optimize enrichment in yeast n-hybrid growth selections.  The 
development of quantitative, medium-throughput assays (i.e., detailed growth curves and 
a colorimetric enrichment assay) to evaluate these selections permitted us to analyze a 
number of conditions to improve their performance.  Comparing systems of increasing 
complexity facilitated the identification of factors that diminished selections’ efficacy.  
This analysis allowed us to make very simple alterations to the yeast two-hybrid selection 
that improved the enrichment factors and the searchable library size by two orders of 
magnitude. 
Here we only looked at the throughput of yeast hybrid selections, or their ability 
to recover one cell with the desired function from a 10
n
-fold excess of cells lacking it. 
Another important aspect of selections is their sensitivity to differences in the function of 
interest; this will be key for directed evolution experiments where researchers are 
endeavoring to maximize the affinity of an interaction.  The methodology described in 
this chapter will be readily applicable to assessing this parameter.  Strains expressing 
mutant fusion proteins with known, varying affinities for a protein (yeast two-hybrid) or 
small molecule (yeast three-hybrid) can be constructed
8,15
, and their growth and 
performance in mock selections can be evaluated, as we did for the null and positive 
strains described above.  Previous qualitative analyses of the correlation between 
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interaction strength and growth in the yeast two-hybrid assay suggest that the LEU2 
reporter may only be capable of determining the presence or absence of an interaction 
above a certain affinity threshold rather than gauging its strength more quantitatively
8
.  
Fortunately, this threshold seems to be adjustable if features of the LEU2 reporter gene, 
such as the number of DNA-binding sites in its promoter, are altered
8
.  This would argue 
for continuing to focus on optimizing the throughput of the LEU2 selection, as described 
in this chapter, for a variety of reporter constructs so that increasingly stringent strains 
could be employed as a function of interest gradually improves over multiple rounds of 
directed evolution. 
Beyond yeast hybrid systems, this same type of comprehensive characterization 
of other growth selections should facilitate the expansion of their use for directed 
evolution applications.  Growth selections have already proven to be a powerful method 
for searching large libraries of mutants for directed evolution applications.  Indeed, the 
directed evolution experiments that have achieved the most substantial changes in the 
function of biomolecules have almost invariably employed such selections in the 
evolution process
16-18
.  However, there seems to be a general hesitancy in the field to 
embrace growth selections as the assay of choice, likely because their performance 
parameters are still ill-defined.  Advances in directed evolution utilizing in vitro display 
selections and microtiter plate screens have repeatedly illustrated that systematic 
calibration and tuning of assays is critical for the success of directed evolution 
applications
19-23
, yet the equivalent characterization experiments
11,24
 have only rarely 
been performed for in vivo growth selections.  Most researchers only provide a qualitative 
analysis of growth selections
8,25
  or report endpoint data (e.g., the cell density at one time 
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point, or the number of days for colonies to appear in a plate assay)
26
.  Our results 
indicated that far more detailed, quantitative analyses of growth selections are crucial for 
developing strategies to optimize their performance. 
As directed evolution is increasingly harnessed to refine in vivo systems for 
synthetic biology rather than only individual biomolecules in vitro, having robust, well-
characterized growth selections to connect a variety of functions to high-throughput 
assays will no longer be optional.  Our experimental approach should provide a useful 
model for the rigorous assessment of growth selections for diverse applications. 
2.4 Experimental methods 
General materials and methods. Standard methods for molecular biology in 
Saccharomyces cerevisiae and Escherichia coli were used
10,27
.  S. cerevisiae strains were 
grown at 30°C in media containing 2% glucose unless otherwise noted.  Restriction 
enzymes and Vent DNA polymerase were purchased from New England Biolabs.  Vent 
polymerase was used for all PCR reactions except yeast or E. coli colony PCR unless 
otherwise noted.  For yeast colony PCR, cells were prepared according to a reported 
protocol (http://labs.fhcrc.org/hahn/Methods/mol_bio_meth/pcr_yeast_colony.html), and 
amplifications were performed with GoTaq DNA polymerase (Promega).  The dNTPs 
used for PCR were purchased from GE Healthcare Life Sciences.  Oligonucleotides were 
purchased from Invitrogen or Integrated DNA Technologies.  DNA sequencing was 
performed by Genewiz.  Plasmid DNA was purified using QIAprep miniprep kits 
(Qiagen); for yeast minipreps, cells were vortexed with acid-washed glass beads (Sigma) 
for five minutes before cell lysis.  PCR products were purified with agarose gel 
electrophoresis and QIAquick spin columns purchased from Qiagen.  Yeast genomic 
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DNA was purified using a YeaStar Genomic DNA Kit (Zymo Research).  For the overlay 
assays, 5-bromo-4-chloro-3-indolyl-beta-D-glucuronic acid, cyclohexylammonium salt 
(X-Gluc) was obtained from Gold Biotechnology, and 5-bromo-6-chloro-3-indolyl-β-D-
galactopyranoside (Magenta-Gal) from Biosynth International.  DNA concentrations 
were determined by absorption at 260 nm, and all absorbance measurements were taken 
on a Molecular Devices SpectraMax Plus 384 instrument.  All aqueous solutions were 
made with distilled water prepared from a Milli-Q Water System. For PCR, a MJ 
Research PTC-200 Pellier Thermal Cycler was employed.  Transformation of E. coli was 
carried out by electroporation using a Bio-Rad E. coli Pulser.  Yeast electroporation was 
carried out using a Bio-Rad Gene Pulser Xcell and a previously reported protocol
28
. 
 Construction of the LEU2 marker, yeast two-hybrid, and yeast three-hybrid 
“null strains.”  The ADH promoter and lacZ gene were amplified from vectors pMW103 
(primers LMW203 and LMW204) and pMW112 (primers LMW201 and LMW202), 
respectively.  Following gel purification, the fragments were combined in a fusion PCR 
reaction to create the pADH-lacZ construct (primers LMW202 and LMW203, Accutaq 
polymerase).  The purified construct was amplified with primers LMW205 and LMW206 
to install an additional 30 bp of homology to the vector, in addition to the 30 bp of 
homology already provided by the fusion PCR primers.  The plasmid pJG4-5 was 
digested with KpnI and EcoRI to remove the B42 fusion cassette and its promoter.  A 
1:10 molar mixture of cut plasmid (1.2 g) and the pADH-lacZ fusion product (8.0 g) 
was transformed into V760Y via electroporation, and transformants were selected on 
SC(HT
−
) (lacking histidine and tryptophan) plates.  Transformants were analyzed via an 
X-Gal overlay assay, and one of the transformants that turned blue in the presence of X-
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Gal was used to miniprep plasmid pLW2570.  The plasmid pLW2570 was retransformed 
into V760Y, and pLW2570 and pBAIT were co-transformed into EGY48.  One of the 
V760Y transformants that tested positive in the X-Gal overlay assay was used as the null 
strain for the LEU2 marker and yeast three-hybrid assays (LW2630Y); one of the EGY48 
transformants that tested positive was used as the null strain for the yeast two-hybrid 
assays (LW2631Y). 
Construction of the LEU2 marker “positive strain.”  The ADH promoter and 
gusA gene were amplified from vectors pMW103 (primers LMW209 and LMW210) and 
pDR8 (primers LMW207 and LMW208), respectively.  Following gel purification, the 
fragments were combined in a fusion PCR reaction to create the pADH-gusA construct 
(primers LMW208 and LMW209, Accutaq polymerase).  The purified construct was 
digested with KpnI and EcoRI, ligated to pJG4-5 that had also been digested with these 
enzymes, and transformed into E. coli.  The resulting plasmid pLW2569 was digested 
with ScaI and PvuII.  The LEU2 marker and its upstream regions were amplified from 
pRS425 with primers LMW211 and LMW213, which incorporated 30 bp of homology to 
the vector, and the purified PCR product was amplified with primers LMW212 and 
LMW214 to incorporate an additional 30 bp of homology.  A 1:10 mixture of cut plasmid 
(1.1 g) and the LEU2 PCR product (3.4 g) was transformed into V760Y, and 
transformants were selected on SC(HTL
−
) (lacking histidine, tryptophan, and leucine) 
plates.  Transformants were analyzed via an X-Gluc overlay assay, and one of the 
transformants that turned blue in the presence of X-Gluc was used to miniprep plasmid 
pLW2627.  The plasmid pLW2627 was retransformed into V760Y, and one of the 
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transformants that tested positive in the X-Gluc overlay assay was used as the positive 
strain for the LEU2 marker (LW2632Y).  
Construction of the yeast two-hybrid “positive strain.”  The ADH promoter 
and gusA gene were amplified from vectors pMW103 (primers LMW216 and LMW210) 
and pDR8 (primers LMW207 and LMW215), respectively.  Following gel purification, 
the fragments were combined in a fusion PCR reaction to create the pADH-gusA 
construct (primers LMW215 and LMW216, Accutaq polymerase).  The purified 
construct was amplified with primers LMW217 and LMW218 to install an additional 30 
bp of homology to the vector, in addition to the 30 bp of homology already provided by 
the fusion PCR primers.  The plasmid pTARGET was digested with ScaI.  A ~1:10 
mixture of cut plasmid (2.4 g) and pADH-gusA fusion (7.5 g) was transformed into 
V760Y via electroporation, and transformants were selected on SC(HT
−
) plates.  
Transformants were analyzed via an X-Gluc overlay assay, and one of the transformants 
that turned blue in the presence of X-Gluc was used to miniprep plasmid pLW2628.  The 
plasmid pLW2628 and pBAIT were co-transformed into EGY48.  One of the EGY48 
transformants that tested positive in the X-Gluc overlay assay was used as the positive 
strain for the yeast two-hybrid assays (LW2633Y). 
Construction of the yeast three-hybrid “positive strain.”  The ADH promoter 
and gusA gene were amplified from vectors pMW103 (primers LMW220 and LMW210) 
and pDR8 (primers LMW207 and LMW225), respectively.  Following gel purification, 
the fragments were combined in a fusion PCR reaction to create the pADH-gusA 
construct (primers LMW220 and LMW225, Accutaq polymerase).  The purified 
construct was amplified with primers LMW221 and LMW226 to install an additional 30 
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bp of homology to the vector, in addition to the 30 bp of homology already provided by 
the fusion PCR primers.  The plasmid pV398E was digested with PvuII.  A ~1:10 
mixture of cut plasmid (2.4 g) and pADH-gusA fusion (7.5 g) was transformed into 
V760Y via electroporation, and transformants were selected on SC(HT
−
) plates.  
Transformants were analyzed via an X-Gluc overlay assay, and one of the transformants 
that turned blue in the presence of X-Gluc was used to miniprep plasmid pLW2629.  The 
plasmid pLW2629 was retransformed into V760Y, and one of the transformants that 
tested positive in the X-Gluc overlay assay was used as the positive strain for the yeast 
three-hybrid assay (LW2634Y). 
Growth curves for LEU2 selections.  A representative experiment testing the 
effect of an induction before selection is described.  Glycerol stocks of the strains 
LW2630Y, LW2631Y, LW2632Y, LW2633Y, and LW2634Y were used to inoculate 1-
mL overnight cultures (SC(HT
−
), 2% glucose).  Cells were harvested (5000 rpm, 5 min, 
room temperature) and washed twice with sterile water.  For each strain, the cells from 
333 L of the original culture were resuspended in SC(HT−), 2% glucose, and cells from 
an equal volume of culture were resuspended in SC(HT
−
), 2% galactose, 2% raffinose.  
After 24 hours of induction, 2 L of cells were used to inoculate 198 L of selection 
media (SC(HTL
−
), 2% galactose, 2% raffinose).  For yeast three-hybrid selections, 1 M 
Dex-Mtx was also included in the selection media.  At least 3 replicate wells were 
inoculated for each condition.  Growth was monitored by absorption at 600 nm. 
LEU2 mock selections.  A representative experiment is described.  One mL of 
SC(HT
−
, 2% glucose) was inoculated from glycerol stocks of strains LW2630Y, 
LW2631Y, LW2632Y, LW2633Y, and LW2634Y.  These starter cultures were used 
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inoculate overnight cultures (10-50 mL) of the same media.  Cells were harvested, 
washed 3x with sterile water, and resuspended in selection media (SC(HTL
−
), 2% 
galactose, 2% raffinose).  The OD600 of the each strain was determined and cells were 






:1 ratios of the null:positive strain for the LEU2 
marker selection (LW2630Y:LW2632Y), the yeast two-hybrid selection 
(LW2631Y:LW2633Y), and the yeast three-hybrid selection (LW2630Y:LW2634Y).  
For yeast three-hybrid selections, Dex-Mtx was added to a final concentration of 1 M.  
Each selection had a final volume of 3 mL and a calculated initial OD600 of 1.  All 
selections were set up in triplicate.  Selections were shaken at 30C.  On days 0, 3, 6, and 
9, cells were plated on SC(HT
−
, 2% glucose), and after 2 days of growth, plates were 
assayed using the overlay assay described below.  After the plates developed, the number 
of red, blue, and white/ambiguous colonies on each plate was counted. 
Magenta-Gal/X-Gluc overlay assay.  The overlay procedure was adapted from a 
reported protocol (http://biochemistry.ucsf.edu/labs/herskowitz/xgalagar.html).  
Potassium phosphate buffer (300 mL; 0.5 M, pH 7.0), 20 mL of DMF, 3.3 mL of 10% 
SDS, and 3.3 g low-melting agarose were combined in an Erlenmeyer flask.  The solution 
was microwaved until the SDS and agarose went into solution.  The flask was cooled in a 
65C water bath.  -mercaptoethanol (165 L), X-Gluc (165 mg dissolved in 1 mL 
DMF), and Magenta-Gal (50 mg dissolved in 1 mL DMF) were added.  After gentle 
mixing, a pipette was used to carefully cover each plate with approximately 10 mL of the 
agarose solution.  The color typically developed sufficiently for plates to be counted 




2.5 Strains, plasmids, and oligonucleotides 
Table 2-1 Strains used in this study 
Name Genotype Source/Reference 
EGY48 MATa trp1 his3 ura3 6LexAop-LEU2 GAL+ R. Brent/8 
V760Y  
MAT trp1 ura3 6LexAop-LEU2 ade4::pGAL1-LexA-
eDHFR(HIS3) GAL+ 
K. Baker/29 
LW2630E V760Y with pLW2570 This study 
LW2631E EGY48 with pLW2570 and pBAIT This study 
LW2632E V760Y with pLW2627 This study 
LW2633E EGY48 with pLW2628 and pBAIT This study 
LW2634E V760Y with pLW2629 This study 
 
Table 2-2. Plasmids used in this study 
Name Details Source/Reference 
pBAIT  pADH-LexA-BAIT 2 HIS3 pBR ori amp
R
 Origene 
pDR8  8LexAop-lacZ 3cIop-gusA 2 URA3 colEI ori kan
R
 I. Serebriiskii/30 
pJG4-5  pGAL1-B42 2 TRP1 pUC ori amp
R
 R. Brent/31 
pMW103  pGAL1-B42 2 TRP1 pUC ori kan
R
 R. Brent/32 
pMW112  8LexAop-lacZ 2 URA3 pBR ori kan
R
 R. Brent/32 
pRS425 2 LEU2 pBIISK ori amp
R
 ATCC #77106 
pTARGET  pGAL1-B42-TARGET 2 TRP1 pUC ori amp
R
 Origene 
pBC398 pGAL1-B42-(GSG)2-rGR2 2 TRP1 pUC ori kan
R
 B. Carter/33 
pLW2569 pADH1-gusA 2 TRP1 pUC ori amp
R
 This study 
pLW2570 pADH1-lacZ 2 TRP1 pUC ori kan
R
 This study 
pLW2627 pADH1-gusA 2 LEU2 TRP1  This study 
pLW2628 pTARGET with pADH-gusA replacing amp
R 
This study 
pLW2629 pBC398E with pADH-gusA replacing (pUC ori kan
R
) This study 
 
Table 2-3 Oligonucleotides used in this study 
Name Sequence (5'-3') 
LMW201  GGGCGGAATGACTAAATCTCATTCAGAA 
LMW202 GAAGAAGTCCAAAGCTTCTCGAGTCGGCCGTTATTTTTGACACCAGACCAA 
LMW203  ATGACATGATTACGAATTAATTCGAGCTCGCAACTTCTTTTCTTTTTTTTTCT 
LMW204 AGATTTAGTCATTCCGCCCGGAATTAAAGC 
LMW205  ACAATTTCACACAGGAAACAGCTATGACATATGACATGATTACGAATTAATT 
LMW206  CTTGATTGGAGACTTGACCAAACCTCTGGCGAAGAAGTCCAAAGCTTCT 
LMW207  GGGCGGAATGTTACGTCCTGTAGAAAC 
LMW208 GACGTGAATTCTTATCATTGTTTGCCTCCCTG 




LMW211  TACACTATTCTCAGAATGACTTGGTTGAGTACAGGGGCGCTATCGCA 
LMW212  ACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACT 
LMW213  GCTTTCCAGTCGGGAAACCTGTCGTGCCAGTCGACTACGTCGTAAGGC 
LMW214  CTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAAC 
LMW215 CTCAGCGATCTGTCTATTTCGTTCATCCATTCATTGTTTGCCTCCCTG 
LMW216  ATTCCCTTTTTTGCGGCATTTTGCCTTCAACTTCTTTTCTTTTTTTTTCT 
LMW217  ATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATT 
LMW218  TTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTT 
LMW220  GCTTTCCAGTCGGGAAACCTGTCGTGCCAGCAACTTCTTTTCTTTTTTTTTCT 
LMW221  CTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAAC 
LMW225 AAGGAAGAGTCCTGAGGCGGAAAGAACCAGTCATTGTTTGCCTCCCTG 
LMW226  ACCCTGATAAATGCTTCAATAATATTGAAAAAGGAAGAGTCCTGAGGC 
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3.0 Chapter outlook 
Adapting counter selections, or selections against activation of a reporter gene, 
for directed evolution applications is particularly challenging due to the need to match 
basal and activated levels of reporter gene expression to the gene product’s toxicity level.  
Our laboratory previously developed a yeast three-hybrid counter selection based on the 
standard URA3 counter selection from yeast genetics; elaboration of this yeast three-
hybrid framework enabled the directed evolution of cellulases via our chemical 
complementation technology.  However, the throughput of the URA3 counter selection in 
our original system was too low for it to be utilized in demanding directed evolution 
experiments requiring large libraries to be searched.  In this chapter, we describe several 
approaches we have taken to improve our yeast three-hybrid counter selection.  We began 
by rigorously characterizing enrichment and growth of strains in the URA3 counter 
selection for both the yeast three-hybrid system and analogous simpler systems, in which 
URA3 is used simply as a digital ―on/off‖ marker.  We found that the poor performance 
of the URA3 reporter in the yeast three-hybrid assay can be attributed to insufficient 
activation of the reporter under selection conditions rather than high basal transcription or 
inherent limitations in the efficacy of the selection.  Given the difficulty of appropriately 
modulating the reporter’s transcription levels, we developed a screening approach to 
empirically identify novel counter selectable reporter genes whose thresholds for toxicity 
match the basal and activated transcription levels already achieved in our system.  A 
screen of only eleven candidate genes yielded a counter selection reporter that, without 
any optimization, performed more effectively than the extensively optimized URA3 




 The rise of synthetic biology is creating a heightened demand for methods to 
connect complex in vivo circuitry to a readily assayable cellular phenotype, such as cell 
growth.  To date, cell engineers have almost exclusively borrowed the standard selections 
for antibiotic resistance and complementation of auxotrophies long used by geneticists.  
However, these traditional selections, historically employed as digital ―on/off‖ markers 
for purposes such as plasmid maintenance or gene knockouts, can be less effective when 
used for applications that require, for example, the detection of small changes in 
transcription levels or the observation of graded, analog responses. 
The yeast three-hybrid (Y3H) assay is an example of a synthetic biology system 
that would benefit from customized selectable markers.  Our laboratory recently 
developed a yeast three-hybrid counter selection based on the classic yeast URA3 counter 
selection
1
, in which the gene product OMP decarboxylase converts 5-fluoroorotic acid (5-
FOA) to the toxic compound 5-fluorouracil.  Without further modification, this yeast 
three-hybrid URA3 selection strain was able to detect cellulase activity upon addition of a 
gene encoding a cellulase and a Methotrexate-Cellotetraose-Dexamethasone (Mtx-Cel-
Dex) dimerizer substrate (Fig. 3-1)
2
.  We then used this cellulase chemical 
complementation system to select improved cellulase variants from a library generated by 
family DNA shuffling
2
.  However, adapting the URA3 counter selection to provide the 
desired growth phenotype in the yeast three-hybrid system was nontrivial, requiring a 
multi-step strain construction, extensive optimization of growth conditions, and the 
screening of numerous strains
2
.  Even after this optimization, the URA3 reporter provided 
relatively small differences in growth in the activated versus the unactivated states in the 
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context of the yeast three-hybrid and cellulase chemical complementation counter 
selections
2
.  While the performance of this counter selection was sufficient for initial 
proof-of-principle studies, the current URA3 counter selection is unlikely to enable the 
effective search of large libraries for demanding directed evolution applications. 
 
Historically, developing counter selections has been more difficult than 
developing positive selections (e.g., resistance to antibiotics or complementation of strain 
auxotrophies).  Only a limited number of yeast counter selections have been reported
3-9
, 
and even fewer have proven to be dependable enough to be widely employed even for 
routine genetic manipulations
10
.  The URA3 marker is considered to be the ―gold 
standard‖ of these established selections because it is the most robust and reliable7, and as 
such, it has been the reporter of choice for converting yeast hybrid systems into counter 
selections
11-13
.  The two yeast two-hybrid systems that utilize this reporter did not 
quantitatively characterize its performance
11,12
.  Using a yeast three-hybrid system with a 
Figure 3-1. The chemical complementation counter selection provides a growth selection for 
cellulase catalysts.  The Mtx-Cel-Dex heterodimer links a LexA DNA-binding domain fused to 
dihydrofolate reductase (DHFR) and a B42 activation domain fused to the glucocorticoid receptor 
(GR), activating transcription of a downstream toxic URA3 reporter gene, thus leading to cell 
death. Active cellulases cleave the β-1,4-glucosidic bond in the cellotetraose linker between Mtx 




LexA DNA-binding domain and a GAL4 activation domain, Chidley et al. recently 
reported a URA3 counter selection designed to reduce the number of false positives 
identified in a positive three-hybrid selection
13
.  However, mock selections indicated that 
their counter selection only provided 10- to 100-fold enrichment factors for large library 
sizes (i.e., enriching cells that do not activate reporter transcription from 1 in 10
4
 to less 




.  While these very low enrichments were satisfactory for their purpose of 
eliminating low-frequency false positives, they would be entirely inadequate for systems 
such as chemical complementation, in which the counter selection is the primary 
selection method.   
One explanation of why optimizing the most robust known counter selection for 
yeast hybrid systems has proven to be so difficult is that there are fundamental 
differences between the yeast three-hybrid assay and typical counter selection 
applications.  When used for purposes such as curing cells of plasmids or knocking out 
genes, the counter selectable marker is either ―on‖ and being expressed from its 
endogenous promoter, or ―off‖ and completely deleted from the cell.  In the yeast three-
hybrid assay, however, the functional reporter gene is present in all cells, and the ―on‖ 
and ―off‖ states reflect activated and basal transcription of the gene, respectively.  If the 
expression level at which the reporter gene begins to inhibit cell growth happens to fall 
outside this window, the counter selection will be unable to discern between activated 
and basal transcription, and low levels of basal transcription of the gene could inhibit cell 
growth even in the absence of the reconstituted transcription factor.   
In this chapter, we take multiple approaches to improving our laboratory’s 
Dexamethasone-Methotrexate-based yeast three-hybrid counter selection.  First, we apply 
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the framework for characterizing genetic selection systems outlined in Chapter 2 to the 
URA3 counter selection reporter.  We identify the key issues impairing its performance 
and describe our efforts to optimize its regulation accordingly.  In addition, we develop a 
library screening approach to discover new counter selection reporters for the yeast three-
hybrid assay.  A small screen yielded a reporter construct that, without any optimization, 
was more effective than the URA3 reporter in our system. 
3.2 Results 
3.2.1 Model of the cellulase chemical complementation system 
We first sought to confirm that our existing chemical complementation 
framework should be able to produce discernable differences in reporter gene expression 
in response to cellulase activity.  We built a simple model to predict how changes in the 
system components should affect assembly of the active transcription complex (Fig. 3-2).  
Current transcriptional activation mechanism models
14
 suggest that reporter gene 
transcription levels should correlate with the ratio of active transcription complex to total 
DNA-binding domain.  Briefly, our chemical complementation model predicts that the 
dynamic range of the assay is determined by rate of conversion of substrate to product by 
the enzyme relative to the rate at which the heterodimer substrate and products can cross 
the plasma membrane and exchange with the extracellular media.  While this model is 
oversimplified and leaves out major events such as transport of the transcription complex 
to the nucleus, it is compelling that the model correctly predicts that the assay should 
detect cellulases with activities on the order of 10
5–106 M-1s-1—the activity levels of the 
cellulases in our first directed evolution experiment
2
.  These results suggest that with the 
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appropriate reporter gene, we should be able to distinguish between 1) active and inactive 
cellulase enzymes and 2) cellulases with high and intermediate levels of activity. 15-18 
 
Figure 3-2. Model of the cellulase 
chemical complementation system 
predicting how the components of the 
system control the levels of reporter 
gene transcription and hence the 
dynamic range of the assay.  (A) The 
fraction of DBD-DHFR that is part of 
an active transcription complex is 
expressed as a fraction of total DBD-DHFR; components of the model containing DBD-DHFR are 
highlighted in red.  S represents the tetrasaccharide substrate; P1 and P2 represent the 
disaccharide products.  Based on previous quantification of protein levels in our system by 
Western blotting
15
, the concentrations of the DBD and AD fusion proteins are assumed to be 10 
M.  Rate constants for small molecule transport in and out of the cell, believed to occur by 
diffusion, are estimated at 0.004 s
-1
 based on values for the cellular uptake of Dex
16
.  Dissociation 
constants for the binding of Dex to GR and Mtx to DHFR are 1 nM and 1 pM, respectively. This 
model was built using COPASI
17
.  (B) The fraction of active transcription complex varies with the 
catalytic efficiency of the enzyme and the concentration of the heterodimer substrate in our 
model.  The enzyme concentration is assumed to be 10 nM, again based on previously reported 







3.2.2 Characterization of the 8LexAop-pSPO13-URA3 reporter gene 
 Having verified that chemical complementation could theoretically provide a 
usable selection for cellulase enzymes, we next tested our hypothesis that the suboptimal 
growth differences observed in our original cellulase chemical complementation selection 
were due to the performance of the URA3 counter selection reporter.  The reporter gene 
in our original chemical complementation selection strain contains the URA3 gene under 
the control of the tightly regulated SPO13 promoter downstream of eight LexA operators
2
 
(four complete colEI operators, each of which binds two LexA dimers
19
).  Taking a 
reductionist approach analogous to that described in Chapter 2, we constructed a series 
of isogenic strains that differed only in the URA3 allele they contained, allowing the 
performance of the URA3 counter selection in the yeast three-hybrid system to be directly 
compared to its performance as when used as a digital selectable marker, as it is in 
conventional genetic applications. 
To determine the maximum achievable dynamic range of the URA3 counter 
selection under the yeast hybrid selection conditions, we first compared the growth of 
strains containing either a wild-type URA3 gene expressed from its endogenous promoter 
or the inactive ura3-52 allele, which produces no functional Ura3 protein.  As shown in 
Figure 3-3, growth curves under counter selection conditions showed that strains 
containing the wild-type allele never grow to saturation, while cultures of strains with the 
inactive allele reach saturation (OD600>1).  Mock selections confirmed that cells with the 
inactive allele can be enriched to a significant proportion of the population (>20%) from 
an excess of at least 10
5
 cells with the wild-type gene (Fig. 3-4).  These observations 
indicate that URA3 should be an effective reporter for the chemical complementation 
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counter selection if sufficient differences in basal versus activated URA3 transcription 
can be obtained. 
  
 Next, we compared the growth of yeast three-hybrid strains containing the 
integrated 8LexAop-pSPO13-URA3 reporter with the LexA-DHFR fusion protein 
required to activate URA3 transcription (active yeast three-hybrid strain), or with only 
LexA (inactive yeast three-hybrid strain).  Growth curves with yeast three-hybrid strains 
that were otherwise isogenic to the control strains described above confirmed that they 
did not grow slower than ura3-52 strains in the presence of 5-FOA (compare Figs. 3-3 
and 6 days of growth in selective media (same composition as Figure 3-3), the percentage of 
ura3 cells in the population was determined using the colorimetric assay described in Chapter 2.  
Figure 3-4. Enrichment of ura3 strains under 
yeast three-hybrid counter selection 
conditions.  Mock selections were performed in 
which the ura3-52 strain, with the inactive 





) of the URA3 strain.  After 0 
and histidine.  Open and closed symbols represent strains with the inactive ura3-52 allele and the 
active URA3 allele, respectively.  A total of four colonies from each transformation were analyzed 
with similar results; representative data from a single colony from each transformation are shown.  
Error bars represent the standard error in the OD600 readings for triplicate cultures.  Note that the 
y-axis is plotted on a logarithmic scale. 
Figure 3-3. Growth of ura3 and URA3 strains 
under yeast three-hybrid counter selection 
conditions.  Growth curves were performed in 
synthetic media containing 2% galactose, 2% 
raffinose, and 0.2% 5-FOA, lacking tryptophan 
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and 3-5, open symbols), demonstrating that basal reporter transcription was not 
problematic.  As expected, for inactive yeast three-hybrid strains with only LexA, growth 
curves with and without the chemical dimerizer Dex-Mtx were superimposable (Fig. 
3-5B).  For the active yeast three-hybrid strain, addition of Dex-Mtx resulted in a 
reproducible but small degree of growth inhibition (Fig. 3-5A).  Mock selections 
indicated that these slight differences in growth were insufficient to enrich an inactive 
yeast three-hybrid strain from only a small excess (10-fold) of active yeast three-hybrid 
cells even after nine days of selection (Fig. 3-6).  These data indicate that 1) the poor 
performance of the cellulase chemical complementation selection can be traced back to 
its yeast three-hybrid framework and 2) the low throughput is due to insufficient 
activation of the URA3 reporter under activated conditions rather than high basal 





amounts of time in selective media (same composition as Figure 3-3, with the addition of 5 M 
Dex-Mtx), the percentage of inactive yeast three-hybrid cells in the population was determined 
using the colorimetric assay described in Chapter 2.  
Figure 3-6. Enrichment of inactive yeast three-
hybrid strains in the URA3 counter selection.  
Mock selections were performed in which the 
inactive yeast three-hybrid strain was mixed 




) of the 
active yeast three-hybrid strain.  After various 
Figure 3-5. Growth of (A) active and (B) inactive yeast three-hybrid strains under URA3 counter 
selection conditions.  Media composition was the same as in Figure 3-3; open and closed 
symbols represent cultures grown in the absence and presence of 5 M Dex-Mtx, respectively.  
Each graph represents the results for a unique, randomly selected colony.  A total of four colonies 
from each transformation were analyzed with similar results.  Error bars represent the standard 




3.2.3 Efforts to optimize the URA3 yeast-three hybrid reporter gene 
Based on these results, we tried several alternative URA3 reporter constructs that 
could potentially increase the expression of the reporter under activated conditions.  First, 
since the original reporter gene was integrated in the chromosome and only present in a 
single copy in cells, we increased the reporter’s copy number by placing the LexAop-
pSPO13-URA3 construct on a high-copy plasmid.  However, these strains grew just as 
robustly as the ura3-52 strain even in the presence of Dex-Mtx, indicating that 
transcription of URA3 was still too low under activated conditions (data not shown).   
Next, we tested alternative promoter constructs known to provide large 
differences in reporter transcription levels.  Specifically, we placed URA3 under the 
control of the 2- and 8LexAop-pGAL-based promoters on low- or high-copy plasmids.  In 
these promoter constructs, the upstream activation sequences of the GAL promoter are 
replaced with LexA operators, and in our Dex-Mtx yeast three-hybrid system, they 
exhibit up to a 100-fold difference in basal versus activated transcription (see Fig. 3-8 in 
Section 3.2.4).  However, basal transcription from all of these promoters was evidently 
too high.  Most colonies did not grow with or without Dex-Mtx, and colonies that did 
grow either did not display small molecule-dependent growth inhibition or exhibited 
variation among replicates, suggesting that growth resulted from strain reversion (data 
not shown). 
3.2.4 A library approach for the discovery of yeast-three hybrid counter selection 
reporter genes 
Given the difficulty of rationally redesigning the URA3 yeast three-hybrid system 
to appropriately modulate the reporter gene’s expression, we hypothesized that the most 
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straightforward route to improve the counter selection would be to screen a library of 
novel candidate reporter genes in the context of the desired application.  We could 
thereby empirically identify one whose threshold for toxicity corresponds to the 
expression levels achieved in our existing system.  Since reporter expression is not 
activated in the absence of the chemical dimerizer, a conditionally lethal reporter (e.g., 
only toxic in the presence of a compound such as 5-FOA) is unnecessary.  This broadens 
the pool of candidate counter selection reporters greatly, as a wealth of genetics studies 
have identified numerous yeast genes that inhibit growth or affect the cell cycle when 
simply overexpressed
20-25
.  Interestingly, in spite of the paucity of effective yeast counter 
selections, this information has seldom been exploited to develop new counter 
selections
9,20,26
.  We thought that an endogenous yeast gene could be a particularly 
suitable yeast three-hybrid counter selection reporter, as the gene’s mere presence in the 
genome implies that the cell is able to tolerate some basal level of expression.  
Accordingly, we drew a list of eleven potential candidate counter selection reporter genes 
(Table 3-1) from overexpression studies in S. cerevisiae.  Since each previous study used 
different expression conditions, we focused on genes that had been identified in multiple 
screens to increase the likelihood that the gene product would be toxic under the specific 









Table 3-1. Candidate counter selection reporter genes. 
Gene Reported Studies  
ACT1 (YFL039C) Refs. 21-23,25 
AMN1 (YBR158W) Ref. 24 
CDH1 (YGL003C) Refs. 21,25 
GIS1 (YDR096W) Refs. 21,24,25 
HSF1 (YGL073W) Refs. 21,22,24 
MSC1 (YML128C) Refs. 21,24,26 
NSR1 (YGR159C) Refs. 21-23,25 
SPC42 (YKL042W) Refs. 24,26 
TPK3 (YKL166C) Refs. 24,26 
TUB2 (YFL037W) Refs. 22,23,25 
WWM1 (YFL010C) Refs. 25 
 
We then constructed a system to quickly and efficiently evaluate candidate 
reporters by constructing libraries of reporters directly in a yeast three-hybrid strain and 
screening for growth inhibition effects under yeast three-hybrid counter selection 
conditions (Fig. 3-7).  We elected to put the reporter genes on low-copy centromeric 
plasmids, allowing us to use plasmid gap repair techniques to generate large libraries of 
reporter constructs in vivo
27,28
 while minimizing cell-to-cell variation in expression 
levels
29
.  To coarsely adjust the levels of basal and activated reporter expression in the 
yeast three-hybrid assay, we built a family of six parental plasmids containing LexA 
operator-promoter constructs that should provide varying expression.  Candidate reporter 
genes, PCR amplified with appropriate homology regions, can be readily inserted into 




Two or eight LexA operators were placed upstream of three different parental 
promoters (pKEX2, pCYC1, and pTEF1), which have been shown to provide a range of 
gene expression of over three orders of magnitude
30
.  In contrast to the promoter 
constructs typically used for hybrid system reporters
31
, the LexA operator sites of our 
promoter library do not replace the parental promoters’ upstream activating sequences.  
Therefore, our promoter library should provide higher basal levels of reporter expression 
and smaller fold increases in transcription when activated.  We confirmed this prediction 
by placing lacZ under the control of each promoter and quantifying lacZ expression in 
our yeast three-hybrid system in the absence and presence of Dex-Mtx (Fig. 3-8).  All of 
the promoters showed Dex-Mtx-dependent increases in reporter expression ranging in 
magnitude from 1.5- to 9-fold.  By comparison, the standard lacZ reporter plasmids, 
containing pGAL promoters with the upstream activating sequences entirely replaced by 
LexA operators, gave 100- to 1000-fold increases in reporter expression in the yeast 
Figure 3-7. Screen for alternative reporters for the yeast three-hybrid counter selection.  Yeast 
three-hybrid strains harboring a library of candidate reporters are constructed in vivo in one step 
by co-transforming pools of candidate reporter genes (green; YFG or “your favorite gene”) and 
plasmids containing various LexA operator-promoter constructs (orange; LexAop-Prom).  
Hundreds of transformants can then be screened in parallel for growth in the presence and 




three-hybrid assay.  This should be advantageous for our purposes since we would expect 
to see smaller changes in transcription during chemical complementation than observed 
in the yeast three-hybrid assay.  Therefore, the performance of a counter selection 
reporter driven by a member of the promoter library in the yeast three-hybrid assay might 
be comparable to that of the same reporter driven by an optimized promoter (e.g., 
LexAop-pGAL) in chemical complementation.  Surprisingly, in our system the ―weak‖ 
KEX2 and ―intermediate‖ strength CYC1 promoters30 provide comparable levels of 
expression, but each promoter construct gave a somewhat different temporal pattern of 
expression.  In addition, lacZ is an imperfect proxy for a counter selection reporter, which 
would likely have manifold effects on the cell depending on the mechanism of growth 
inhibition. 
Dexamethasone-Methotrexate.  The 48-hour time point is shown here.  2x and 8x represent the 
number of LexA operators upstream of the parental promoter.  Error bars represent the standard 
error of measurements from three or four unique colonies transformed with the promoter-lacZ 
constructs.  Note that the y-axis is plotted on a logarithmic scale. 
 
Figure 3-8. Characterization of 
lacZ expression from the promoter 
library.  ONPG assays were 
performed after 24, 48, and 96 
hours of growth in synthetic media 
containing 2% galactose, 2% 
raffinose, lacking tryptophan and 
histidine, with or without 1 M 
75 
 
We constructed our counter selection reporter library by co-transforming the 
promoter library plasmids and the candidate reporter genes as a pool into our yeast three-
hybrid strain, conveniently generating the 66 potential reporter plasmids in vivo by 
plasmid gap repair.  With the exception of the reporter gene, we used a strain containing 
our previously reported yeast three-hybrid framework, which has been optimized to 
ensure a consistent reporter readout
32
.  To ensure full coverage of the reporter library, we 
picked two hundred transformants and monitored their growth in the presence and 
absence of Dex-Mtx.  As shown in Figure 3-9, almost 20% of the colonies exhibited 
chemical dimerizer-dependent growth inhibition.  Five unique constructs were identified 
from the ten best colonies, and four of these continued to provide some degree of growth 
inhibition reproducibly upon retransformation into the yeast three-hybrid strain (Figs. 
3-10 and -11). 
 
 
Figure 3-9. Representation of 200 
colonies’ performance in the counter 
selection reporter screen.  Colonies 
were grown in synthetic media 
containing 2% galactose, 2% raffinose, 
lacking tryptophan and histidine, with 
or without 1 M Dexamethasone-Methotrexate.  Since colonies exhibited a variety of growth 
patterns, Dex-Mtx-dependent growth inhibition was scored by the maximum observed ratios of 
the cell densities (OD600) of the –Dex-Mtx culture to the +Dex-Mtx culture for each colony, and the 
number of colonies that fell within each range is shown.  Reporters from the ten best colonies 




3.2.5 Characterization of the GIS1 counter selection reporter 
The most promising reporter construct, 8LexAop-pTEF1-GIS1, was selected for 
further characterization.  After retransformation of the reporter plasmid into the yeast 
three-hybrid strain, 26 colonies were individually assayed for growth in the presence and 
absence of Dex-Mtx.  Significantly, using our unoptimized selection conditions, several 
Figure 3-10. Growth curves for retransformed yeast three-hybrid counter selection reporter hits.  
Figure 3-10.  Growth curves for retransformed yeast three-hybrid counter selection reporter 
candidates (A) 8LexAop-pCYC1-TUB2, (B) 2LexAop-pTEF1-GIS1, (C) 8LexAop-pTEF1-ACT1, 
and (D) 8LexAop-pKEX2-GIS1.  Each graph represents the results for a unique, randomly 
selected colony.  Media composition was as in Figure 3-9.  Open and closed symbols represent 
cultures grown in the absence and presence of 1 M Dex-Mtx, respectively.  Error bars represent 
the standard error in the OD600 readings for duplicate cultures.  All reporters except 8LexAop-
pKEX2-GIS1 again provided some degree of growth inhibition in the yeast three-hybrid assay. 
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GIS1 reporter clones demonstrated superior growth inhibition relative to our extensively 
optimized URA3 counter selection strain
2
 when it was tested under analogous conditions 
(Fig. 3-11). 
We explicitly tested the ability of the GIS1 reporter to provide enrichment in the 
yeast three-hybrid counter selection by attempting to enrich an inactive three-hybrid 
strain, containing only the B42 activation domain, from an excess of active three-hybrid 
strains, containing the requisite B42-GR fusion protein.  Cells were mixed to provide an 
initial ratio of 100:1 or 1000:1 active:inactive strains and subjected to yeast three-hybrid 
selection conditions.  After four days of growth, the inactive yeast three-hybrid cells 
comprised the majority of the population for both selections (Fig. 3-12).  Diluting the 
1000:1 selection into fresh media on the second day, or ―seeding‖ the selection, was even 
more effective, allowing the inactive yeast three-hybrid strain essentially to overtake the 
culture.    
Figure 3-11.  Characterization of 8LexAop-
pTEF1-GIS1 as a yeast three-hybrid counter 
selection reporter.  Twenty-six randomly selected 
Y3H colonies retransformed with the reporter 
plasmid were assayed for growth with or without 
1 M Dex-Mtx.  Selective media was as in 
Figure 3-9.  Two metrics were used to evaluate 
each colony’s performance: the maximum 
observed ratio of the OD600 reading for the –Dex-Mtx culture and the +Dex-Mtx culture (Maximum 
OD600 ratio (–/+)), and the difference in time required for the –Dex-Mtx and +Dex-Mtx cultures to 
reach an OD600 of 1 (t).  Each blue data point represents one colony, and the performance of 
our published URA3 Y3H counter selection strain
2




We then tested the efficacy of the counter selection reporter in the cellulase 
chemical complementation assay.  Since there is significant clonal variation in the GIS1 
yeast three-hybrid strains (Fig. 3-11), we screened a number of colonies and selected two 
with the greatest growth difference with and without Dex-Mtx to test in chemical 
complementation.  These strains were transformed with plasmids containing cellulases 
and their corresponding active-site nucleophile mutants.  When growth was tested with 
under chemical complementation selection conditions (Fig. 3-1), no Dex-Cel-Mtx or 
cellulase-dependent growth effects were observed (data not shown). 
3.2.6 Efforts to optimize the GIS1 counter selection reporter 
Efforts to optimize the GIS1 yeast three-hybrid counter selection, with the goal of 
translating these improvements into our chemical complementation system, were not 
immediately successful.  We first tested to see if the GIS1 counter selection could be 
improved simply by optimizing the promoter.  Since the 8LexAop-pGAL promoter gave 
comparable activated expression to the 8LexAop-pTEF promoter, but exhibited lower 
basal transcription (Fig. 3-8), we tested the 8LexAop-pGAL-GIS1 reporter construct.  The 
new GIS1 reporter construct also served as a counter selection reporter, but its 
performance was no better than the original reporter plasmid (data not shown).  This 
Figure 3-12.  GIS1 mock selection results.  
Active and inactive yeast three-hybrid cells 
were mixed in 100:1 or 1000:1 ratios and grown 
in selective media (as in Fig. 3-9) in the 
presence of 1 M Dex-Mtx.  The percentage of 
inactive cells was determined after 0, 2, and 4 
days of selection using the colorimetric enrichment assay.  For the “seeding” selection, 2 rounds 
of 2-day selections, rather than one longer 4-day selection, were performed. 
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could be at least partially due to issues of timing; having a higher level of basal 
transcription may slow cells’ growth until the toxic gene product has time to accumulate. 
GIS1 encodes a cAMP-dependent kinase-regulated transcription factor involved 
in the response to nutrient limitation; it is believed to activate the expression of a gene or 
genes that inhibit proliferation
33
.  Attenuation of cAMP-dependent kinase activity has 
been reported to potentiate GIS1-mediated growth inhibition
33
.  Accordingly, we 
reconstructed the GIS1 yeast three-hybrid system in a strain with a temperature-sensitive 
allele of CDC25
34
, which encodes a guanine nucleotide-exchange factor that indirectly 
regulates cAMP levels, to see if this would enhance the counter selection’s efficacy.  
Since the altered strain background might require lower levels of basal GIS1 expression, 
the GIS1 reporter was again screened with the entire promoter library (Section 3.2.4).  
However, no constructs exhibited an improved growth difference with and without Dex-
Mtx as compared to the wild-type strain (data not shown). 
3.3 Discussion 
 The yeast three-hybrid counter selection exemplifies the problem of adapting 
classic genetic selections for advanced synthetic biology applications.  As for the LEU2 
positive selection described in Chapter 2, we found that rigorous, quantitative 
characterization of the yeast three-hybrid URA3 counter selection lent new insights into 
the limitations of this selection system and their root causes.  Our data indicate that the 
URA3 counter selection has the potential to serve as a robust reporter.  The challenge will 
now be to appropriately regulate the reporter’s expression to achieve essentially zero 
basal transcription while still attaining high levels of activated transcription.  One 
intriguing possibility would be to exploit the synthetic biology community’s recent 
80 
 
successes in the design of genetic circuits to build feedback loops into our system, 
thereby maximizing the differences between background and induced reporter gene 
transcription.  Alternatively, the stability of the protein gene product could be modulated 
to adjust its toxicity. 
The difficulty of rationally redesigning genetic selections to function robustly in 
engineered in vivo systems argues for the more widespread use of directed evolution and 
other library approaches in their optimization.  We found that a straightforward screen of 
only a small library of candidate genes yielded multiple alternate counter selection 
reporter genes for the yeast three-hybrid assay.  Furthermore, one of these proved to be as 
effective as the ubiquitous URA3 counter selection in our system.  Employing a library 
approach allowed us to define the conditions we wanted to use in our assay while still 
circumventing the laborious optimization process required to adapt the URA3 reporter for 
the yeast three-hybrid assay.   
As synthetic biologists endeavor to develop an arsenal of effective parts that will 
function in increasingly complex and diverse systems, our results underscore the 
importance of looking beyond the standard components historically used by geneticists, 
which were selected for their functionality in a different context.  Rather, we should think 
broadly and creatively as we design the next generation of bioengineering tools.  
Furthermore, we should acknowledge that there will not always be ―one-size-fits-all‖ 
solutions when designing sophisticated in vivo applications, and we should embrace the 





3.4 Experimental methods  
 General materials and methods.  General materials and methods were as in 
Chapter 2. 
Plasmid construction.  The LexAop-promoter library was constructed by in vivo 
plasmid gap repair in S. cerevisiae as follows.  The 2x- and 8xLexA operators were 
amplified from plasmids pMW109 and pMW112, respectively, using primers LMW328 
and LMW329, which add 30 bp of homology to pRS416GAL before the GAL promoter.  
The KEX2, CYC1, and TEF1 promoters were amplified from FY251 genomic DNA with 
primers LMW330/LMW331, LMW332/LMW333, and LMW334/LMW335, 
respectively, which add 30 bp of homology to the LexAop fragments at the 5’ end and 30 
bp of homology to the pRS416GAL multiple cloning site (MCS) at the 3’ end.  Plasmid 
pRS416GAL was digested with SacI and XbaI to cut out the GAL promoter.  Each of the 
six combinations of the LexAop and promoter fragments was separately co-transformed 
with digested pRS416GAL in a 100:100:1 ratio into yeast.  Transformants were 
miniprepped to recover plasmid DNA, which was retransformed into E. coli.  The 
plasmids used for the final promoter library were pLW2571, pLW2572, pLW2573, 
pLW2574, pLW2575, and pLW2576. 
Plasmids containing B42 constructs and a constitutively expressed colorimetric 
marker were constructed as follows.  Plasmids pBC398 and pJG4-5 were digested with 
SalI to cleave at the 3’ end of the ADH1 terminator following the pGAL1-B42 constructs.  
Constructs containing pADH1-gusA and pADH1-lacZ were amplified from plasmids 
pLW2569 and pLW2570 with primers LMW323/LMW324 and LMW325/LMW324, 
respectively.  These primers incorporated 30 bp of homology to the digested plasmids 
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and oriented the colorimetric markers so that they would be transcribed towards the 
bidirectional ADH1 terminator.  Digested pBC398 and the gusA PCR product, and 
digested pJG4-5 and the lacZ PCR product were co-transformed into yeast in 1:100 ratios 
and moved to E. coli for plasmid maintenance, as described above.  The final plasmids 
used in the active and inactive yeast three-hybrid mock selection strains were pLW2578 
and pLW2577, respectively. 
To make an integration plasmid to integrate pGAL-LexA-eDHFR into the HO 
locus, pKB521 was digested with SacI/EaeI/PvuII to obtain a pGAL-LexA-eDHFR-tADH 
fragment that could be isolated by gel purification, and this insert was cloned into 
SacI/SmaI-digested pRS423 to place this construct next to the HIS3 marker, giving 
pLW2665.  The insert was expected to have SacI/EaeI ends, but evidently PvuII 
exhibited star activity, resulting in a slightly truncated ADH terminator.  Since 335 bp of 
the terminator still remained, pLW2665 was carried forward.  A pGAL-LexA-eDHFR-
tADH-HIS3 fragment was obtained by digesting pLW2665 with SacI/SmaI and cloning it 
into SacI/AfeI-digested pV2265 (integration vector for the HO locus), giving pLW2666.   
Evaluation of the URA3 reporter with isogenic strains.  Strains were 
transformed with the plasmids required for the yeast three-hybrid assay as shown in 
Table 3-2.  All strains were derivatives of FY251.  LW2635Y was obtained by growing 
PPY2240Y under non-selective conditions until colonies that had been cured of all 







Table 3-2. Construction of URA3 counter selection strains. 
 Parental Strain Plasmids Transformed 
Strains for growth curves   
URA3 with endogenous promoter (pURA3) V2169Y pKB521, pBC398 
ura3-52 (inactive allele) FY251 pKB521, pBC398 
Active Y3H (LexAop-pSPO13-URA3) LW2635Y pKB521, pBC398 
Inactive Y3H (LexAop-pSPO13-URA3) LW2635Y pMW103, pBC398 
Strains for Mock Selections   
pURA3-URA3 blue strain (URA3 marker) V2169Y pKB521, pLW2578 
ura3-52 red strain (inactive URA3 marker) FY251 pKB521, pLW2577 
LW2636Y (URA3 active Y3H blue strain) LW2635Y pKB521, pLW2629 
LW2637Y (URA3 inactive Y3H red strain) LW2635Y pKB521, pLW2570 
For growth curves, 4 unique doubly transformed colonies from each 
transformation were inoculated into SC(HT
−
) (lacking histidine and tryptophan) media 
and grown to saturation.  One L of cells were inoculated into 199L of (SC(HT−), 2% 
galactose, 2% raffinose, 0.2% 5-FOA) (with or without 5 M Dex-Mtx* for the active 
and inactive yeast three-hybrid strains) to begin the growth curves.   
For the mock selections, see Chapter 2 for a general description of selection set-
up.  For evaluation of URA3 as a marker gene, the selective media was (SC(HT
−
), 2% 
galactose, 2% raffinose, 0.2% 5-FOA); for evaluation of URA3 as a yeast three-hybrid 
reporter, the selective media was (SC(HT
−
), 2% galactose, 2% raffinose, 0.2% 5-FOA 
media, 5 M Dex-Mtx*). 
*A stock of Dex-Mtx that works significantly better at 5 M than at 1 M was used. 
Construction of strains with different promoters for the URA3 reporter.  
Strains with multiple copies of the LexAop-pSPO13-URA3 reporter were made by 
transforming pPPY2176 into a colony resulting from FY251/pKB521/pBC398 
transformation described above.  Low- or high-copy plasmids containing LexAop-pGAL-
URA3 reporters were made by in vivo gap repair as follows.  The 2- and 8LexAop-pGAL 
promoters were amplified with appropriate homology regions from pMW109 and 
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pMW112, respectively, using primers LMW328 and LMW541.  The URA3 coding 
sequence was amplified from plasmid pRS416 with appropriate homology regions using 
primers LMW542 and LMW543.  The MET promoters of pRS415MET and pRS425MET 
were removed by digestion with SacI and BamHI, and the digested plasmids were co-
transformed with a promoter PCR and the URA3 PCR into an FY251/pKB521/pBC398 
colony.  The resulting transformants were tested directly in growth assays.   
Characterization of the promoter library in ONPG assays.  The lacZ gene was 
amplified from plasmid pLW2570 with primers LMW505 and LMW506, and the 
unpurified PCR product was amplified with primers LMW339 and LMW340.  The PCR 
product was co-transformed with the individual members of the promoter library 
(plasmids pLW2571, pLW2572, pLW2573, pLW2574, pLW2575, and pLW2576 
digested with ClaI) and pBC398 into strain V704Y.  Plasmids pMW109 and pMW112 
were also co-transformed with pBC398 into the same strain for comparison.  Four 
colonies from each transformation were inoculated into 100 L SC(HTU− (lacking 
histidine, tryptophan, and uracil), 2% galactose, 2% raffinose) (inducing) media.  After 
24 hours, 1 L of the cultures were inoculated into 199 L of the same media with or 
without 1 M Dex-Mtx.  ONPG assays were conducted on the cultures at various time 
points.  After 24, 48, and 96 hours of growth, the cell densities of the cultures were 
measured, and 50 L were harvested.  The cells were washed once with Z buffer35, 
resuspended in 100 L YPER, and lysed for 30 minutes at room temperature.  A solution 
of ONPG in Z buffer (8.5 L of a 10 mg/mL solution) was added to the lysates, and the 
reactions were quenched with 110 L of 1M Na2CO3 after most wells turned visibly 
yellow.  The reactions were centrifuged at 2000 rpm for 5 min to pellet cellular debris, 
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and the A420 of 100 L of the supernatant was measured.  -galactosidase units were 
calculated as (1000* A420)/(time*volume*A600) (time in minutes, volume in mL). 
Construction of a yeast three-hybrid counter selection reporter library.  
Equal amounts of the six promoter library plasmids listed above were combined and 
digested in the MCS with ClaI.  Eleven candidate reporter genes were amplified from 
FY251 genomic DNA with the primers indicated in Table 3-3.  The unpurified PCR 
products were then amplified with LMW339 and LMW340; the two PCR reactions added 
a total of 30 bp of homology to the promoter library MCS at the 5’ end and 30 bp of 
homology to the CYC1 terminator at the 3’ end.  The PCR products were mixed in an 
equimolar ratio and co-transformed with the digested promoter library in a 100:1 ratio 
and with pV398E into V704Y.  Double transformants were selected on SC(HTU
−
) plates. 
Table 3-3. PCR amplification of candidate counter selection reporter genes. 
Gene Primers 
ACT1 (YFL039C) LMW391/LMW392 
AMN1 (YBR158W) LMW393/LMW394 
CDH1 (YGL003C) LMW395/LMW396 
GIS1 (YDR096W) LMW397/LMW398 
HSF1 (YGL073W) LMW399/LMW400 
MSC1(609-1359) (YML128C) LMW401/LMW402 
NSR1 (YGR159C) LMW403/LMW404 
SPC42 (YKL042W) LMW405/LMW406 
TPK3 (YKL166C) LMW407/LMW408 
TUB2 (YFL037W) LMW409/LMW410 
WWM1 (YFL010C) LMW411/LMW412 
Counter selection reporter library screening.  Two hundred double 
transformants from the counter selection reporter library were inoculated into SC(HTU
−
) 
media containing 2% galactose and 2% raffinose.  After 24 hours of growth, cultures 
were diluted into nonselective (SC(HTU
−
), 2% gal, 2% raf) and selective (SC(HTU
−
), 2% 
gal, 2% raf, 1 M Dex-Mtx) media (200 L).  Cell density was periodically monitored by 
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measuring the absorbance of cultures at 600 nm.  Forty-four colonies whose growth 
appeared to be inhibited by Dex-Mtx in the initial screen were retested, and 36 again 
demonstrated significant small molecule-dependent growth inhibition.  Reporter plasmids 
from the ten best-performing colonies were miniprepped, transformed into E. coli, and 
sequenced to determine the constructs’ identities. 
Growth curves.  Growth curves for reporter plasmids retransformed into the 
yeast three-hybrid strain (pLW2579, pLW2580, pLW2581, pLW2582, and pLW2583) 
were carried out as described for the counter selection library screening, except that all 
cultures were set up at least in duplicate.  For URA3 counter selection strain growth curve 
(PPY2240Y), the media used was SC(HT
−
), 0.2% 5-FOA, 2% galactose, 2% raffinose, 
with or without 1 M Dex-Mtx.  During exponential growth, OD600 readings were taken 
approximately every 12 hours.  The ratio of the averaged OD600 value readings of the      
–Dex-Mtx and +Dex-Mtx cultures was calculated for each time point.  The difference in 
time for the –Dex-Mtx and +Dex-Mtx cultures to reach an OD600 of 1 was calculated 
from the averaged data points immediately before and after this OD600 was reached, 
assuming exponential growth during the entire interval: 
OD600(final) = OD600(initial) x 2
(time(final)−time(initial))/doubling time 
For analysis of chemical complementation using the GIS1 reporter, two yeast 
three-hybrid strains retransformed with pLW2579 were selected after their performance 
in the yeast three-hybrid counter selection was  characterized (Fig. 3-11).  These strains, 
LW2672Y and LW2673Y, were transformed with plasmids pV2230 and pV2557.  
Growth curves for transformants were performed as for the GIS1 yeast three-hybrid 
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counter selection, but with media that also lacked leucine and with 1 M Dex-Cel-Mtx 
rather than Dex-Mtx. 
Mock selections.  Plasmids pLW2578 and pLW2577 were co-transformed with 
the reporter plasmid pLW2579 into V704Y to generate active and inactive yeast three-
hybrid strains.  Sixteen colonies from each transformation were tested in growth curves to 
verify their performance in the yeast three-hybrid assay and to ensure that they had the 
same growth rates under non-selective conditions.  One active (LW2585Y) and one 
inactive (LW2584Y) yeast three-hybrid strain that best met both conditions were glycerol 
stocked for use in mock selections.  To begin the mock selections, cultures were 
inoculated directly from the glycerol stocks into SC(HTU
−
), 2% glucose media, and once 
these cultures reached saturation, they were inoculated into SC(HTU
−
), 2% galactose, 2% 
raffinose media (1 mL).  After 24 hours, the cultures were harvested (2000 rpm, 5 
minutes) and resuspended in fresh SC(HTU
−
), 2% galactose, 2% raffinose media (1 mL).  
The OD600 of the cells was measured, and the cultures were mixed and diluted with media 
to give 3 mL of the desired ratio of strains at an OD600=0.1.  Dex-Mtx was added to 1 mL 
of the culture to a concentration of 1 M, and another 1 mL was used to start a parallel 
non-selective (–Dex-Mtx) culture.  For the ―seeding‖ selection, the OD600 of the 1000:1 
selections were measured, and a sample of the culture was used to inoculate fresh media 
(+ or  – 1M Dex-Mtx) to an OD600=0.1.  On days 0, 2, and 4, a sample of each culture 
was plated on non-selective SC(HTU
−
), 2% glucose media.  After 3 days of growth, 
colonies (>100 for each sample) were assayed for lacZ and gusA expression using an 
agarose overlay assay
36
, replacing X-Gal with X-Gluc and Magenta-Gal.  Colonies’ 
colors developed within hours, and the numbers of red and blue colonies were counted to 
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score the percentage of active and inactive yeast three-hybrid cells in the culture.  For 
cultures without Dex-Mtx, the percentage of inactive strain always remained below 10%.  
Construction of an alternate reporter plasmid for the GIS1 counter selection.  
GIS1 was amplified from pLW2579 with homology to pMW112 5’ and 3’ to the open 
reading frame of lacZ using primers LMW527 and LMW528.  The PCR product was co-
transformed with MluI-digested pMW112 into V704Y to construct a 2 plasmid 
containing the reporter construct 8LexAop-pGAL-GIS1 by gap repair.  Transformants 
were miniprepped, retransformed into E. coli, and analyzed by colony PCR.  Three of the 
resulting plasmids that had the reporter construct and pLW2579 were co-transformed 
with pBC398 into V704Y.  Growth assays were performed as described above for the 
GIS1 reporter. 
Construction of Y3H strain with a cdc25-2 background.  Strain V2668Y, 
containing a temperature-sensitive cdc25-2 allele, was obtained from the Elledge 
laboratory
37
, and the genotype was verified by PCR and restriction analysis of the locus.  
This strain and all of its derivatives were grown at room temperature rather than at 30°C.  
The plasmid pLW2666 was digested with ApaLI and transformed into V2668Y.  A HIS3 
colony was analyzed for correct integration of the LexA-DHFR construct by PCR and 
sequencing of its genomic DNA, and it was glycerol stocked as LW2667Y.  Yeast three-
hybrid strain was constructed by co-transformation of pBC398 and the appropriate 






3.5 Strains, plasmids, and oligonucleotides 
Table 3-4. Strains used in this study 
Name Genotype Source/Reference 
FY251 MATa trp1Δ63 his3Δ200 ura3-52 leu2Δ 1 Gal+ M. Carlton 
PPY2240Y 
MATa trp1Δ63 his3Δ200 8LexAop-pSPO13-URA3 
leu2Δ1 Gal+ pKB521 pBC398 
P. Peralta-Yahya/2 
V2169Y MATa trp1Δ63 his3Δ200 URA3 leu2Δ1 Gal+ P. Peralta-Yahya/2 
V2668Y 




MATa trp1Δ63 his3Δ200 ura3-52 leu2Δ1 ade4::pGAL1-
LexA-eDHFR(HIS3) GAL+ 
K. Baker/15 
LW2584Y VC704Y with pLW2577 and pLW2579 This study 
LW2585Y VC704Y with pLW2578 and pLW2579 This study 
LW2635Y 
MATa trp1Δ63 his3Δ200 8lexAop-Spo13-URA3 leu2Δ1 
Gal+  (PPY2240Y cured of plasmids) 
This study 
LW2636Y LW2635Y with pLW2629 and pKB521 This study 
LW2637Y LW2635Y with pLW2570 and pKB521 This study 
LW2667Y V2668Y with pLW2666 integrated This study 
LW2672Y V704Y with pBC398 and pLW2579 This study 
LW2673Y V704Y with pBC398 and pLW2579 This study 
 
Table 3-5. Plasmids used in this study 
Name Details Source/Reference 
pBC398 pGAL1-B42-(GSG)2-rGR2 2 TRP1 pUC ori kan
R
 B. Carter/38 
pJG4-5 pGAL1-B42 2 TRP1 pUC ori amp
R
 R. Brent/31 
pKB521 pGAL1-LexA-eDHFR 2 HIS3 pBR ori kan
R
 K. Baker/32 
pMW103 pGAL1-B42 2 TRP1 pUC ori kan
R
 R. Brent/39 
pMW109 2LexAop-lacZ 2 URA3 pBR ori kan
R
 R. Brent/39 
pMW112 8LexAop-lacZ 2 URA3 pBR ori kan
R
 R. Brent/39 
pPPY2176 pRS425MET carrying 8LexAop-pSPO13-URA3 fusion P. Peralta-Yahya/2 
pRS415MET pMET25 CEN6/ARSH4 LEU2 pBIISK ori amp
R
 ATCC #87322 
pRS416 CEN6/ARSH4 URA3 pBIISK ori amp
R
 ATCC #87521 
pRS416GAL pGAL1 CEN6/ARSH4 URA3 pBIISK ori amp
R
 ATCC #87332 
pRS423 2 HIS3 pBIISK ori amp
R
 ATCC #77104 
pRS425MET pMET25 2 LEU2 pBIISK ori amp
R
 ATCC #87323 
pVC2230 pRS425MET-Erwinia carotovora CelN P. Peralta-Yahya/2 
pVC2265 HO-polylinker-KanMX4-HO D. Stillman/40 
pVC2557 pRS425MET-CelN:E226G V. Mondol 
pLW2569 pADH1-gusA 2 TRP1 pUC ori amp
R
 This study 
pLW2570 pADH1-lacZ 2 TRP1 pUC ori kan
R
 This study 
pLW2571 pRS416 2xLexAop-pKEX2-MCS-tCYC This study 
pLW2572 pRS416 8xLexAop-pKEX2-MCS-tCYC This study 
pLW2573 pRS416 2xLexAop-pCYC1-MCS-tCYC This study 
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pLW2574 pRS416 8xLexAop-pCYC1-MCS-tCYC This study 
pLW2575 pRS416 2xLexAop-pTEF-MCS-tCYC This study 
pLW2576 pRS416 8xLexAop-pTEF-MCS-tCYC This study 
pLW2577 pJG4-5 with pADH-lacZ inserted This study 
pLW2578 pBC398E with pADH-gusA inserted This study 
pLW2579 pLW2576 with GIS1 in the MCS This study 
pLW2580 pLW2574 with TUB2 in the MCS This study 
pLW2581 pLW2575 with GIS1 in the MCS This study 
pLW2582 pLW2576 with ACT1 in the MCS This study 
pLW2583 pLW2572 with GIS1 in the MCS This study 
pLW2629 pBC398E with pADH-gusA replacing (pUC ori kan
R
) This study 
pLW2665 pRS423 with pGAL-LexA-eDHFR-tADH  This study 
pLW2666 pVC2265 with pGAL-LexA-eDHFR-tADH-HIS3 This study 
 
Table 3-6. Oligonucleotides used in this study 
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4.0 Chapter outlook 
Installing customized multi-gene pathways in the cell is arguably the first step of 
any synthetic biology experiment.  Currently, building such constructs requires choosing 
between two unsatisfactory alternatives: high-yielding but resource-intensive in vitro 
DNA assembly methods, or straightforward but low-yielding in vivo methods.  We 
envisioned that we could exploit the known efficiency of double-strand break repair by 
homologous recombination in yeast to develop a robust platform for in vivo DNA 
assembly.  Our system, Reiterative Recombination, elongates a construct of interest in a 
stepwise manner by employing pairs of alternating, orthogonal endonucleases and 
selectable markers.  In this chapter, we present the design, development, and first 
demonstration of Reiterative Recombination.  First, we designed and constructed a 
system for Reiterative Recombination in Saccharomyces cerevisiae.  Next, we verified 
that endonuclease cleavage of the chromosome led to high-efficiency recombination that 
was amenable to cyclical repetition.  Finally, we challenged Reiterative Recombination to 
build multi-gene constructs in vivo by integrating readily assayable reporter genes into 
the yeast chromosome, creating a three-gene, 8.5-kilobase “pathway,” and rigorously 
characterizing the resulting strains both phenotypically and genotypically.  To our 
knowledge, Reiterative Recombination is the first high-yielding technology for the 
assembly of multi-gene constructs in vivo.  This attribute, together with its technical 
straightforwardness, should make it a robust and accessible methodology for a broad 
spectrum of researchers to build large, custom DNA pathways and should allow it to 




A key bottleneck to reengineering cells for diverse synthetic biology applications 
is the technical difficulty of constructing optimized, multi-gene pathways in vivo.  The 
advent of synthetic biology has raised the tantalizing prospect of reprogramming cells at 
will for purposes ranging from the biosynthesis of high-value feedstocks and natural 
product analogs to the development of cell-based sensors and therapeutics
1
.  Engineering 
cells for such tasks requires the introduction of numerous exogenous genes into the 
genome to create novel “pathways.”  However, standard molecular biology and genetic 
techniques, developed for the manipulation of single genes, become unwieldy or 
ineffective when applied to much larger multi-gene constructs
2
.  A new generation of 
robust, accessible tools for building pathways inside the cell is needed. 
The difficulty of rationally designing complex systems that operate as desired in 
the cellular milieu
3
 further argues that the ability to construct not only individual 
pathways but also libraries of pathways in vivo will be essential.  Precedent has indicated 
that multi-component systems introduced into the cell typically require refinement to 
function optimally
4,5
.  By analogy to the directed evolution approaches that empowered 
the routine discovery of proteins and nucleic acids with prescribed functions, generating 
large numbers of variant pathways in parallel and screening for those that exhibit the 
required behavior could streamline optimization efforts
6
.  Library-based approaches 
could circumvent the gaps in our knowledge, immediately yielding functional systems, 
but they will also require DNA assembly methods that can reliably generate sizable 
collections of pathways (>10
3
) inside of the cell, an especially high standard of 
efficiency.   
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4.1.1 Methods for assembling multi-gene pathways in vitro 
 Though several technologies for building large DNA constructs have been 
reported, none has yet emerged as the transformative solution that will be required for the 
routine assembly of large, customized DNA for the era of synthetic biology.  Initial 
approaches to custom DNA assembly have sought to stretch the limits of standard 
molecular biology tools that were designed to manipulate single genes
7-12
.  While these in 
vitro technologies have allowed entire biosynthetic pathways to be assembled, often in 
high yield, they are inherently resource intensive, relying on expensive enzymatic 
reagents and repeated cycles of multi-step DNA manipulation.   
Early efforts in this area were pioneered by researchers at Kosan Biosciences, 
who introduced “ligation by selection” for the convergent construction of polyketide 
synthase genes in 2004
13-16.  Fully synthetic gene “synthons” are cloned into donor and 
acceptor plasmids designed to present compatible restriction sites and unique selective 
marker combinations; correct ligation of the digested donor and acceptor generates a 
plasmid with a different marker pair combination.   
Related strategies have proliferated in more recent years
17,18
.  For example, Codon 
Devices introduced “pairwise selection assembly” for convergent, large-scale DNA 
assembly
19
.  Fragments to be assembled are cloned into vectors so that they are flanked 
on both sides with “activation tags” that turn on expression of two antibiotic resistance 
genes.  Two fragments are then excised with only one activation tag each, ligated to 
create a fragment with tags on both ends, and cloned into a vector with a different pair of 
resistance genes that require the activation tags for expression.  This creates a stringent 
selection for correct assembly.  However, all of these types of strategies necessitate 
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repeated cycles of moving the growing constructs in and out of E. coli and handling 
large, unwieldy DNA fragments in vitro.   
Other researchers have focused on developing “in vitro recombination protocols,” 
which have the advantage of not relying on restriction sites that may also appear in the 
DNA being assembled.  First developed by the Elledge group
10
, in vitro recombination 
imitates in vivo homologous recombination by using a 5’ to 3’ exonuclease to reveal 
complementary single-stranded DNA at the ends of two fragments.  After fragments 
anneal, polymerase and ligase enzymes repair the DNA to generate the intact product.  
Gibson et al. have extensively optimized in vitro recombination to develop a one-step 
“isothermal assembly” protocol that uses only commercially available reagents8,9.  
Impressively, the authors are able to use it to assemble even genome-sized DNA 
molecules (>500 kb).  Despite its reported high efficiency and the field’s intense interest 
in combinatorial pathway construction, the Venter Institute has only published a single 
example of using this technology to construct a “library”20 (see Chapter 5).  Moreover, 
this approach does not inherently address the issue of efficiently moving the resulting 
large DNA constructs into the desired host, particularly for applications that require the 
stable integration of pathways into the chromosome.     
4.1.2 Methods for assembling multi-gene pathways in vivo 
Several other laboratories have begun to exploit homologous recombination for 
DNA assembly directly in cells
21-24
.  While attractive for their simplicity, these assembly 
protocols have basically consisted of co-transforming multiple DNA fragments and 
determining the limit of the cell’s ability to join them together correctly.  Not 
surprisingly, these methods are inherently low yielding.  For example, Zhao and co-
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workers reported the assembly of up to a 19-kb, two-pathway cluster by co-
transformation of nine overlapping DNA fragments into yeast
23
.  Zhao recovered only 
~100 recombinants under conditions that would typically yield ~10
7
 transformants 
(0.001% efficiency), making this approach completely impracticable for library 
applications.  This method also does not allow subsequent modification of constructs. 
The next breakthrough will be to combine the control and high efficiency of in 
vitro methods with the technical ease of performing recombination directly in the cell.  
Itaya and co-workers have performed pioneering work in this arena, using homologous 
recombination in conjunction with elegant marker recycling strategies to integrate 
constructs ranging in size from 16 kb to 3.5 Mb into the Bacillus subtilis genome
25,26
.  
However, their systems require over 700 bp of overlapping homology and still only yield 
dozens to hundreds of colonies per round.  
4.2 Design of Reiterative Recombination 
 We envisioned that we could overcome the critical shortcoming of existing in vivo 
DNA assembly methods—their very low efficiencies—by coupling assembly to the 
repair of double-strand DNA breaks (DSBs).   Building on an established technique for 
targeted gene disruption
27,28
, Reiterative Recombination introduces these defined DSBs, 
which stimulate homologous recombination, using homing endonucleases with large 
recognition sequences (~20 bp) that will only cleave at engineered sites.  As shown in 
Figure 4-1, these cleavage sites are placed between fragments of the construct of interest 
and selectable markers in “donor” and “acceptor” modules.  Upon endonuclease cleavage 
of the acceptor module, the donor module provides homology to repair the DSB through 
a short region of overlap between the fragments to be assembled on one side of the break, 
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and a homology region upstream of the selectable markers on the other side.  Repair by 
homologous recombination adds the donor module’s fragment to the acceptor module’s 
growing construct and replaces the acceptor module’s endonuclease cleavage site and 
selectable marker.  Since only the acceptor module’s marker is actively transcribed, 
recombinants can be readily identified.  During the next round of elongation, the 
endonuclease cleavage site and selectable marker return to the original configuration, 
allowing assembly to proceed in a cyclical format. 
 
achieved by recombination between an “acceptor module” (in the linear chromosome) and a 
“donor module” (in the circular plasmid).  The two modules contain orthogonal homing 
endonuclease cleavage sites (triangles) adjacent to different selectable markers (purple and 
green).  Both markers are downstream of a homology region (gray), but only the acceptor module 
contains a promoter (white) driving marker expression.  Endonuclease cleavage of the acceptor 
module stimulates recombination, joining the fragments being assembled (orange) and replacing 
the acceptor module’s endonuclease site and expressed selectable marker with those of the 
donor module.  Repeating this procedure with a donor module of the opposite polarity returns the 
acceptor module to its original state, allowing the assembly to be elongated indefinitely. 
 
Figure 4-1. General scheme of Reiterative Recombination, 
showing two rounds of elongation.  Each round of elongation is 
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 Several lines of evidence from studies of homologous recombination in S. 
cerevisiae supported our hypothesis that pathways could be constructed with high 
accuracy and efficiency using this Reiterative Recombination strategy.   Paques et al. 
demonstrated that repair of an HO endonuclease-induced chromosomal DSB by 
homologous recombination from a plasmid template proceeded with high efficiency 
(>5%) even when fragments up to 9.1 kb in length were inserted in the repair process, 
demonstrating that we should be able to integrate gene-sized fragments in our analogous 
system
29
.  Inbar and Kupiec found that when two templates were available for the repair 
of an HO endonuclease-induced break, one containing homology immediately adjacent to 
the DSB and one containing homology distant from the break, donors with homology 1 to 
6 kb from the DSB were utilized with high frequency (≥40% of cells)30.  This suggests 
that the presence of selectable markers between the endonuclease cleavage site and the 
homology regions upstream of the markers should not impede efficient repair.    Finally, 
homology regions as short as ~30 bp are sufficient to effect gene conversion or accurate 
repair of DSBs in systems expected to have varying degrees of mechanistic similarity to 
Reiterative Recombination
31-34
.  Using such short homology regions between assembled 
subfragments would be advantageous for Reiterative Recombination, as it would allow 
homology to be incorporated by PCR, eliminating the need to use more sophisticated in 
vitro techniques (e.g., overlap extension PCR) to add homology to adjacent subfragments 







4.3.1 Construction of a system for Reiterative Recombination 
We constructed our initial Reiterative Recombination system in S. cerevisiae.  For 
the orthogonal endonucleases, we turned to the two well-studied S. cerevisiae enzymes 
employed throughout the homologous recombination literature, HO and SceI.  HO 
specifically cleaves the MAT locus to stimulate mating-type switching
35,36
; SceI is 
encoded by an intron in yeast mitochondrial DNA and has no recognition sites at all in 
yeast nuclear DNA
37,38
.  These enzymes were placed under the GAL1 promoter, the most 
widely used inducible promoter in yeast genetics (Fig. 4-2).   
 
We then created a pair of orthogonal selectable markers with appropriate 
homology regions (Fig. 4-2).  We chose HIS3 and LEU2, which provide robust, widely 
used growth selections by complementing the histidine and leucine auxotrophies of many 
common yeast strains. To provide an upstream homology region, we constructed 
N-terminal GFP fusions of both markers, and we inserted an HO or SceI recognition site 
downstream of their terminators.  We placed the GFP-HIS3 construct under a constitutive 
PYK1 promoter to create an actively expressed acceptor module marker, and we placed 
both GFP-marker fusions into centromeric (low-copy) shuttle vectors without promoters 
Figure 4-2.  Details of Reiterative 
Recombination.  Donor plasmids contain the 
HO or SceI endonucleases under the control 
of the galactose-inducible GAL promoter and 
GFP-HIS3 or GFP-LEU2 genes that lack a 
promoter.  Acceptor modules have a GFP-
HIS3 or GFP-LEU2 gene downstream of the 
constitutive pPYK1 promoter. 
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to create donor modules.  The donor plasmids also contain a positive and negative 
selectable URA3 marker, allowing cells to be cured of donor plasmids after each 
elongation round by growth on 5-fluoroorotic acid (5-FOA)
39
.    
To build an initial strain for Reiterative Recombination, we began with BY4733, a 
background strain with full deletions of all markers used in our system
40
, eliminating the 
potential for unwanted homologous recombination events.  We used standard “pop-
in/pop-out” gene replacement41 to put a silent mutation in the MAT allele to eliminate its 
HO cleavage site
42
 (Fig. 4-3).  Then we placed the acceptor module into an integration 
vector targeting the HO locus
43
, simultaneously integrating the construct and eliminating 
homology to the endonuclease gene in the donor plasmid.  This basic parental acceptor 
strain can be used for the assembly of any desired DNA construct.  For some 
applications, it may be desirable to use a different background strain.  Now that the 
appropriate integration plasmids have been constructed, it will only require two 
integration steps, known to proceed efficiently, to convert any strain with the appropriate 
auxotrophies into an acceptor cell. 
 
4.3.2 Validation of the Reiterative Recombination system 
First, we sought to verify that endonuclease-stimulated recombination occurred as 
expected, leading to both 1) conversion between the alternating HIS3 and LEU2 markers 
Figure 4-3.  Construction of the 
parental acceptor Reiterative 
Recombination strain.   
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and 2) the insertion of exogenous DNA adjacent to the endonuclease cleavage site.  We 
therefore transformed our Reiterative Recombination parental acceptor strain with a 
donor plasmid that contained a 950-bp region of homology to the HO locus adjacent to 
the KanMX gene, which confers resistance to G418 in yeast, as shown in Figure 4-4A. 
 
Figure 4-4. Validation of endonuclease-stimulated integration of DNA via Reiterative 
Recombination.  (A) The Reiterative Recombination parental acceptor strain was transformed 
with a donor plasmid containing the features shown.  Homologous recombination stimulated by 
HO endonuclease cleavage of the chromosome is expected to lead to integration of the KanMX 
marker and conversion of the expressed alternating marker from HIS3 to LEU2. (B) 
Transformants were grown in synthetic media lacking uracil (to select for the donor plasmid) and 
containing 2% galactose/2% raffinose or in 2% glucose for 14 hours, and 100 L was plated on 
synthetic media lacking leucine to assay for acquisition of actively expressed LEU2.  (C) Genomic 
DNA was purified from 4 LEU2 colonies cured of the donor plasmid and analyzed by PCR and 
restriction analysis.  Primers amplified from the ho allele to GFP.  PCR products were digested 




As shown in Figure 4-4B, induction of transformants with galactose, which 
activates HO endonuclease expression, instead of glucose, which represses endonuclease 
expression, resulted in a large increase in the number of recombinants as assayed by 
selection for acquisition of the LEU2 marker.  Correct integration of the KanMX gene 
was validated by curing the recombinants of the donor plasmid and showing that the cells 
were still resistant to G418.  The genomic DNA from four colonies was purified, and the 
acceptor module was PCR amplified and analyzed by restriction mapping (Fig. 4-4C); all 
recombinants had the expected digestion pattern.  
Next, we tested whether efficient homologous recombination could still occur in 
our system when increasingly shorter homology regions were utilized.  As shown in 
Figure 4-5, galactose induction of transformants with donor plasmids containing regions 
of homology to the ho locus as short as 41 bp still resulted in high-efficiency acquisition 
of the LEU2 phenotype.  As homology regions decreased in length, background levels of 
recombination in glucose media due to leaky endonuclease expression or unstimulated 
homologous recombination also decreased (Table 4-1); induction of the endonuclease 
became increasingly important for obtaining maximal recombination efficiency.    
Importantly, 40-bp homology regions are short enough to be readily incorporated with 
PCR primers, meaning that Reiterative Recombination can easily be used to assemble 



























 Finally, we confirmed that the recombination process could be continued for 
multiple consecutive rounds.  We transformed the cured recombinants obtained in the 
above experiments with a donor plasmid of the opposite polarity that contained a 134-bp 
homology region and then induced expression of the orthogonal SceI endonuclease with 






Figure 4-5.  Marker conversion 
efficiencies in Reiterative 
Recombination with decreasing 
lengths of homology.  Experiments 
were performed as in Figure 4-4B 
but using donor plasmids containing 
various lengths of homology to the 
ho locus.  Twelve-hour inductions in 
galactose or glucose were 





galactose (Fig. 4-6A).  Galactose induction resulted in a high rate of acquisition of the 
HIS3 marker (Fig. 4-6B), returning recombinants to the parental acceptor’s strain 
phenotype.  Using these cured round 2 recombinants, we then verified that we could 
continue the cyclical Reiterative Recombination process for a third round, as shown in 
Figure 4-6C,D. 
 
Figure 4-6.  Consecutive rounds of Reiterative Recombination.  Cured recombinants from the 
experiments in (A,B) Figure 4-4 or (C,D) Figure 4-6A,B were transformed with donor plasmids 
containing the features shown.  Homologous recombination stimulated by endonuclease 
cleavage of the chromosome is expected to lead to conversion of the expressed alternating 
marker from (A) LEU2 to HIS3 or (C) HIS3 to LEU2. (B,D) Transformants were grown for 12 
hours in galactose or glucose media as in Figure 4-4, and 100 L was plated on synthetic media 
lacking (B) histidine or (D) leucine to assay for acquisition of actively expressed HIS3 or LEU2, 
respectively.   
Galactose  Glucose 
Galactose  Glucose 
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4.3.3 Construction of a “pathway” of genes via Reiterative Recombination 
Having validated the basic machinery of Reiterative Recombination, we then 
employed our system to build a “pathway” of genes, forcing our system to cycle through 
multiple rounds of elongation.  We sequentially integrated the reporter genes lacZ (-
galactosidase; red when assayed with Magenta-Gal), gusA (-glucuronidase; blue when 
assayed with X-Gluc), and MET15 (O-acetylserine and O-acetylhomoserine 
sulfhydrylase; complements methionine auxotrophy) using three rounds of assembly, 
creating an 8.5-kb construct (Fig. 4-7).   
 
Subfragments for integration were PCR amplified as one or two overlapping 
pieces using primers that incorporated short regions of homology (30-40 bp) 1) to the 
preceding piece of the growing assembly and 2) to the donor plasmid.  PCR products 
were co-transformed with a digested, generic donor plasmid into the acceptor strain to 
Figure 4-7.  Construction of a reporter gene “pathway” by Reiterative Recombination.  Details of 
the assembly process in which the three reporter genes lacZ, gusA, and MET15 were 
sequentially integrated into the chromosome. 
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generate intact donor plasmids by plasmid gap repair (Fig. 4-8)
44
.  Our procedure thus 
eliminates any in vitro manipulation (e.g., subcloning) other than basic PCR.   
 
As negative controls, we transformed donor plasmids lacking the endonuclease 
gene and/or homology to the previously integrated subfragment in the pathway at every 
round.  These transformants were induced with galactose and glucose in media in parallel 
to the intact donor plasmid.  Galactose induction of endonuclease expression in the 
transformants led to a high rate of marker conversion only when both the endonuclease 
gene and the homology on both sides of the endonuclease cut site were present (Fig. 4-9).   
Figure 4-8.  Construction of donor plasmids by plasmid gap repair.  A digested universal donor 
plasmid and PCR fragments with appropriate homology regions are co-transformed into the 




Phenotypic analysis of recombinants following donor plasmid curing indicated 
that auxotrophies for histidine and leucine alternated with each round of elongation, as 
expected (Fig. 4-10A, columns).  Each newly integrated reporter (lacZ, gusA, or MET15) 
was functional in 75-100% of recombinants when >40 individual colonies from each 
round were assayed (Fig. 4-10B,C,D), and previously integrated reporters were 
maintained (Fig. 4-10A, rows).  We also confirmed that integration occurred in the 
expected manner by analyzing the purified genomic DNA of cured recombinants by PCR 
and restriction digestion (Fig. 4-11). 
Figure 4-9.  Donor plasmid controls in the 
reporter gene “pathway” assembly. Results of 
the round 2 induction step are shown as a 
representative example.  Cells containing 
identical donor plasmids lacking the SceI 
endonuclease gene and/or the gusA fragment 
with lacZ homology were induced in parallel.  
A calculated 6x10
6
 cells were plated on 
synthetic media lacking histidine to assay for selective marker conversion after a 12-hour 
galactose induction. Homologous recombination stimulated by SceI endonuclease cleavage of 
the chromosome is expected to lead to conversion of the expressed alternating marker from 







Figure 4-10.  Phenotypic analysis of cured recombinants from the reporter gene “pathway” 
assembly. (A) Phenotypes of 12 unique cured colonies from each round of assembly.  In 
columns, recombinants are assayed for the HIS3 (synthetic media lacking histidine) and LEU2 
(synthetic media lacking leucine) markers.  In rows, recombinants are assayed for lacZ (Magenta-
Gal), gusA (X-Gluc), and MET15 (synthetic media lacking methionine). (B-E) Phenotypic analysis 
of a larger number of phrogged cured recombinants from (B) round 1, (C) round 2, and (D) round 
3 of the reporter gene proof-of-principle system assayed with Magenta-Gal, X-Gluc, and 
methionine-deficient media, respectively.  No colonies were phrogged in the boxed area of (C).   
(E) Phenotypic analysis with Magenta-Gal of cured round 1 recombinants resulting when lacZ 
was amplified as two overlapping subfragments. 
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To determine the source of the recombinants with inactive lacZ and gusA 
reporters in the reporter proof-of-principle system, we purified the genomic DNA of three 
of the white round 1 colonies and the single white round 2 colony shown in Figure 
4-10A.  PCR and restriction analysis of the white round 2 colony indicated correct 
construction of the pathway.  Sequencing of the integrated gusA gene showed that it had 
two mutations in the amino acid sequence, D436G and F551V.  For the white round 1 
Figure 4-11.  Genotypic analysis of cured recombinants from the reporter gene “pathway” 
assembly.  Genomic DNA was purified from four to six colonies from each round and analyzed by 
PCR and restriction digestion.  Representative data from round 3 colonies are shown.  In the 
diagram of the integrated construct, solid lines between regions of different color represent new 
junctions that were created during endonuclease-stimulated integration; dashed lines indicate 
new junctions that were created between PCR fragments by plasmid gap repair.  (P=undigested 
PCR product, B=BfuAI digest, W=BsaWI digest, G=BsrGI digest, G/H=BsrGI/HindIII digest, 




colonies, we could amplify the 5’ end of the expected construct (HO(L)pADH) but not 
the 3’ end (tADHLEU2), indicating that the complete fragment had not integrated as 
expected.  We have not observed this result for any of the other constructs tested.  
Analysis of the original lacZ PCR product transformed during round 1 revealed that there 
was a truncated DNA fragment that could not be removed by gel purification.  We 
subsequently repeated round 1, amplifying lacZ as two shorter, overlapping subfragments 
rather than as a single subfragment.  As shown in Figure 4-10E, a higher percentage of 
colonies (42 out of 48, or 87.5%) tested positive for lacZ using this modified protocol, 
and PCR analysis of the white colonies indicated that all contained the complete 
fragment. 
4.4 Discussion 
In this work, we have designed, implemented, and characterized a high-yielding, 
robust system for installing multi-gene pathways in the yeast chromosome.  Coupling the 
integration of DNA fragments to endonuclease cleavage of the chromosome and the 
conversion of a selectable marker enforces accurate and efficient DNA assembly.  The 
Reiterative Recombination framework is not construct specific, meaning that essentially 
any desired pathway of genes can be built with our existing strain.  In addition, if the use 
of a strain with a specific genetic background is required, most standard S. cerevisiae 
strains can easily be prepared for Reiterative Recombination in less than two weeks’ 
time.  Finally, DNA assembly systems analogous to our initial Reiterative Recombination 
method could be built in any organism with efficient homologous recombination 
machinery (e.g., Bacillus subtilis). 
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By providing a high-yielding method for the assembly of multi-gene constructs in 
vivo, Reiterative Recombination opens the door to the routine construction of gene 
circuits, pathways, and libraries thereof in the cell.  Reiterative Recombination’s high 
efficiency, together with its technical straightforwardness, makes it a reliable method for 
building pathways that is accessible to non-experts without specialized equipment.  While 
a handful of laboratories that are experts in the field have described landmark 
achievements in the realm of large-scale DNA assembly, these techniques have not yet 
been widely adopted by the scientific community.  Reiterative Recombination distills the 
construction of individual pathways into a user-friendly process that can be carried out by 
any laboratory equipped for basic molecular biology. 
The introduction of what we now consider “basic” molecular biology tools 
revolutionized our ability to study the function of individual genes and proteins; in the 
same way, we will need new, equally empowering technologies as the scale of our 
ambitions increases and our applications move into living cells.  Technologies such as 
Reiterative Recombination will contribute to the advance of synthetic biology by 
allowing cell engineers to easily build and refine new pathways in vivo so that 
reprogramming the cell can become a routine reality rather than a rare success.  
4.5 Experimental methods 
General materials and methods.  General materials and methods were as in 
Chapter 2. 
Construction of odd donor plasmid (pLW2592).  A 200-bp region of Humicola 
insolens Cel7B flanked by SfiI sites between SpeI and XbaI sites was amplified from 
pHL1262 with primers LMW244 and LMW245.  The PCR product and pRS416 were 
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digested with SpeI and XbaI and ligated to create vector pLW2639.  LEU2 was amplified 
from pRS425 with primers LMW250 and LMW255, and the product was amplified with 
primers LMW287 and LMW288; the 2 rounds of PCR added 20 bp of homology to the 
pPYK promoter at the 5’ end and an SceI cleavage site plus 30 bp of homology to 
pLW2639 at the 3’ end.  The pPYK promoter was amplified from FY251 genomic DNA 
with primers LMW284 and LMW286, adding 30 bp of homology to pLW2639 at the 5’ 
end and 20 bp of homology to LEU2 at the 3’ end.  The vector pLW2639 was digested 
with BstXI and co-transformed with the pPYK and LEU2 fragments into yeast to create 
vector pLW2641, containing LEU2 under control of the PYK promoter.  The yEGFP gene 
was amplified from pJEB2289E with primers LMW304 and LMW308, and the product 
was amplified with primers LMW305 and LMW308, adding an XbaI restriction site and 
32 bp of homology to pLW2641 at the 5’ end, and a (GSG)2 linker followed by 40 bp of 
homology to LEU2 at the 3’ end.  Vector pLW2641 was digested in the pPYK region 
with SnaBI and co-transformed with the GFP fragment into yeast to create vector 
pLW2646, containing a promoterless GFP-(GSG)2-LEU2 fusion protein.  The HO 
endonuclease gene was amplified from the genomic DNA of V2237Y with primers 
LMW310 and LMW311, containing 30 bp of homology to the GAL promoter and CYC1 
terminator of pRS426GAL.  The vector pLW2638, containing H. insolens Cel7B in 
pRS426GAL, was digested in the Cel7B gene and multiple cloning site with SalI and 
BstXI and co-transformed with the HO PCR product into yeast to create vector 
pLW2649, containing the HO endonuclease gene under the control of the galactose 
promoter.  The entire pGAL-HO-tCYC construct was amplified from pLW2649 with 
primers LMW300 and LMW301, containing 30 bp of homology to pLW2646 3’ to the 
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GFP-LEU2 fusion and SfiI stuffer region.  The vector pLW2646 was digested with SalI 
and co-transformed with the HO PCR product into yeast to create vector pLW2592.  The 
parental odd donor plasmid pLW2592 contains (promoterless) GFP-LEU2, followed by 
an SceI cleavage site, followed by an SfiI stuffer, followed by tCYC-HO-pGAL 
(transcribed towards the SfiI stuffer) (Fig. 4-12). The plasmid pLW2592 can be digested 
with HindIII, BsaBI, NotI, EagI, AleI, Eco53kI, or SacI to prepare it for plasmid gap 
repair. 
Construction of round 1 donor plasmid (pLW2594).  The HO(L)-KanMX 
region was amplified from pVC2265 with primers LMW336 and LMW337 and co-
transformed with BsaBI-digested pLW2592 into yeast to generate pLW2594 (Fig. 4-12).  
This plasmid can be used in place of the universal odd donor plasmid pLW2592 in round 
1.  The HO(L) region provides homology to facilitate integration of the first subfragment.  
The KanMX region can be cut out by restriction digestion (SmaI, XmaI, TspMI, BsoBI, 
or AvaI) before gap repair to make the desired linearized round 1 donor plasmid.  Uncut 
pLW2594 can be used as a positive control during the first round of Reiterative 
Recombination, as cured recombinants acquire resistance to G418 due to integration of 
the KanMX marker.  
Construction of even donor plasmid (pLW2593).  HIS3 was amplified from 
pRS423 with primers LMW253 and LMW256, and the product was amplified with 
primers LMW289 and LMW290; the 2 rounds of PCR added 20 bp of homology to the 
pPYK promoter at the 5’ end and an HO cleavage site plus 30 bp of homology to 
pLW2639 at the 3’ end.  The pPYK promoter was amplified from FY251 genomic DNA 
with primers LMW284 and LMW285, adding 30 bp of homology to pLW2639 at the 5’ 
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end and 20 bp of homology to HIS3 at the 3’ end.  The vector pLW2639 was partially 
digested with TfiI and co-transformed with the pPYK and HIS3 fragments into yeast to 
create plasmid pLW2640, containing HIS3 under the control of the PYK promoter.  An 
SfiI site was removed from the HIS3 gene by site-directed mutagenesis with primers 
LMW302 and LMW303 (Stratagene QuikChange Lightning) to generate vectors 
pLW2642 and pLW2643.  Vector pLW2642 was later found to have an insert in HIS3 
that appeared to be the result of concatamerization of the mutagenesis primers.  The 
yEGFP gene was amplified from pJEB2289 with primers LMW306 and LMW308, and 
the product was amplified with primers LMW307 and LMW308, adding an XbaI 
restriction site and 32 bp of homology to pLW2642 at the 5’ end, and a (GSG)2 linker 
followed by 40 bp of homology to HIS3 at the 3’ end.  Vectors pLW2642 and pLW2643 
were digested in the pPYK region with SnaBI and co-transformed with the GFP fragment 
into yeast to create vectors pLW2644 and pLW2645, respectively, containing a 
promoterless GFP-(GSG)2-HIS3 fusion protein.  The pGAL-SceI-tCYC construct was 
amplified with primers LMW300 and LMW301, containing 30 bp of homology to 
pLW2644 3’ to the GFP-HIS3 fusion and SfiI stuffer region.  The vector pLW2644 was 
digested with SalI and co-transformed with the SceI PCR product into yeast to create the 
vector pLW2648.   To eliminate the insertion in HIS3 in pLW2648, the GFP-HIS3 
construct from pLW2650 was amplified with primers LMW290 and LMW308 and co-
transformed with pLW2648, which had been digested with MscI and NheI to cut out part 
of the GFP-HIS3 gene, into yeast to create the vector pLW2652.  The MCS from pUC18 
was amplified with primers LMW360 and LMW361 and co-transformed with NotI-
digested pLW2652 into yeast.  The resulting generic even donor plasmid pLW2593 
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contains (promoterless) GFP-HIS3, followed by an HO cleavage site, followed by a 
multiple cloning site, followed by tCYC-SceI-pGAL (transcribed towards the multiple 
cloning site) (Fig. 4-12).  The plasmid pLW2593 can be digested with SphI, SalI, TspMI, 
XmaI, SmaI, Eco53kI, SacI, or EcoRI to prepare it for plasmid gap repair. 
Construction of donor plasmid negative controls (pLW2595 and pLW2596).  
The pGAL-MCS-tCYC construct from pRS416GAL was amplified using primers 
LMW300 and LMW301.  The plasmids pLW2646 and pLW2593 were digested with SalI 
and BseRI, respectively, and co-transformed with the PCR product into yeast to create 
the desired plasmids via homologous recombination.  The resulting plasmid pLW2595 
(from pLW2646) is equivalent to the odd donor plasmid pLW2592 except that there is no 
HO endonuclease gene under the control of the GAL promoter; the resulting plasmid 
pLW2596 (from pLW2593) is identical to the even donor plasmid pLW2593 except that 
there is no SceI endonuclease gene under the control of the GAL promoter. 
Construction of acceptor module integration plasmid (pLW2590).  The pPYK 
promoter was amplified from pLW2641 with primers LMW284 and LMW309, adding 30 
bp of homology to pLW2644 at the 5’ end and 36 bp of homology to pLW2644 (5’ end 
of GFP) at the 3’ end.  The vector pLW2644 was digested with XbaI and co-transformed 
with the pPYK fragment into yeast to create vector pLW2650, containing the pPYK-GFP-
HIS3-HO site construct.  (As transformants were selected on media lacking both histidine 
and uracil, the insert in HIS3 evidently looped out via homologous recombination to 
restore a functional HIS3 gene.)  Plasmids pRS416 and pVC2265 were digested with 
SpeI and ligated in order to place the HO(L)-KanMX-HO(R) integration module into a 
centromeric vector.  The desired plasmid pLW2653 was recovered by selecting for the 
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KanMX marker via G418 resistance in yeast and kanamycin resistance in E. coli.  The 
pPYK-GFP-HIS3-HO site acceptor module was amplified from pLW2650 with primers 
LMW326 and LMW327, containing 30 bp of homology to HO(L) (HO cleavage site end) 
and HO(R) (pPYK end).  The vector pLW2653 was digested in KanMX with EcoNI and 
BseRI and co-transformed with the acceptor module PCR into yeast to create vector 
pLW2590.  A fragment to integrate the odd acceptor module can be created by digesting 
pLW2590 with SpeI (Fig. 4-12).  
 
Figure 4-12.  Maps of donor plasmids and the acceptor module integration fragment for 





Construction of acceptor strain.  The MATa-inc allele was amplified from 
DY3025 genomic DNA with primers LMW312 and LMW313, incorporating homology 
to pRS426GAL, and co-transformed with SalI- and BstXI-digested pLW2638 into yeast 
to create plasmid pLW2651.  The 2 origin of replication was cut out of plasmid 
pLW2651 with AfeI, and the vector was religated and transformed into E. coli to create 
the integration vector pLW2588.  The vector pLW2588 was digested with BglII in the 
MATa-inc allele, transformed into BY4733, and selected on SC(−Uracil) media.  All 
transformants analyzed by colony PCR had the MATa-inc allele 5’ (in the W to Z 
direction
36
) to the plasmid sequences and the wild-type MATa allele 3’ to the plasmid 
sequences.  Transformants were grown non-selectively in YPD to allow loop-out of the 
duplicated gene and then plated on synthetic media containing 0.1% 5-FOA.  Five out of 
32 5-FOA-resistant colonies analyzed by colony PCR and restriction mapping with AciI 
contained the MATa-inc allele, including LW2589Y.  The genotype of this colony was 
further verified by sequencing of the MAT locus.  The vector pLW2590 was digested 
with SpeI and transformed into LW2589Y to integrate the odd acceptor module at the HO 
locus.  Correct integration was confirmed by colony PCR of HIS
+
 transformants, 
including the acceptor strain LW2591Y. 
Basic Reiterative Recombination protocol.  The protocol for an even round 
(e.g., round 2) of Reiterative Recombination is described.   
1) Preparation of subfragments: Subfragments were amplified with primers that 
added appropriate homology to adjacent fragments and to the donor plasmid (see 
below).  All PCR products were gel purified. 
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2) Transformation: The PCR products were co-transformed with the digested even 
donor plasmid (pLW2593) in a 100:1 ratio into the cured round 1 strain.  
Transformants were selected on synthetic complete media lacking leucine and 
uracil (SC(−Leucine, −Uracil)).   
3) Pre-Induction: (Optional) After two days of growth, transformants were lifted 
from the transformation plates, washed once with sterile water, resuspended in 
pre-induction media (SC(Lactate, −Leucine, −Uracil)) to an OD600 of 1, and 
shaken at 30°C for three hours.  (All experiments in this chapter incorporated a 
pre-induction step, but we have subsequently found that the pre-induction does 
not significantly improve the efficiency of marker conversion in Reiterative 
Recombination.) 
4) Induction: Cells were then harvested, washed once with sterile water, and 
resuspended in induction media (SC(−Uracil, 2% galactose, 2% raffinose)) to an 
OD600 of 0.1.  Cells were shaken at 30°C for 12 hours.   
5) Selection: For control experiments, aliquots of the induction cultures were 
immediately plated on selective media SC(−Histidine) to determine the efficiency 
of marker switching.  Colonies were counted after two days of growth.  The 
remaining cells were inoculated into SC(−Histidine) liquid media, shaken at 30°C 
for one day, and plated on SC(−Histidine, 0.1% 5-FOA) to cure recombinants of 
the donor plasmid. 
6) Reiteration: To begin the next round of Reiterative Recombination, after two days 
of growth, a single cured colony from the SC(−Histidine, 0.1% 5-FOA) plates 
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was inoculated into SC(−Histidine) liquid media to begin an overnight culture for 
the next transformation. 
For odd rounds of Reiterative Recombination, pLW2592 was used as the donor plasmid, 
and the use of histidine and leucine in dropout media was reversed.  All other aspects of 
the protocol remained the same. 
 
 Fragment design.  For clarity, a “fragment” refers to the total pathway-specific 
region of each donor plasmid, shown in orange in the figures.  When convenient, 
fragments were divided into “subfragments” that were PCR amplified from different 
templates and assembled into the full fragment by plasmid gap repair upon 
transformation into yeast.   Fragments contain 30 bp of homology to the donor plasmid 
and 20 bp of homology to the adjacent fragments (to provide a total of 40 bp of 
homology for each integration event) (Fig. 4-14).  Overlapping ends of subfragments 
(within fragments) contained a total of 40 bp of homology.  All regions of homology 
were incorporated with PCR primers.  
Figure 4-13. Reiterative Recombination 
timeline.  Arrows represent procedural steps; 
times indicate periods of growth. 
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The sequence of the assembled reporter gene pathway is provided in the 
Appendix.  The primers used to amplify constructs for donor plasmids made by plasmid 
gap repair in this chapter are shown in Table 4-2.  The numbers (1) and (2) indicate the 
primers and templates used for the first and second rounds of amplification of the 
subfragments if more than one round was necessary.  We used two rounds of PCR so that 
we could create universal outer primers that added homology to the donor plasmids.  This 
decreased the cost of primers and kept them short enough to require only standard 
desalting purification.  Primers LMW374 and LMW367 would be used as the outer 
primers for all subsequent odd rounds of Reiterative Recombination, and primers 
LMW374 and LMW375 serve as the outer primers for all even rounds of Reiterative 
Recombination.  From 5’ to 3’, inner primers contain an annealing region for the outer 
primers (if necessary), 20 bp of homology to the adjacent fragment or subfragment, and a 
priming region for the subfragment being amplified.  Typically we could use the 
unpurified PCR from first reaction as a template for the second round.  For the round 1 
reporter gene pathway subfragment, we added homology to HO(L) and used the round 1 
donor plasmid pLW2594 rather than the universal odd donor plasmid pLW2592. 
 
 
Figure 4-14. General design of subfragment 
homology regions for plasmid gap repair and 
Reiterative Recombination.  The recombination 
events that create a construct-specific donor 
plasmid from a universal donor plasmid and 




Table 4-2. PCR amplification of subfragments for Reiterative Recombination. 
Elongation 
Round 
Subfragment Construct Primers Template 
Homology length test 
1 
(pLW2592 donor) 
41 bp homology HO(L)-KanMX LMW353/337 pVC2265 
70 bp homology HO(L)-KanMX LMW354/337 pVC2265 
101 bp homology HO(L)-KanMX LMW355/337 pVC2265 
950 bp homology HO(L)-KanMX LMW336/337 pVC2265 




1) LMW419/420  
2) LMW419/367 
1) pLW2577 






1) LMW421/422  
2) LMW374/422 
1) pLW2655 




1) LMW423/424  
2) LMW423/375 
1) FY251 gDNA 







1) LMW425/426  
2) LMW374/426 
1) FY251 gDNA 






1) FY251 gDNA 
2) PCR (1) 
 Validation of Reiterative Recombination system.  The HO(L)-KanMX region 
of pVC2265 was amplified with 5’ primers that annealed to different positions on HO(L) 
to obtain homology regions of different lengths as shown in Table 4-2.  The primers also 
added 30 bp of homology to pLW2592.  The vector pLW2592 was digested in the SfiI 
stuffer region with BsaBI and co-transformed with the HO(L)-KanMX insert into 
LW2591Y.  Colonies were lifted from the transformation plates (SC(−Histidine, 
−Uracil)), washed with sterile water, resuspended in 5 mL of pre-induction media 
(SC(Lac, −Histidine, −Uracil)), and shaken at 30ºC for 3 hours.  Two 2-mL aliquots were 
harvested separately, washed with sterile water, resuspended in 5 mL of induction media 
(SC(−Uracil, 2% galactose, 2% raffinose)) or non-inducing media (SC(−Uracil, 2% 
glucose)), and shaken at 30ºC for 14 hours.  Cells were plated on SC(−Leucine) to 
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identify successful round 1 recombinants, which were counted after 2 days of growth at 
30ºC.  Colonies scraped from the SC(−Leucine) plates (from the galactose induction) 
were plated on SC(−Leucine, 0.1% 5-FOA) to cure the cells of remaining donor plasmid.  
Pooled 5-FOA-resistant colonies were plated on YPD, YPD/G418, and SC(−Uracil) to 
verify successful integration of the KanMX marker and loss of the donor plasmid.  
Genomic DNA from four round 1 recombinants was purified and analyzed by PCR and 
restriction analysis to verify that recombination occurred as expected, and the acceptor 
module from one of these colonies was sequenced as further verification. 
To begin round 2, these 5-FOA-resistant round 1 recombinants were transformed 
with pLW2652.  Colonies were lifted from the transformation plates (SC(−Leucine, 
−Uracil)), washed with sterile water, resuspended in 3 mL pre-induction media 
(SC(Lactate, (−Leucine, −Uracil)), and shaken at 30ºC for 3 hours.  Two 1-mL aliquots 
were harvested separately, washed with sterile water, resuspended in 1.5 mL of induction 
media (SC(−Uracil, 2% galactose, 2% raffinose)) or non-inducing media (SC(−Uracil, 
2% glucose)), and shaken at 30ºC for 12 hours.  Cells were plated on SC(−Histidine) to 
identify successful round 2 recombinants, which were counted after 2 days of growth at 
30ºC.  Colonies scraped from the SC(−Histidine) plates (from the galactose induction) 
were plated on SC(−Histidine, 0.1% 5-FOA) to cure the cells of the remaining donor 
plasmids. 
 To begin round 3, these 5-FOA-resistant round 2 recombinants were transformed 





4.6 Strains, plasmids, and oligonucleotides 
 
Table 4-3. Strains used in this study 
Name Genotype Source/Reference 
BY4733 MATa his3200 leu20 met150 trp163 ura30  ATCC #200895/40 
DY3025 
MATa-inc ade2-101 his3-200 leu21 
lys2-801::pUCGALHO::LYS2 trp11 
ATCC #MYA-2358/45 
FY251 MATa trp1Δ63 his3Δ200 ura3-52 leu2Δ 1 GAL+ M. Carlson 
V2237Y 
MATa pGAL-HO hmla trp1 leu2 his3 ura3 ade2-1 
can1-100 SWI+ 
K. Nasmyth/46 
LW2589Y BY4733 MATa-inc This study 
LW2591Y 
Reiterative Recombination parental acceptor strain 
BY4733 MATa-inc pLW2590 integrated 
This study 
LW2659Y Round 1 recombinant from reporter gene pathway This study 
LW2660Y Round 2 recombinant from reporter gene pathway This study 
LW2661Y Round 3 recombinant from reporter gene pathway This study 
 
Table 4-4. Plasmids used in this study 
Name Details Source/Reference 
pHL1262 pRS426MET- H. insolens Cel7B H. Lin/47 
pJEB2289 Plasmid containing 8LexAop-pGAL-yEGFP B. Petersen/48 
pRS416 CEN6/ARSH4 URA3 pBIISK ori amp
R
 ATCC #87521 
pRS416GAL pGAL1 CEN6/ARSH4 URA3 pBIISK ori amp
R
 ATCC #87332 
pRS423 2 HIS3 pBIISK ori amp
R
 ATCC #77104 
pRS425 2 LEU2 pBIISK ori amp
R
 ATCC #77106 
pRS426GAL pGAL1 2 URA3 pBIISK ori amp
R
 ATCC #87333 
pUC18 pMB1 ori amp
R
  
pVC2265 HO-polylinker-KanMX4-HO D. Stillman/43 
pLW2577 pJG4-5 with pADH-lacZ inserted This study 
pLW2588 Integrating version of pLW2651 This study 
pLW2590 
Plasmid containing acceptor module integration 
fragment for Reiterative Recombination 
pRS416 with HO(R)-pPYK-GFP-HIS3-HO site-HO(L) 
This study 
pLW2592 
Universal odd donor plasmid for Reiterative 
Recombination 
pGAL1-HO-tCYC GFP-LEU2-SceI cleavage site 





Universal even donor plasmid for Reiterative 
Recombination 
pGAL1-SceI-tCYC GFP-HIS3-HO cleavage site 





Round 1 donor plasmid for Reiterative Recombination 
pGAL1-HO-tCYC GFP-LEU2-SceI cleavage site-





pGAL1-tCYC GFP-LEU2-SceI cleavage site 







pGAL1-tCYC GFP-HIS3-HO cleavage site 




pLW2638 pRS426GAL- H. insolens Cel7B This study 
pLW2639 pRS416 with Cel7B stuffer between SfiI sites This study 
pLW2640 pPYK-HIS3-HO site in pLW2639 This study 
pLW2641 pPYK-LEU2-SceI site in pLW2639 This study 
pLW2642 pPYK-HIS3*-HO site (SfiI stuffer removed) in pLW2639 This study 
pLW2643 pPYK-HIS3-HO site (SfiI stuffer removed) in pLW2639 This study 
pLW2644 GFP-HIS3*-HO site in pLW2639 This study 
pLW2645 GFP-HIS3-HO site in pLW2639 This study 
pLW2646 GFP-LEU2-SceI site in pLW2639 This study 
pLW2648 pGAL1-SceI-tCYC GFP-HIS3*-HO site in pLW2639 This study 
pLW2649 pRS426GAL-HO This study 
pLW2650 pPYK-GFP-HIS3-HO site in pLW2639 This study 
pLW2651 pRS426GAL-MATa-inc This study 
pLW2652 pGAL1-SceI-tCYC GFP-HIS3-HO site in pLW2639 This study 
pLW2653 pRS416 with HO(L)-KanMX-HO(R) This study 
pLW2655 pBC398 with pADH-LacZ inserted This study 
 
Table 4-5. Oligonucleotides used in this study 
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*The content of this chapter will be partially published in  
L.M. Wingler, V.W. Cornish. “Reiterative Recombination for the In Vivo Assembly of 
Libraries of Multi-Gene Pathways,” submitted. 
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5.0 Chapter outlook 
Metabolic engineering holds the promise of ultimately offering a general and 
elegant solution for the production of complex natural product therapeutics and their 
analogs.  However, simply transplanting the genes required to biosynthesize a given 
natural product into a heterologous organism “as is” is rarely sufficient.  Obtaining 
natural product production at all, much less in competitively high yields, typically 
requires multiple changes to the biosynthetic pathway and the host strain’s genetic 
background.  Modifying and rebuilding biosynthetic pathways to optimize compound 
production has become a rate-limiting step in the metabolic engineering field.  Here we 
show that our Reiterative Recombination system for in vivo DNA assembly can address 
several technical challenges associated with customizing biosynthetic pathways.  First, 
Reiterative Recombination provides a robust and straightforward method for building 
individual pathways.  We explicitly demonstrate the construction first of a functional 
minimal pathway for biosynthesis of the terpenoid pigment lycopene in yeast and then of 
an extended pathway over 20 kilobases in length that was designed to optimize lycopene 
yields.  Second, Reiterative Recombination’s high efficiency makes it uniquely suitable 
for generating large collections of pathway variants inside of the cell for combinatorial 
optimization.  We show we can construct libraries of ≥104 different pathways, using a 
mock screen of active to inactive lycopene pathways that explicitly tests library size.  
Third, pathways built in yeast via Reiterative Recombination can be shuttled to other 
organisms if a different host is preferred, as we show by moving an operon directing 
carotenoid biosynthesis into E. coli.  The development of next-generation versions of 




5.1.1 Multi-gene pathways for metabolic engineering 
 Metabolic engineering has the potential to transform the production of the natural 
products and derivatives that dominate the pharmaceutical market1,2.  Though expert 
organic chemists have made enormous strides in synthesizing these structurally complex 
compounds3,4, each total synthesis is truly its own tour de force, limiting the number and 
quantity that can be chemically synthesized.  An attractive alternative is to use cells’ 
natural biosynthetic machinery to produce natural products or advanced intermediates.  
While most natural products cannot be obtained in substantial amounts from their native 
hosts5, a handful of recent, high-profile breakthroughs in metabolic engineering6-9 have 
raised the tantalizing prospect of, ultimately, routinely biosynthesizing any desired 
natural product or analog in tractable heterologous microorganisms10-12. 
Our ability to engineer cells to produce natural products, however, currently is 
obstructed by the technical difficulty of constructing optimized, multi-gene biosynthetic 
pathways in the host cell.  Simply transplanting a given set of biosynthetic genes into a 
new organism “as is” is rarely productive.  For optimal performance, the original DNA 
sequence typically must be modified by, for example, replacing promoters, optimizing 
genes’ codon usage, and adding or overexpressing genes for precursor production (Fig. 
5-1A)12,13.  In addition, researchers have endeavored to produce novel analogs by 
deleting, mutating, exchanging, or adding pathway genes (Fig. 5-1B)14-19.  Making these 
multiple, defined changes within a pathway or rebuilding pathways from smaller 
fragments increases in difficulty with pathway size5,18.  As sequences become longer, 
fewer unique restriction sites exist, and simply handling the DNA in vitro becomes 
cumbersome.  The crux of the problem is that standard molecular biology tools, intended 
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for the manipulation of single genes, are simply not intended to address these larger-scale 
applications. 
 
Many of the multi-gene DNA assembly techniques reported in recent years have 
been developed with an eye towards introducing defined modifications within large 
biosynthetic pathways.  Researchers at Kosan Biosciences, focusing on polyketide gene 
clusters, solve this problem by constructing entirely synthetic DNA sequences in vitro20.  
They begin with chemically synthesized, 40-bp oligonucleotides, allowing them to fully 
specify the desired sequence of the final pathway.  These oligonucleotides are 
hierarchically assembled into pathways tens of kilobases in length using a series of PCR-
based assembly methods and “ligation by selection,” a cyclical, stringent subcloning 
method (see Section 4.1.1).  However, the expense of synthesizing such a large number 
of oligonucleotides and the time-consuming nature of the assembly process make this in 
vitro construction process impractical for most researchers. 
Figure 5-1. Modifying biosynthetic pathways for metabolic engineering. (A) Metabolite yields 
can be improved more rapidly by testing multiple variables (e.g. mutating pathway enzymes, 
testing isozymes, or adjusting expression levels) in parallel. (B) Generating libraries of modified 
pathways can enable the biosynthesis of natural product analogs.  Both applications can benefit 
from combinatorial approaches. 
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Shao et al. have used DNA assembler to assemble biosynthetic pathway variants 
in vivo21.  In this method, multiple overlapping DNA fragments are co-transformed into 
yeast to assemble pathways by homologous recombination22 (see Section 4.1.2).  Point 
mutations can be incorporated into the pathway through the appropriate design of PCR 
primers used to amplify the overlapping fragments, and the authors demonstrated this by 
mutating a conserved motif in a gene in the aureothin biosynthetic pathway, thereby 
inactivating the enzyme and generating a different polyketide product21.  They also used 
DNA assembler to create a hybrid pathway derived from the closely related aureothin and 
spectinabilin gene clusters21.  However, the authors report needing to use long (400-bp) 
regions of overlap between fragments whenever possible to promote assembly.  This 
constraint will limit the ability of this method to piece together fragments arising from 
different sources; overlap regions would need to be added on using in vitro methods (e.g., 
overlap extension PCR). 
5.1.2 Multi-gene libraries for metabolic engineering 
 Despite enormous advances in our understanding of systems-level biology in the 
past decade, our ability to rationally predict the effects of perturbations to the cell’s 
metabolism remains limited23,24.  Thus, in addition to the technical difficulty of 
modifying biosynthetic pathways, there is an intellectual bottleneck hindering the 
optimization of heterologous natural product biosynthesis.  Library approaches can 
bypass these gaps in our knowledge, and metabolic engineers have repeatedly improved 
natural product yields and synthesized analogs by searching libraries of isozymes18,25, 
mutant biosynthetic enzymes9,26, or promoters and regulatory regions that modulate the 
expression levels of genes that alter pathway flux27,28.  However, the scope of these 
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experiments has been very limited due to the technical difficulty of building libraries of 
pathways in vivo.  Typically only one or two components of a pathway can be 
manipulated in a single experiment, potentially missing synergistic effects, and only very 
small libraries can be generated, often using very labor-intensive routes. 
In spite of the proliferation of DNA assembly techniques in recent years, and in 
spite the often-professed desire of researchers in fields such as metabolic engineering to 
generate libraries of pathways, there are very few reports of using these methods to 
generate libraries of optimized or modified biosynthetic pathways.  For example, Kosan 
Biosciences, the creators of “ligation by selection,” surprisingly did not employ this 
method when they later constructed a library of pathways to make polyketide natural 
products18.  Rather, using a very labor-intensive strategy, the researchers replaced two 
modules in a polyketide synthase pathway with 11 and 14 variants in separate plasmids in 
vitro and individually co-transformed each combination of plasmids to generate 154 
different triketide synthase pathways.   
 The Venter Institute has only published a single example of constructing a library 
using their “in vitro isothermal assembly” method29 (see Section 4.1.1), even though they 
report that it proceeds with very high efficiency30,31.  The authors made a small, 144-
member library of two-gene pathways designed to enable mutant E. coli strains to utilize 
acetate as their sole carbon source29.  Though the researchers argued that their 
transformation efficiency (10,000 clones) is more than sufficient to cover their library, 
they did not explicitly demonstrate that all possible library constructs were made.  After 
selection for acetate utilization, which would eliminate any non-functional or weakly 
functional pathways, they characterized just 37 clones and showed that the 30 out of 37 
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clones that actually had the correctly assembled pathway represented ~10% of the 
theoretical library.     
There are no reports of making libraries of pathways using in vivo assembly 
methods.  It is important to note that these techniques yield only tens to hundreds of 
recombinants at a time22,32-35, and these numbers represent the maximum library 
complexity that these methods can achieve, even if the method allows iterative pathway 
elongation34,35.  Given that library sizes rapidly swell when exploring multiple variables 
in the context of pathway optimization (e.g., testing 100 mutants of enzyme 1 against 100 
mutants of enzyme 2 is already 104 combinations), much higher assembly efficiencies are 
needed to even begin sampling the potential diversity available. 
Having established that Reiterative Recombination provides a facile and efficient 
method for the assembly of multi-gene constructs (Chapter 4), here we show that 
Reiterative Recombination can begin to address several challenges faced by metabolic 
engineers.  First, we demonstrate that Reiterative Recombination can build functional 
biosynthetic pathways, including constructs that are over 20 kilobases in length.  
Compared to conventional strain construction techniques and alternative DNA assembly 
methods, this process is robust, modular, and user-friendly.  Next, we explicitly show that 
Reiterative Recombination can generate large libraries of pathways, containing at least 
104 variants, inside of the cell using a mock screen.  Finally, we establish that 
biosynthetic pathways built by Reiterative Recombination in the yeast chromosome can 






5.2.1 Application of Reiterative Recombination to the construction of the lycopene 
biosynthetic pathway 
 Our first objective was to demonstrate that Reiterative Recombination could be 
used to construct functional biosynthetic pathways in vivo, thereby establishing its 
generality and its utility for metabolic engineering.  We strategically selected the 
terpenoid pigment lycopene for this purpose.  Most valuable terpenoids (e.g., taxol, 
artemisinin) lack high-throughput assays for measuring production, and lycopene is 
widely used as a convenient colorimetric screen to optimize yields of common terpenoid 
precursors (Fig. 5-2A; see Section 5.2.2).  Coupling lycopene biosynthesis to primary 
yeast metabolism requires the addition of three exogenous genes36: crtE (geranylgeranyl 
diphosphate synthase), crtB (phytoene synthase), and crtI (phytoene desaturase). 
Using Reiterative Recombination, we integrated codon-optimized versions of 
Erwinia herbicola crtE (round 1), crtB (round 2), and crtI (round 3) to generate a yeast 
strain capable of producing lycopene (Fig. 5-2B).  We also integrated the selectable 
marker TRP1 during round 3 to provide further verification of correct pathway assembly.  
After the third round of assembly, 99% of the resulting recombinants exhibited the 
expected orange phenotype that is indicative of lycopene production (Fig. 5-2F).  In 
parallel, as negative controls, we built pathways containing nonsense mutations in crtB 




5.2.2 Construction of an optimized biosynthetic pathway via Reiterative 
Recombination 
Our next objective was to challenge our technology, not just to build pathways, 
but 1) to build significantly longer pathways (>10 kb in length) requiring numerous 
rounds of elongation and 2) to build defined pathways designed to optimize yields of 
natural products, specifically terpenoids.  Terpenoids are a particularly prominent class of 
metabolic engineering targets.  Though they are all derived from the universal precursor 
isopentenyl pyrophosphate (IPP), the >55,000 terpenoids isolated to date exhibit vast 
Figure 5-2. Assembly of the lycopene biosynthetic pathway using Reiterative Recombination.  (A) 
Terpenoids such as taxol, artemisinin, and lycopene share the same common precursor FPP.  
Therefore, lycopene production can be used as a colorimetric screen to optimize flux towards the 
terpenoid pathway.  (B) Order of crt gene insertion.  Phenotypes of cured round 3 colonies 
containing wild-type crtE and (C) crtB-stop + crtI-stop, (D) crtB-stop + crtI-silent, (E) crtB-silent + 
crtI-stop, and (F) crtB-silent + crtI-silent.  For (F), 315 out of 317 colonies had an orange 
phenotype; none of the other plates contained any orange colonies. 
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structural and functional diversity37.  Many terpenoids, such as the chemotherapeutics 
taxol (paclitaxel) and vinblastine and the antimalarial artemisinin, are frontline 
therapeutics but cannot be sustainably supplied to the commercial market from their 
natural sources38,39.  Routine expression of these structurally complex small molecules in 
robust, heterologous hosts such as yeast and bacteria would be (and in the case of 
artemisinin, is6,40,41) a breakthrough for the production of known pharmaceuticals and the 
discovery of potent new terpenoids. 
Yeast metabolism, however, is not inherently geared toward high-titer terpenoid 
production, and terpenoid precursors (e.g., IPP and farnesyl pyrophosphate (FPP)) are 
largely channeled into sterol production39.  Metabolic engineers have repeatedly 
improved terpenoid yields in yeast by overexpressing endogenous, heterologous, or 
mutant genes encoding regulatory proteins or biosynthetic enzymes that divert metabolic 
flux towards FPP (ALD642, S. cerevisiae or Salmonella enterica ACS142, truncated  
HMG16,43-46, ERG206, BTS144, upc2-16,46,47).  However, there are few examples of 
searching for additive effects by overexpressing multiple genes6,23,42,48, undoubtedly 
because of the difficulty of constructing such strains. 
Our collaborators in the Stephanopoulos group at the Massachusetts Institute of 
Technology previously made a yeast strain containing the three E. herbicola crt genes 
required for lycopene production along with five additional genes known to improve 
terpenoid yields when overexpressed individually (P. Ajikumar and G. Stephanopoulos, 
personal communication).  Introducing this unusually large number of overexpressed 
genes into a single strain took two students almost a year using conventional genetic 
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techniques.  The five “extra” genes indeed increased lycopene production 4-fold (to 14 
mg/L). 
Clearly, faster strain construction routes are needed to achieve truly high-titer 
terpenoid production in yeast.  Thus, we explicitly demonstrated the utility of Reiterative 
Recombination for such tasks by constructing a strain containing the same eight 
overexpressed genes.  Beginning with the minimal lycopene-producing strain constructed 
in Figure 5-2, we continued the Reiterative Recombination process for an additional five 
rounds, giving a final construct 21 kb in length resulting from a total of eight rounds of 
elongation (Fig. 5-3A).  Significantly, reconstructing the entire pathway took less than 
two months using a protocol that required minimal effort in its design and execution.  We 
verified the pathway’s integrity by PCR, restriction analysis, and sequencing of strains’ 
genomic DNA (Fig. 5-3B).  To recreate the Stephanopoulos laboratory’s strain as 
faithfully as possible, we used the same three strong, constitutive promoters to drive the 
expression of all eight genes.  We eliminated the possibility of having these repeated 
elements “loop out” by homologous recombination and delete portions of the pathway by 
separating repeats with the selectable markers TRP1 and MET15.  Since metabolic 
engineers frequently reuse a small number of preferred regulatory elements, this now-
validated design strategy should expand the utility of Reiterative Recombination.   
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5.2.3 Construction of libraries of biosynthetic pathways via Reiterative 
Recombination 
A distinctive advantage of Reiterative Recombination is that every step of the 
cyclical elongation process proceeds with very high efficiency.  Using a basic yeast 
electroporation protocol, we can readily obtain as many as 106-108 transformants per 
transformation49; the induction, which is readily scalable, typically gives ≫104 
Figure 5-3. Assembly of an optimized lycopene biosynthetic pathway using Reiterative 
Recombination.  (A) Order of gene insertion using eight rounds of Reiterative Recombination.  (B)
The purified genomic DNA of a colony from the eighth round of Reiterative Recombination was 
analyzed by PCR and restriction mapping.  The subfragments lifted by each PCR reaction and 
the expected sizes of the PCR products and restriction fragments are shown in the table.  For 
each pair of lanes in the gel, the left lane is the undigested PCR reaction; the right lane is the 
digested PCR reaction. (100bp=100 bp DNA ladder, 1kb= 1 kb DNA ladder) 
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recombinants per milliliter of culture.  We therefore expected that we could generate 
larger libraries of pathways than attainable with other in vivo DNA assembly techniques, 
which generate only tens to hundreds of constructs at a time.  To test this hypothesis, we 
used the lycopene biosynthesis pathway to explicitly challenge Reiterative 
Recombination’s ability to construct large libraries.   
We repeated rounds 2 and 3 of the minimal lycopene pathway assembly, this time 
transforming various ratios of crtB and crtI alleles that contained either nonsense or silent 
mutations with diagnostic restriction sites (Fig. 5-4).  Initially, we did not recover 
lycopene-producing colonies from our libraries at the expected frequencies.  Further 
analysis of the pool of cured recombinants obtained from various Reiterative 
Recombination rounds, both from the reporter proof-of-principle system (Section 4.3.3) 
and the lycopene pathway assembly, revealed that a small percentage of cured 
recombinants (≤0.2%; Table 5-1) acquired both the HIS3 and LEU2 markers.  This 
subpopulation of cells was sufficient to skew the observed ratios of orange colonies after 
carrying the library forward for multiple rounds.   
 
 
Figure 5-4. Construction of mock libraries of 
lycopene biosynthetic pathways via 




Table 5-1. Percentage of cells with the HIS LEU phenotype in cured recombinant pools from 
various rounds of Reiterative Recombination.   
Round Percentage of recombinants 
with HIS LEU phenotype 
Reporter proof-of-principle 
 
Round 1 0.2% 
Round 2 0.00007% 
Lycopene library round 2 
 
10:1 crtB stop:silent 0.006% 
100:1 crtB stop:silent 0.01% 
While we are developing a next-generation Reiterative Recombination system 
that eliminates this problem entirely (Section 5.2.5), we were immediately able to 
construct large libraries in this first-generation system by simply selecting for the TRP1 
marker at the end of the pathway (Fig. 5-2A) after the last round of assembly.  This 
additional selection served as a stringent final purification step for our libraries and, 
importantly, is a general solution that could be used for any desired library application.  
As shown in Table 5-2, we were readily able to recover lycopene-producing colonies at 
the expected frequencies from mock libraries of up to 104.  These colonies contained the 
expected silent mutations in crtB and crtI, demonstrating that they arose from the silent 




Figure 5-5. Restriction 
analysis of cured 
recombinants from the 
lycopene library screen.  
(C,D) Ten orange colonies from the 10:1 crtB stop:silent + 0:1 crtI stop:silent library.  (E,F) The 
five orange colonies from the 100:1 crtB stop:silent + 0:1 crtI stop:silent library.  (G,H) The three 
orange colonies from the 100:1 crtB stop:silent + 10:1 crtI stop:silent library.  (I,J) Ten white 
colonies from the 100:1 crtB stop:silent + 100:1 crtI stop:silent library.  (K,L) The three orange 
colonies from the 100:1 crtB stop:silent + 100:1 crtI stop:silent library.   
Regions of the crtB (A,C,E,G,I,K) and 
crtI (B,D,F,H,J,L) genes containing 
the diagnostic mutations were 
amplified by colony PCR and 
digested with EcoRV and BsmBI, 
respectively.  Only alleles containing 
the silent mutations are cut by these 
enzymes.  The plasmids with the 
B-stop, B-silent, I-stop, and I-silent 
alleles that served as PCR templates 
for the subfragments were PCR 
amplified and digested in parallel as 
controls.  “Ladder” is a 100 bp ladder.  
(A,B) From left to right, four colonies 
each from the crtB-stop + crtI-stop,
crtB-stop + crtI-silent, crtB-silent + 
crtI-stop, and crtB-silent + crtI-silent 
“libraries” from Figure 5-2(C-F).  
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Table 5-2. Mock screen for lycopene-producing strains via Reiterative Recombination. 













10:1 0:1 101 2360 225 10% 0.5 
100:1 0:1 102 587 5 0.9% 0.7 
100:1 10:1 103 2079 3 0.1% 0.4 
100:1 100:1 104 18450 3 0.02% 0.4 
aSince the plated cells represented a randomly selected aliquot (<0.1%) of the population, a 
1-proportion z-test was used to test if the observed percentages of orange colonies were 
significantly different than the expected percentages.  All P-values were greater than α=0.1, 
indicating that none were significantly different. 
5.2.4 Transfer of a Reiterative Recombination pathway to a heterologous 
organism 
While S. cerevisiae is gaining popularity as a host organism for metabolic 
engineering applications, other organisms such as E. coli, Streptomyces coelicolor, and 
Streptomyces lividans are the preferred heterologous hosts for many natural products10,11.  
Only very simple polyketides50,51 and non-ribosomal peptides52, for example, have been 
successfully produced in yeast.  To demonstrate that Reiterative Recombination is not 
limited to the assembly of DNA for yeast, we reconstructed a previously described, three-
gene pathway for tetradehydrolycopene synthesis in E. coli (Fig. 5-6A)53.  Since our first 
Reiterative Recombination system can only be used to assemble genes in the yeast 
chromosome, we attempted to move the construct onto an E. coli shuttle vector using 
plasmid gap repair from the chromosome54.  Though gap repair is an established 
technique for applications such as the retrieval of mutant alleles55, recovery of the much 
larger carotenoid pathway was inefficient, so we used a fourth round of elongation to add 
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a gene for kanamycin resistance, giving a 5-kb construct, and created a self-cleaving 
recovery vector to stimulate homologous recombination (Fig. 5-6B).  E. coli 
retransformed with the recovery vector were selected for kanamycin resistance, leading to 
identification of a plasmid with the intact construct.  Colonies with this plasmid had the 
same colorimetric phenotype due to tetradehydrolycopene production as those with the 
previously reported plasmid (Fig. 5-6C)53.  The shuttle vector containing the recovered 
plasmid was 15 kb, near the size limit for pMB origins of replication, and poor stability in 
E. coli likely contributed to our difficulty moving the construct.  
 
Figure 5-6.  Assembly and shuttling of the E. 
coli carotenoid biosynthetic pathway.  (A) Order 
of gene insertion by Reiterative Recombination.  
(B) The assembled pathway was recovered 
from the yeast chromosome into an E. coli shuttle vector using a self-cleaving plasmid as shown. 
(C) Following retransformation of the plasmid into E. coli, colonies that exhibited the expected 
orange phenotype indicative of tetradehydrolycopene production were identified.  Colonies were 
transferred to filter paper to show the colorimetric phenotype more clearly.  Positive and negative 
control strains are shown in the top left and right corners, respectively.  The bottom filter contains 
strains with the pathway built by Reiterative Recombination. 
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5.2.5 Design of next-generation Reiterative Recombination systems 
 To expand the scope and utility of Reiterative Recombination, we have designed 
and are constructing several next-generation systems.  First, we are developing 
methodology to assemble pathways on plasmids rather than on the yeast chromosome to 
facilitate their transfer to other organisms.  Our preliminary results showed that recovery 
and transfer of even a short, 5-kb pathway from the yeast chromosome was difficult and 
inefficient (Section 5.2.4).  We anticipate that the most effective strategy for DNA 
transfer will be to build constructs directly in shuttle vectors.  The ideal acceptor plasmid 
for transfer to heterologous hosts will 1) stably maintain large inserts in both yeast and 
the heterologous organism and 2) lack homology to the yeast chromosome and to donor 
plasmids that could lead to unwanted recombination.  As an example, to transfer 
Reiterative Recombination constructs to E. coli, we plan to construct an acceptor plasmid 




 Second, we plan to replace the alternating selectable HIS3 and LEU2 selectable 
markers in Reiterative Recombination with markers that have both positive and negative 
selections, namely TRP157 and LYS258 (Fig. 5-7B).  As shown in Table 5-1, a small 
Figure 5-7.  Next-generation Reiterative Recombination systems. (A) The S. cerevisiae/E. coli
shuttle vector will contain 1) the Reiterative Recombination acceptor module, 2) sequences to 
propagate the plasmid as a bacterial artificial chromosome (F-factor) and centromeric vector 
(CEN4) in E. coli and yeast, respectively, 3) and selectable markers for E. coli (CmR) and yeast 
(TRP1). (B) Reiterative Recombination using positive- and negative-selectable alternating 
markers. (C) Conversion of acceptor modules into donor modules enables convergent DNA 
assembly, allowing combination of existing pathways and decreasing the number of cycles 
needed to build long clusters. (D) Conversion of acceptor modules into donor modules is 
accomplished by adding a second copy of GFP upstream of the acceptor module’s promoter, 
creating a direct repeat.  We will use URA3 and LYS2, which have both positive and negative 
selections, as the GFP-marker fusions. Counter selection against URA3 and LYS2 can be used 
to identify cells in which recombination between the GFP repeats has led to deletion of the 
promoter (frequency ~10-4, 56), effectively converting the acceptor module into a chromosomal 
donor module.  At all other times, selection for expression of the GFP-marker will eliminate cells 
that excise the promoter.  Haploid cells of opposite mating type (a and α) will be mated to 
generate diploids with both acceptor and donor modules.   
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minority of colonies acquire both alternating selectable markers during each round of 
Reiterative Recombination.  This phenomenon does not interfere with the construction of 
individual pathways, where single colonies can be carried forward, but it does become 
problematic when libraries are carried forward through multiple rounds.  Having counter 
selectable alternating markers will allow libraries to be purified of cells that did not 
undergo correct marker conversion at every round.  Even though the TRP1 and LYS2 
counter selections are less robust than the favored URA3 counter selection, which is 
already being employed for donor plasmid curing, they should be adequate to eliminate 
the already low fraction of cells with both selectable markers. 
 Finally, an intriguing strategy that we ultimately want to incorporate into strain 
optimization is combinatorially combining pathways.  Towards this end, we plan to 
exploit sexual reproduction for convergent DNA assembly (Fig. 5-7C).  The key features 
of this variation on Reiterative Recombination are 1) mating and sporulation cycles and 
2) conversion of acceptor modules into donor modules (Fig. 5-7D).  Conversion is 
achieved by excising acceptor modules’ promoters with direct repeats and by employing 
counter selectable markers.  We will use mating and sporulation, rather than 
transformation, to bring donor and acceptor modules together.  Other elements of 
Reiterative Recombination will be the same as in the original system.   
Convergent assembly will add exciting new dimensions to Reiterative 
Recombination.  First, we envision both rationally and combinatorially building “super 
strains” combining the best pathways identified in separate experiments. Second, 
convergent pathway assembly will dramatically decrease the time and effort required to 
build long pathways (# linear assembly rounds = 2(# convergent assembly rounds − 1)).  Concretely, 
154 
 
the time to construct even the relatively modestly-sized 21-kb optimized lycopene 
pathway (Fig. 5-3A) would be cut in half (one versus two months).  In the longer term, 
this advance will be a sine qua non as we anticipate assembling pathways such as 
polyketide synthase gene clusters that can be >100 kb (e.g., assembling a 100-kb pathway 
in 5-kb increments would take 4-5 months with Reiterative Recombination via linear 
assembly, but only one month with convergent assembly).   
5.3 Discussion 
We have demonstrated that Reiterative Recombination addresses multiple 
technical bottlenecks being encountered by the metabolic engineering community, 
namely, the construction of individual defined biosynthetic pathways, the generation of 
large libraries of pathway variants, and the transfer of constructed pathways into 
preferred host organisms.  The construction of a functional biosynthetic pathway in yeast, 
specifically the lycopene biosynthesis pathway, establishes the generality of Reiterative 
Recombination for DNA assembly and its application to metabolic engineering.  We also 
demonstrated that biosynthetic pathways built in yeast via Reiterative Recombination can 
be transferred to and functionally expressed in other organisms, though alternative 
strategies will need to be developed to make the transfer step reliably efficient.    
The use of recyclable markers and endonucleases in Reiterative Recombination 
renders it useful for the assembly and integration of very large DNA constructs.  We have 
demonstrated that elongation can be continued indefinitely (at least eight rounds) to build 
pathways tens of kilobases in length.  Recycling markers in Reiterative Recombination 
eliminates the perennial problem of running out of selectable markers during complex 
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strain constructions, and the modular protocol minimizes the effort needed to design each 
integration step.   
Reiterative Recombination’s robustness makes it capable of building sizable 
libraries of pathways (≥104) containing diversity at multiple loci.  Though methods for 
constructing multi-gene pathways have proliferated in recent years, there are surprisingly 
few examples of using them to build libraries.  Our mock library experiment is key 
because it explicitly tests the library sizes Reiterative Recombination can generate and 
shows that members of the library are present in the expected proportions.  To our 
knowledge, this is the first DNA assembly method whose ability to create such libraries 
in vivo has been rigorously characterized in this way.  In addition, though we only 
attempted to build libraries of up to 104—due to the limits of our ability to visually screen 
large numbers of colonies for lycopene production—the high efficiency and 
straightforward scalability of the recombination step suggests that it is only the 
transformation efficiency of yeast (~106-108) that will limit library size in Reiterative 
Recombination.  The development of highly efficient DNA assembly methods is an 
essential first step towards the combinatorial optimization of pathways in vivo, and    
efficient technologies for pathway construction such as Reiterative Recombination should 
ultimately allow the power of directed evolution and other library optimization 
approaches to be brought to bear on metabolic engineering and synthetic biology 
problems to an unprecedented extent. 
Reiterative Recombination is part of a growing toolbox of techniques for making 
large-scale modifications to the genome.  One strategy is de novo genome synthesis, 
which allows complete customization of the genome.  However, in spite of recent heroic 
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feats in this field32,59 and the falling price of chemical DNA synthesis60, such ambitious 
undertakings are neither technically nor economically feasible for most researchers.  The 
alternative is to reprogram well-characterized host organisms, such as E. coli and S. 
cerevisiae, for novel functions through genetic engineering, which will require 1) the 
modification of strains’ genetic background and 2) the introduction of multiple 
exogenous genes into the chromosome.  To meet the first of these needs, classic 
mutagenesis techniques such as mutator strains can be useful for phenotypic 
optimization, but they do not provide control over the extent and location of mutations61.  
The recently reported multiplex genome engineering (MAGE) platform can efficiently 
introduce specified deletions, point mutations, and short insertions (<~30bp) throughout 
the chromosome in E. coli, generating up to billions of variant strains62.  Reiterative 
Recombination is one of several techniques that tackle the second issue, integrating 
exogenous pathways of genes into the chromosome22,34,35.  However, Reiterative 
Recombination is uniquely able to integrate pathways in a highly efficient manner to 
access large numbers of variant strains. 
In conclusion, we foresee Reiterative Recombination becoming a powerful 
addition to the 21st-century molecular biology toolkit.  Its simplicity and robustness will 
make it a user-friendly option for any lab equipped for basic molecular biology to 
assemble multi-gene constructs.  Its cyclical format means that it can be used to build 
pathways of indefinite length.  Since it is highly efficient, in contrast to other in vivo 
DNA assembly technologies, it can be used to assemble libraries of ≥104 pathways 
directly in the chromosome.  Reiterative Recombination, as part of the expanding arsenal 
of cutting-edge cell engineering tools, will ensure the continued rapid development of 
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synthetic biology as the scale of our ambitions increases and our applications move into 
the cell.   
5.4 Experimental methods 
General materials and methods.  General materials and methods were as in 
Chapter 2. 
Plasmid construction.  Donor plasmids containing crtB and crtI alleles with stop 
or silent mutations and diagnostic restriction sites were constructed as follows.  The 3’ 
region of crtB was amplified from LW2670Y genomic DNA with primers LMW374 and 
LMW529 (crtB-stop) or LMW374 and LMW530 (crtB-silent).  The 5’ region of crtB and 
the PGK promoter were amplified from LW2670Y genomic DNA with primers 
LMW491 and LMW375.  These fragments (either crtB-stop or crtB-silent) were co-
transformed with SmaI-digested pLW2593 into yeast.  The pTEF-crtI-tACT construct 
was amplified from LW2671Y genomic DNA with primers LMW454 and LMW459.  
The unpurified reaction was used as a template to amplify the TEF promoter and the 5’ 
region of crtI with primers LMW374 and LMW531 (crtI-stop) or primers LMW374 and 
LMW532 (crtI-silent).  Using the same template, the 3’ region of crtI and the ACT 
terminator were amplified with primers LMW452 and LMW459.  TRP1 was amplified 
from pRS414GAL with primers LMW460 and LMW461, followed by a second round of 
amplification with LMW460 and LMW367.  These fragments (either crtI-stop or crtI-
silent) were co-transformed with HindIII-digested pLW2592 into yeast.  Following donor 
plasmid construction by plasmid gap repair, plasmids were retransformed into E. coli.  
Plasmids with the desired mutations in crtB and crtI were identified by PCR and 
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restriction analysis and confirmed by sequencing (pLW2597, crtB-stop; pLW2598, crtB-
silent; pLW2599, crtI-stop; pLW2600, crtI-silent).    
A plasmid to recover Reiterative Recombination pathways from the chromosome 
(pLW2662) was constructed as follows.  The pGAL-SceI-tCYC construct was amplified 
using primers LMW300 and LMW301. Plasmid pLW2654 was digested with PspXI.  
The SceI PCR and the pLW2654 digest were co-transformed into yeast.  Transformants 
were miniprepped from yeast without analysis, retransformed into E. coli, and then 
verified by colony PCR and sequencing.   
Pathway construction via Reiterative Recombination.  Reiterative 
Recombination was performed using the protocol described in Chapter 4, beginning with 
LW2591Y as the parental acceptor strain.  The primers used to amplify constructs for 
donor plasmids made by plasmid gap repair in this chapter are shown in Table 5-3.  
Sequences of the assembled pathways are provided in the Appendix.  The minimal 
lycopene pathway (Section 5.2.1) consists of rounds 1-3 of the lycopene pathway.  For 
the complete, 8-gene lycopene pathway, the TRP1 and MET15 markers were selected for 
at all times after they were added in rounds 3 and 6, respectively.   
Table 5-3. PCR amplification of subfragments for Reiterative Recombination. 
Elongation 





1a pGPD LMW433/445   LW2647Y gDNA 
1b crtE LMW446/447 pSC203 
1c tADH 1) LMW448/449  2) LMW448/367 
1) LW2647Y gDNA 




2a crtB (reverse 
complement) 
1) LMW450/451 
2) LMW374/451  
1) pSC203 
2) PCR (1) 




1) LW2647Y gDNA 






3a pTEF 1) LMW454/455 2) LMW374/455 
1) LW2647Y gDNA 
2) PCR (1) 
3b crtI LMW456/457 pSC203 
3c tACT LMW458/459 LW2647Y gDNA 
3d TRP1 1) LMW460/461 2) LMW460/367 
1) pRS414GAL 




4a pGPD 1) LMW464/465 2) LMW374/465 
1) LW2589Y gDNA 
2) PCR (1) 
4b tHMG1 LMW466/467 pUCAD-tHMG1 
4c tADH 1) LMW468/469 2) LMW468/375 
1) LW2589Y gDNA 









2) PCR (1) 




1) LW2589Y gDNA 




6a pPGK 1) LMW476/477 2) LMW374/477 
1) LW2589Y gDNA 
2) PCR (1) 
6b ALD6 LMW478/479 pSC302 
6c tACT LMW480/481 LW2589Y gDNA 
6d MET15 1) LMW482/483  2) LMW482/375 
1) FY251 gDNA 




7a pTEF 1) LMW484/485 2) LMW374/485 
LW2589Y gDNA 
2) PCR (1) 
7b acs LMW486/487 pSC302 
7c tADH 1) LMW488/489 2) LMW488/367 
1) LW2589Y gDNA 









2) PCR (1) 
8b pPGK (reverse 
complement) 
1) LMW503/504  
2) LMW503/375 
1) LW2589Y gDNA 





2a crtB-stop (reverse 
complement) LMW374/451  pLW2597 
2a crtB-silent (reverse 
complement) LMW374/451 pLW2598 
2b pPGK (reverse 




3abc pTEF-(crtI-stop)-tACT LMW374/459 pLW2599 
3abc pTEF-(crtI-stop)-tACT LMW374/459 pLW2600 
3d TRP1 LMW460/367 pLW2599 
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1a pLac LMW370/371 pAC-crtE-crtB-crtI 
1b crtE 1) LMW372/373 2) LMW372/367 
1) pAC-crtE-crtB-crtI 




2 crtB 1) LMW376/377   2) LMW374/375 
1) pAC-crtE-crtB-crtI 




3 crtI14 1) LMW382/383   2) LMW374/367 
1) pAC-crtE-crtB-crtI14 




4 KanMX 1)LMW429/430 2)LMW374/375 
1) pVC2265 
2) PCR (1) 
  Library construction via Reiterative Recombination. Based on phylogenetic 
analyses of the crtB and crtI genes63,64, we selected two adjacent, fully conserved amino 
acid residues in each gene to replace with stop codons.  Using plasmid gap repair, 
plasmids were created containing crtB alleles with the following sequences at nucleotide 
positions 514 through 531 (mutated residues in lower case):  
crtB-stop: AAC ATt GCG taa tag ATT (stop codons at amino acid residues 175 
and 176 and a new BsrDI restriction site, underlined)  
crtB-silent: AAC ATC GCG AGg GAT ATc (only silent mutations and a new 
EcoRV restriction site, underlined) 
and crtI alleles with the following sequences at nucleotide positions 52 through 66: 
crtI-stop: ATA taa tag CAA GCT (stop codons at amino acid residues 19 and 20 
and a new Cac8I restriction site, underlined) 
crtI-silent: ATt cgt ctc CAA GCT (only silent mutations and a new BsmBI 
restriction site, underlined) 
These alleles were used as PCR templates for amplification of the crtB and crtI 
genes for the lycopene libraries, and purified PCR products were mixed in the desired 
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ratios (0:1, 10:1, or 100:1 stop/silent) during the round 2 and round 3 transformations. 
“Libraries” containing only the stop or only the silent alleles at each position were 
constructed in parallel, and the resulting cured colonies are shown in Figure 5-2, C-F.   
Following the third round of Reiterative Recombination, libraries were plated on 
SC(−Leucine, −Tryptophan, 0.1% 5-FOA) media for curing.  Plates were grown at 30°C 
for three days rather than two days to allow full development of the orange color.  The 
expected percentage of orange colonies was, for example, 100 x (1/101) x (1/11) = 0.90% 
for the 100:1 crtB stop/silent x 10:1 crtI stop/silent library.  Single colonies from the 
libraries were analyzed by colony PCR and restriction analysis, following streak 
purification if necessary. 
 Analysis of HIS LEU mutants.  The pool of cured recombinants was lifted from 
the curing plate for the rounds of Reiterative Recombination shown in Table 5-1.  Serial 
dilutions of the resuspended cells were plated on SC(−Leucine) and SC(−Histidine) 
media.  After two days of growth at 30°C, the number of colonies on each type of media 
was counted.  Colonies that grew on the “wrong” media (SC(−Leucine) for even rounds, 
and SC(−Histidine) for odd rounds) were assayed for growth on the “correct” media 
(SC(−Histidine) for even rounds, and SC(−Leucine) for odd rounds) to confirm that they 
were prototrophic for both amino acids, and all tested colonies grew on both types of 
media.  The percentages of colonies with this HIS LEU phenotype observed in four 
different Reiterative Recombination trials are shown in Table 5-1.   
Shuttling of Carotenoid Pathway to E. coli.  Strain LW2663Y was transformed 
with pLW2662.  The pool of resulting colonies were grown overnight in SC(−Histidine, 
−Uracil) media and then plated on SC(−Histidine, −Uracil, 2% galactose, 2% raffinose).  
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The resulting pool of colonies was miniprepped and retransformed into E. coli TG1 cells, 
giving 6 KanR colonies.  Colony PCR analysis indicated that one of these colonies had 
the crtI construct.  This colony was miniprepped, and the plasmid was transformed into 
JM109 cells.  All but one (of ~30) transformants had the desired orange phenotype, 
including LW2664E.  JM109 cells were not used for the initial transformation of yeast 
plasmid DNA into E. coli only because the available competent JM109 cells had very 
low transformation efficiencies.   
5.5 Strains, plasmids, and oligonucleotides 
Table 5-4. Strains used in this study 
Name Genotype Source/Reference 
FY251 MATa trp1∆63 his3∆200 ura3-52 leu2∆1 GAL+ M. Carlson 
LW2589Y BY4733 MATa-inc This study 
LW2591Y Reiterative Recombination parental acceptor strain BY4733 MATa-inc pLW2590 integrated This study 
LW2647Y BY4733 MAT∆::URA3 This study 
LW2656Y Round 1 recombinant from E. coli carotenoid pathway This study 
LW2657Y Round 2 recombinant from E. coli carotenoid pathway This study 
LW2658Y Round 3 recombinant from E. coli carotenoid pathway This study 
LW2663Y Round 4 recombinant from E. coli carotenoid pathway This study 
LW2664E JM109 E. coli with pLW2662 + recovered round 4 
carotenoid pathway This study 
LW2669Y Round 1 recombinant from lycopene pathway This study 
LW2670Y Round 2 recombinant from lycopene pathway This study 
LW2671Y Round 4 recombinant from lycopene pathway This study 
LW2674Y Round 5 recombinant from lycopene pathway This study 
LW2675Y Round 6 recombinant from lycopene pathway This study 
LW2676Y Round 7 recombinant from lycopene pathway This study 
LW2677Y Round 8 recombinant from lycopene pathway This study 
LW2678Y Round 3 recombinant from lycopene pathway with crtB-
stop, crtI-stop This study 
LW2679Y Round 3 recombinant from lycopene pathway with crtB-
stop, crtI-silent This study 
LW2680Y Round 3 recombinant from lycopene pathway with crtB-
silent, crtI-stop This study 
LW2681Y Round 3 recombinant from lycopene pathway with crtB-





Table 5-5. Plasmids used in this study 
Name Details Source/Reference 
pAC-crtE-
crtB-crtI 










pRS414GAL pGAL1 CEN6/ARSH4 TRP1 pBIISK ori ampR ATCC #87336 
pSC103 TRP1 integration plasmid with overexpressed tHMG1, ERG20, and UPC2 
P. Ajikumar and G. 
Stephanopoulos 
pSC203 URA3 integration plasmid with overexpressed crtE, 
crtB, and crtI 
P. Ajikumar and G. 
Stephanopoulos 
pSC302 LEU2 integration plasmid with overexpressed ALD6 
and acs  
P. Ajikumar and G. 
Stephanopoulos 
pUCAD-
tHMG1 ADE1 integration plasmid with overexpressed tHMG1 
P. Ajikumar and G. 
Stephanopoulos 
pVC2265 HO-polylinker-KanMX4-HO D. Stillman/65 
pLW2592 
Universal odd donor plasmid for Reiterative 
Recombination 
pGAL1-HO-tCYC GFP-LEU2-SceI cleavage site 
CEN6/ARSH4 URA3 pBIISK ori ampR  
This study 
pLW2593 
Universal even donor plasmid for Reiterative 
Recombination 
pGAL1-SceI-tCYC GFP-HIS3-HO cleavage site 
CEN6/ARSH4 URA3 pBIISK ori ampR 
This study 
pLW2594 
Round 1 donor plasmid for Reiterative Recombination 
pGAL1-HO-tCYC GFP-LEU2-SceI cleavage site-
KanMX-HO(L) CEN6/ARSH4 URA3 pBIISK ori ampR  
This study 
pLW2597 pLW2593 with lycopene 2 fragment with crtB-stop This study 
pLW2598 pLW2593 with lycopene 2 fragment with crtB-silent This study 
pLW2599 pLW2592 with lycopene 3 fragment with crtI-stop This study 
pLW2600 pLW2592 with lycopene 3 fragment with crtI-silent This study 
pLW2654 pRS416 with HO(R)-pPYK-GFP-LEU2-SceI site-HO(L) This study 
pLW2662 pLW2654 with pGAL-SceI-tCYC This study 
 
Table 5-6. Oligonucleotides used in this study 
Name Sequence (5'-3') 
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A.1  Sequence of the reporter gene pathway 
Sequence of the completed reporter gene pathway, which is shown schematically in 
Figure 4-7.  To show the context of the sequence in the chromosome, the last 30 bp of 
the HO(L) region on the 5’ end and the first 30 bp of the acceptor module (containing the 
SceI cleavage site and the LEU2 terminator) on the 3’ end are shown. 
   1 . . 30   HO(L) 
  31 . . 4145 Fragment 1 (pADH-lacZ-tADH) 
4146 . . 5957 Subfragment 2a (gusA, reverse complement) 
5958 . . 6452 Subfragment 2b (pCYC, reverse complement) 
6453 . . 8086 Subfragment 3a (tMET-MET15, reverse complement) 
8087 . . 8498 Subfragment 3b (pTEF, reverse complement) 
8499 . . 8528 Acceptor module 
 
   1  AAAATTGTGC CTTTGGACTT AAAATGGCGT CAACTTCTTT TCTTTTTTTT 
  51  TCTTTTCTCT CTCCCCCGTT GTTGTCTCAC CATATCCGCA ATGACAAAAA 
 101  AATGATGGAA GACACTAAAG GAAAAAATTA ACGACAAAGA CAGCACCAAC 
 151  AGATGTCGCT GTTCCAGAGC TGATGAGGGG TATCTCGAAG CACACGAAAC 
 201  TTTTTCCTTC CTTCATTCAC GCACGCTACT CTCTAATGAG CAACGGTATA 
 251  CGGCCTTCCT TCCAGTTACT TGAATTTGAA ATAAAAAAAA GTTTGCTGTC 
 301  TTGCTATCAA GTATAAATAG ACCTGCAATT ATTAATCTTT TGTTTCCTCG 
 351  TCATTGTTCT CGTTCCCTTT CTTCCTTGTT TCTTTTTCTG CACAATATTT 
 401  CAAGCTATAC CAAGCATACA ATCAACTCCA AGCTTGAATT AATACCGGGC 
 451  GGAATGACTA AATCTCATTC AGAAGAAGTG ATTGTACCTG AGTTCAATTC 
 501  TAGCGCAAAG GAATTACCAA GACCATTGGC CGAAAAGTGC GGAATTCCAA 
 551  GCTTGGCCAA GCCCGGATCC GGAGCTTGGC TGTTGCCCGT CTCACTGGTG 
 601  AAAAGAAAAA CCACCCTGGC GCCCAATACG CAAACCGCCT CTCCCCGCGC 
 651  GTTGGCCGAT TCATTAATGC AGCTGGCACG ACAGGTTTCC CGACTTAATC 
 701  GCCTTGCAGC ACATCCCCCT TTCGCCAGCT GGCGTAATAG CGAAGAGGCC 
173 
 
 751  CGCACCGATC GCCCTTCCCA ACAGTTGCGC AGCCTGAATG GCGAATGGCG 
 801  CTTTGCCTGG TTTCCGGCAC CAGAAGCGGT GCCGGAAAGC TGGCTGGAGT 
 851  GCGATCTTCC TGAGGCCGAT ACTGTCGTCG TCCCCTCAAA CTGGCAGATG 
 901  CACGGTTACG ATGCGCCCAT CTACACCAAC GTAACCTATC CCATTACGGT 
 951  CAATCCGCCG TTTGTTCCCA CGGAGAATCC GACGGGTTGT TACTCGCTCA 
1001  CATTTAATGT TGATGAAAGC TGGCTACAGG AAGGCCAGAC GCGAATTATT 
1051  TTTGATGGCG TTAACTCGGC GTTTCATCTG TGGTGCAACG GGCGCTGGGT 
1101  CGGTTACGGC CAGGACAGTC GTTTGCCGTC TGAATTTGAC CTGAGCGCAT 
1151  TTTTACGCGC CGGAGAAAAC CGCCTCGCGG TGATGGTGCT GCGTTGGAGT 
1201  GACGGCAGTT ATCTGGAAGA TCAGGATATG TGGCGGATGA GCGGCATTTT 
1251  CCGTGACGTC TCGTTGCTGC ATAAACCGAC TACACAAATC AGCGATTTCC 
1301  ATGTTGCCAC TCGCTTTAAT GATGATTTCA GCCGCGCTGT ACTGGAGGCT 
1351  GAAGTTCAGA TGTGCGGCGA GTTGCGTGAC TACCTACGGG TAACAGTTTC 
1401  TTTATGGCAG GGTGAAACGC AGGTCGCCAG CGGCACCGCG CCTTTCGGCG 
1451  GTGAAATTAT CGATGAGCGT GGTGGTTATG CCGATCGCGT CACACTACGT 
1501  CTGAACGTCG AAAACCCGAA ACTGTGGAGC GCCGAAATCC CGAATCTCTA 
1551  TCGTGCGGTG GTTGAACTGC ACACCGCCGA CGGCACGCTG ATTGAAGCAG 
1601  AAGCCTGCGA TGTCGGTTTC CGCGAGGTGC GGATTGAAAA TGGTCTGCTG 
1651  CTGCTGAACG GCAAGCCGTT GCTGATTCGA GGCGTTAACC GTCACGAGCA 
1701  TCATCCTCTG CATGGTCAGG TCATGGATGA GCAGACGATG GTGCAGGATA 
1751  TCCTGCTGAT GAAGCAGAAC AACTTTAACG CCGTGCGCTG TTCGCATTAT 
1801  CCGAACCATC CGCTGTGGTA CACGCTGTGC GACCGCTACG GCCTGTATGT 
1851  GGTGGATGAA GCCAATATTG AAACCCACGG CATGGTGCCA ATGAATCGTC 
1901  TGACCGATGA TCCGCGCTGG CTACCGGCGA TGAGCGAACG CGTAACGCGA 
1951  ATGGTGCAGC GCGATCGTAA TCACCCGAGT GTGATCATCT GGTCGCTGGG 
2001  GAATGAATCA GGCCACGGCG CTAATCACGA CGCGCTGTAT CGCTGGATCA 
2051  AATCTGTCGA TCCTTCCCGC CCGGTGCAGT ATGAAGGCGG CGGAGCCGAC 
2101  ACCACGGCCA CCGATATTAT TTGCCCGATG TACGCGCGCG TGGATGAAGA 
2151  CCAGCCCTTC CCGGCTGTGC CGAAATGGTC CATCAAAAAA TGGCTTTCGC 
174 
 
2201  TACCTGGAGA GACGCGCCCG CTGATCCTTT GCGAATACGC CCACGCGATG 
2251  GGTAACAGTC TTGGCGGTTT CGCTAAATAC TGGCAGGCGT TTCGTCAGTA 
2301  TCCCCGTTTA CAGGGCGGCT TCGTCTGGGA CTGGGTGGAT CAGTCGCTGA 
2351  TTAAATATGA TGAAAACGGC AACCCGTGGT CGGCTTACGG CGGTGATTTT 
2401  GGCGATACGC CGAACGATCG CCAGTTCTGT ATGAACGGTC TGGTCTTTGC 
2451  CGACCGCACG CCGCATCCAG CGCTGACGGA AGCAAAACAC CAGCAGCAGT 
2501  TTTTCCAGTT CCGTTTATCC GGGCAAACCA TCGAAGTGAC CAGCGAATAC 
2551  CTGTTCCGTC ATAGCGATAA CGAGCTCCTG CACTGGATGG TGGCGCTGGA 
2601  TGGTAAGCCG CTGGCAAGCG GTGAAGTGCC TCTGGATGTC GCTCCACAAG 
2651  GTAAACAGTT GATTGAACTG CCTGAACTAC CGCAGCCGGA GAGCGCCGGG 
2701  CAACTCTGGC TCACAGTACG CGTAGTGCAA CCGAACGCGA CCGCATGGTC 
2751  AGAAGCCGGG CACATCAGCG CCTGGCAGCA GTGGCGTCTG GCGGAAAACC 
2801  TCAGTGTGAC GCTCCCCGCC GCGTCCCACG CCATCCCGCA TCTGACCACC 
2851  AGCGAAATGG ATTTTTGCAT CGAGCTGGGT AATAAGCGTT GGCAATTTAA 
2901  CCGCCAGTCA GGCTTTCTTT CACAGATGTG GATTGGCGAT AAAAAACAAC 
2951  TGCTGACGCC GCTGCGCGAT CAGTTCACCC GTGCACCGCT GGATAACGAC 
3001  ATTGGCGTAA GTGAAGCGAC CCGCATTGAC CCTAACGCCT GGGTCGAACG 
3051  CTGGAAGGCG GCGGGCCATT ACCAGGCCGA AGCAGCGTTG TTGCAGTGCA 
3101  CGGCAGATAC ACTTGCTGAT GCGGTGCTGA TTACGACCGC TCACGCGTGG 
3151  CAGCATCAGG GGAAAACCTT ATTTATCAGC CGGAAAACCT ACCGGATTGA 
3201  TGGTAGTGGT CAAATGGCGA TTACCGTTGA TGTTGAAGTG GCGAGCGATA 
3251  CACCGCATCC GGCGCGGATT GGCCTGAACT GCCAGCTGGC GCAGGTAGCA 
3301  GAGCGGGTAA ACTGGCTCGG ATTAGGGCCG CAAGAAAACT ATCCCGACCG 
3351  CCTTACTGCC GCCTGTTTTG ACCGCTGGGA TCTGCCATTG TCAGACATGT 
3401  ATACCCCGTA CGTCTTCCCG AGCGAAAACG GTCTGCGCTG CGGGACGCGC 
3451  GAATTGAATT ATGGCCCACA CCAGTGGCGC GGCGACTTCC AGTTCAACAT 
3501  CAGCCGCTAC AGTCAACAGC AACTGATGGA AACCAGCCAT CGCCATCTGC 
3551  TGCACGCGGA AGAAGGCACA TGGCTGAATA TCGACGGTTT CCATATGGGG 
3601  ATTGGTGGCG ACGACTCCTG GAGCCCGTCA GTATCGGCGG AATTCCAGCT 
175 
 
3651  GAGCGCCGGT CGCTACCATT ACCAGTTGGT CTGGTGTCAA AAATAATTAC 
3701  AACAGGTGTT GTCCTCTGAG GACATAAAAT ACACACCGAG ATTCATCAAC 
3751  TCATTGCTGG AGTTAGCATA TCTACAATTG GGTGAAATGG GGAGCGATTT 
3801  GCAGGCATTT GCTCGGCATG CCGGTAGAGG TGTGGTCAAT AAGAGCGACC 
3851  TCATGCTATA CCTGAGAAAG CAACCTGACC TACAGGAAAG AGTTACTCAA 
3901  GAACAAGAAT TTTCGTTTTA AAACCTAAGA GTCACTTTAA AATTTGTATA 
3951  CACTTATTTT TTTTATAACT TATTTAATAA TAAAAATCAT AAATCATAAG 
4001  AAATTCGCTT ATTTAGAAGT GTCAACAACG TATCTACCAA CGATTTGACC 
4051  CTTTTCCATC TTTTCGTAAA TTTCTGGCAA GGTAGACAAG CCGACAACCT 
4101  TGATTGGAGA CTTGACCAAA CCTCTGGCGA AGAAGTCCAA AGCTTTCATT 
4151  GTTTGCCTCC CTGCTGCGGT TTTTCACCGA AGTTCATGCC AGTCCAGCGT 
4201  TTTTGCAGCA GAAAAGCCGC CGACTTCGGT TTGCGGTCGC GAGTGAAGAT 
4251  CCCTTTCTTG TTACCGCCAA CGCGCAATAT GCCTTGCGAG GTCGCAAAAT 
4301  CGGCGAAATT CCATACCTGT TCACCGACGA CGGCGCTGAC GCGATCAAAG 
4351  ACGCGGTGAT ACATATCCAG CCATGCACAC TGATACTCTT CACTCCACAT 
4401  GTCGGTGTAC ATTGAGTGCA GCCCGGCTAA CGTATCCACG CCGTATTCGG 
4451  TGATGATAAT CGGCTGATGC AGTTTCTCCT GCCAGGCCAG AAGTTCTTTT 
4501  TCCAGTACCT TCTCTGCCGT TTCCAAATCG CCGCTTTGGA CATACCATCC 
4551  GTAATAACGG TTCAGGCACA GCACATCAAA GAGATCGCTG ATGGTATCGG 
4601  TGTGAGCGTC GCAGAACATT ACATTGACGC AGGTGATCGG ACGCGTCGGG 
4651  TCGAGTTTAC GCGTTGCTTC CGCCAGTGGC GCGAAATATT CCCGTGCACC 
4701  TTGCGGACGG GTATCCGGTT CGTTGGCAAT ACTCCACATC ACCACGCTTG 
4751  GGTGGTTTTT GTCACGCGCT ATCAGCTCTT TAATCGCCTG TAAGTGCGCT 
4801  TGCTGAGTTT CCCCGTTGAC TGCCTCTTCG CTGTACAGTT CTTTCGGCTT 
4851  GTTGCCCGCT TCGAAACCAA TGCCTAAAGA GAGGTTAAAG CCGACAGCAG 
4901  CAGTTTCATC AATCACCACG ATGCCATGTT CATCTGCCCA GTCGAGCATC 
4951  TCTTCAGCGT AAGGGTAATG CGAGGTACGG TAGGAGTTGG CCCCAATCCA 
5001  GTCCATTAAT GCGTGGTCGT GCACCATCAG CACGTTATCG AATCCTTTGC 
5051  CACGTAAGTC CGCATCTTCA TGACGACCAA AGCCAGTAAA GTAGAACGGT 
176 
 
5101  TTGTGGTTAA TCAGGAACTG TTCGCCCTTC ACTGCCACTG ACCGGATGCC 
5151  GACGCGAAGC GGGTAGATAT CACACTCTGT CTGGCTTTTG GCTGTGACGC 
5201  ACAGTTCATA GAGATAACCT TCACCCGGTT GCCAGAGGTG CGGATTCACC 
5251  ACTTGCAAAG TCCCGCTAGT GCCTTGTCCA GTTGCAACCA CCTGTTGATC 
5301  CGCATCACGC AGTTCAACGC TGACATCACC ATTGGCCACC ACCTGCCAGT 
5351  CAACAGACGC GTGGTTACAG TCTTGCGCGA CATGCGTCAC CACGGTGATA 
5401  TCGTCCACCC AGGTGTTCGG CGTGGTGTAG AGCATTACGC TGCGATGGAT 
5451  TCCGGCATAG TTAAAGAAAT CATGGAAGTA AGACTGCTTT TTCTTGCCGT 
5501  TTTCGTCGGT AATCACCATT CCCGGCGGGA TAGTCTGCCA GTTCAGTTCG 
5551  TTGTTCACAC AAACGGTGAT ACGTACACTT TTCCCGGCAA TAACATACGG 
5601  CGTGACATCG GCTTCAAATG GCGTATAGCC GCCCTGATGC TCCATCACTT 
5651  CCTGATTATT GACCCACACT TTGCCGTAAT GAGTGACCGC ATCGAAACGC 
5701  AGCACGATAC GCTGGCCTGC CCAACCTTTC GGTATAAAGA CTTCGCGCTG 
5751  ATACCAGACG TTGCCCGCAT AATTACGAAT ATCTGCATCG GCGAACTGAT 
5801  CGTTAAAACT GCCTGGCACA GCAATTGCCC GGCTTTCTTG TAACGCGCTT 
5851  TCCCACCAAC GCTGATCAAT TCCACAGTTT TCGCGATCCA GACTGAATGC 
5901  CCACAGGCCG TCGAGTTTTT TGATTTCACG GGTTGGGGTT TCTACAGGAC 
5951  GTAACATTAT TAATTTAGTG TGTGTATTTG TGTTTGTGTG TCTATAGAAG 
6001  TATAGTAATT TATGCTGCAA AGGTCCTAAT GTATAAGGAA AGAATATTTA 
6051  GAGAAAAGAA GAAAACAAGA GTTTTATATA CATACAGAGC ACATGCATGC 
6101  CATATGATCA TGTGTCGTCG CACACATATA TATATGCCTG TATGTGTCAG 
6151  CACTAAAGTT GCCTGGCCAT CCACGCTATA TATACACGCC TGGCGGATCT 
6201  GCTCGAGGAT TGCCTACGCG TGGGCTTGAT CCACCAACCA ACGCTCGCCA 
6251  AATGAACTGG CGCTTTGGTC TTCTGCCATC GTCCGTAAAC CCCGGCCAAA 
6301  GAGACCGGAA AGATCGGTGA AAACATCTTG ATCTTGCTCC CGGGAATTTT 
6351  AGATTCAGGT AGGAAATTGA TTACATCAAT ACTGTTACCC TGAATCATAT 
6401  TCGACGATGT CGTCTCACAC GGAAATATAA TTCATTTCTT GGTTTTCCAA 
6451  AGAAACCTCC ATCATCCTCT TTTGTAACTT GGTCCTACAA TAAATTTATC 
6501  CAGTGTGACA GCTTTATAGG AGGCGTAAAG TAGTCTCATG AAGTAGATGA 
177 
 
6551  GTCTTGTTCA CCATATTTTT CTTCTCGACT GCGAATTAAC ACTGTTCTTT 
6601  GATGTTAGAA CAATTTAGGT TCAAAGTACG AGTCACGACA TGTAACAAGG 
6651  GAAAAAAAGG ATATTCATTT CAATAAAGTT CGTTTTATAA AAGTATAGTA 
6701  CTTGTGAGAG AAAGTAGGTT TATACATAAT TTTACAACTC ATTACGCACA 
6751  CTCATGGTTT TTGGCCAGCG AAAACAGTTT CAAAAGATTG CTGGAAGTCT 
6801  GCAATAATGT CATCAATAAA TTCGATACCA ACAGAGACAC GAATTAAGTC 
6851  CTTGGTAACA CCAGATGCCA ACTTTTCTTT GTCATTTAAT TGTTTGTGGG 
6901  TAGTGAAGTA TGGAGCAATG ACTAAGGTCT TGGCATCACC AACATTGGCC 
6951  AAGTTAGAGG CAAGCTTTAA ATTGTCAACA ACTTGAGCAC CAGAAAGTTT 
7001  GAATGGGTCA GTTTCCTTGT CGGCATTTGG TAAGTCTTTT ACACCGAAAG 
7051  ATAAGACACC ACCGAAACCG TTAGATAGAT ACTTCTTAGC ATTTTCATGA 
7101  TGAGAATGAG ATGCTAAACC AGGGTATGAA ACCCAAGATA CGTATGGGGA 
7151  TTGTTCTAAC CATTTGGCTA ACTTCAATGC ATTTTCACCG TGTCTTTCAG 
7201  CTCTCAAAGA TAATGTTTCA ACACCTTGTA GTAGCAAGAA AGAGGCAAAT 
7251  GGGTTCATCA ATGGACCCAA ATCTCTTAAT AGTTCAGTTC TAACATGAAC 
7301  GATGTATGCC AAGTTACCGT AGGCTTCATT GTAGATAGTA CCGTGATATC 
7351  CTTCGGCAGG TTGAGAGAAT TGAGGGAACT TTTCTGGGTA GTCCTTCCAT 
7401  GGGAACTTAC CAGAGTCAAC AATAATACCA CCGATAGTAG TACCATGACC 
7451  ACCAATCCAT TTGGTAGCAG AATGTGTTAC AATATCAGCA CCGTATTTAA 
7501  TTGGCTGACA GAAGTAACCA CCGGCACCAA ATGTGTTGTC AACGACAACT 
7551  GGAATACCGT GTTTGTGAGC AATTGCAACA ATTTTTTCAA AATCCGGAAC 
7601  ATTGTACTTT GGATTACCAA TGGTTTCCAA ATAAACAGCC TTGGTTCTTT 
7651  CATCAAAGAC CTTTTCGAAT TCTTCTGGAT TGTCACCTTC AACAAATCTA 
7701  GCCTCGATAC CAAATCTTTT GAACGAGATT TTGAACTGGT TATAAGTACC 
7751  ACCGTATAAG TAAGAAGTGG AAACGATGTT GTCACCAGTG TGTGCCAAAC 
7801  CTTGGATGGC AAGGGTTTGA GCGGCTTGAC CGGAGGAAAC AGCCAAAGCA 
7851  GCAGCACCAC CTTCTAAAGC AGCAATTCTT TCTTCCAAAA CATTACTGGT 
7901  TGGGTTTTGG AAACGGGAAT AGACGTAACC TGGAACTTCT AGACCAAACA 
7951  ATTGCGAACC ATGCTTAGAG TTTTCGAAAA CATAAGAAGT GGTGGCGTAA 
178 
 
8001  ATTGGTACAG CTCTGGATCT GTGAGCATTG TCACCAGGGT TCTCTTGGCC 
8051  GGCGTGTAGT TGAACAGTAT CGAAATGAGA TGGCATTTTG TAATTAAAAC 
8101  TTAGATTAGA TTGCTATGCT TTCTTTCTAA TGAGCAAGAA GTAAAAAAAG 
8151  TTGTAATAGA ACAAGAAAAA TGAAACTGAA ACTTGAGAAA TTGAAGACCG 
8201  TTTATTAACT TAAATATCAA TGGGAGGTCA TCGAAAGAGA AAAAAATCAA 
8251  AAAAAAAAAT TTTCAAGAAA AAGAAACGTG ATAAAAATTT TTATTGCCTT 
8301  TTTCGACGAA GAAAAAGAAA CGAGGCGGTC TCTTTTTTCT TTTCCAAACC 
8351  TTTAGTACGG GTAATTAACG ACACCCTAGA GGAAGAAAGA GGGGAAATTT 
8401  AGTATGCTGT GCTTGGGTGT TTTGAAGTGG TACGGCGATG CGCGGAGTCC 
8451  GAGAAAATCT GGAAGAGTAA AAAAGGAGTA GAAACATTTT GAAGCTATAT 
8501  TACCCTGTTA TCCCTAagat tgtactga 
 
A.2  Sequence of the lycopene biosynthetic pathway 
 Sequence of the completed 8-round lycopene biosynthetic pathway, which is 
shown schematically in Figure 5-3.  The minimal lycopene biosynthetic pathway (Fig. 
5-2) consists of subfragments 1a through 3d.  To show the context of the sequence in the 
chromosome, the last 30 bp of the HO(L) region on the 5’ end and the first 30 bp of the 
acceptor module (containing the HO cleavage site and the HIS3 terminator) on the 3’ end 
are shown. 
      1 . . 30  HO(L) 
     31 . . 703 Subfragment 1a (pGPD) 
   704 . . 1627 Subfragment 1b (crtE) 
  1628 . . 1793 Subfragment 1c (tADH) 
  1794 . . 2723 Subfragment 2a (crtB, reverse complement) 
  2724 . . 3723 Subfragment 2b (pPGK, reverse complement) 
  3724 . . 4135 Subfragment 3a (pGPD) 
  4136 . . 5614 Subfragment 3b (crtI) 
179 
 
  5615 . . 5869 Subfragment 3c (tACT) 
  5870 . . 6872 Subfragment 3d (TRP1) 
  6873 . . 7545 Subfragment 4a (pGPD) 
  7546 . . 9123 Subfragment 4b (tHMG1) 
  9124 . . 9289 Subfragment 4c (tADH) 
 9290 . . 10358 Subfragment 5a (ERG20, reverse complement) 
10359 . . 10760 Subfragment 5b (pTEF, reverse complement) 
10761 . . 11712 Subfragment 6a (pPGK) 
11713 . . 13215 Subfragment 6b (ALD6) 
13216 . . 13470 Subfragment 6c (tACT) 
13471 . . 15396 Subfragment 6d (MET15) 
15397 . . 15808 Subfragment 7a (pTEF) 
15809 . . 17767 Subfragment 7b (acs) 
17768 . . 17933 Subfragment 7c (tADH) 
17934 . . 20675 Subfragment 8a (UPC2, reverse complement) 
20676 . . 21675 Subfragment 8b (pPGK, reverse complement) 
21676 . . 22705 Acceptor module 
 
    1 AAAATTGTGC CTTTGGACTT AAAATGGCGT AGTTTATCAT TATCAATACT CGCCATTTCA  
   61 AAGAATACGT AAATAATTAA TAGTAGTGAT TTTCCTAACT TTATTTAGTC AAAAAATTAG  
  121 CCTTTTAATT CTGCTGTAAC CCGTACATGC CCAAAATAGG GGGCGGGTTA CACAGAATAT  
  181 ATAACATCGT AGGTGTCTGG GTGAACAGTT TATTCCTGGC ATCCACTAAA TATAATGGAG  
  241 CCCGCTTTTT AAGCTGGCAT CCAGAAAAAA AAAGAATCCC AGCACCAAAA TATTGTTTTC  
  301 TTCACCAACC ATCAGTTCAT AGGTCCATTC TCTTAGCGCA ACTACAGAGA ACAGGGGCAC  
  361 AAACAGGCAA AAAACGGGCA CAACCTCAAT GGAGTGATGC AACCTGCCTG GAGTAAATGA  
  421 TGACACAAGG CAATTGACCC ACGCATGTAT CTATCTCATT TTCTTACACC TTCTATTACC  
  481 TTCTGCTCTC TCTGATTTGG AAAAAGCTGA AAAAAAAGGT TGAAACCAGT TCCCTGAAAT  
  541 TATTCCCCTA CTTGACTAAT AAGTATATAA AGACGGTAGG TATTGATTGT AATTCTGTAA  
180 
 
  601 ATCTATTTCT TAAACTTCTT AAATTCTACT TTTATAGTTA GTCTTTTTTT TAGTTTTAAA  
  661 ACACCAGAAC TTAGTTTCGA ATAAACACAC ATAAACAAAC AAAATGGTTT CTGGTTCGAA  
  721 AGCAGGAGTA TCACCTCATA GGGAAATCGA AGTCATGAGA CAGTCCATTG ATGACCACTT  
  781 AGCAGGATTG TTGCCAGAAA CAGATTCCCA GGATATCGTT AGCCTTGCTA TGAGAGAAGG  
  841 TGTTATGGCA CCTGGTAAAC GTATCAGACC TTTGCTGATG TTACTTGCTG CAAGAGACCT  
  901 GAGATATCAG GGTTCTATGC CTACACTACT GGATCTAGCT TGTGCTGTTG AACTGACACA  
  961 TACTGCTTCC TTGATGCTGG ATGACATGCC TTGTATGGAC AATGCGGAAC TTAGAAGAGG  
 1021 TCAACCAACA ACCCACAAGA AATTCGGAGA ATCTGTTGCC ATTTTGGCTT CTGTAGGTCT  
 1081 GTTGTCGAAA GCTTTTGGCT TGATTGCTGC AACTGGTGAT CTTCCAGGTG AAAGGAGAGC  
 1141 ACAAGCTGTA AACGAGCTAT CTACTGCAGT TGGTGTTCAA GGTCTAGTCT TAGGACAGTT  
 1201 CAGAGATTTG AATGACGCAG CTTTGGACAG AACTCCTGAT GCTATCCTGT CTACGAACCA  
 1261 TCTGAAGACT GGCATCTTGT TCTCAGCTAT GTTGCAAATC GTAGCCATTG CTTCTGCTTC  
 1321 TTCACCATCT ACTAGGGAAA CGTTACACGC ATTCGCATTG GACTTTGGTC AAGCCTTTCA  
 1381 ACTGCTAGAC GATTTGAGGG ATGATCATCC AGAGACAGGT AAAGACCGTA ACAAAGACGC  
 1441 TGGTAAAAGC ACTCTAGTCA ACAGATTGGG TGCTGATGCA GCTAGACAGA AACTGAGAGA  
 1501 GCACATTGAC TCTGCTGACA AACACCTGAC ATTTGCATGT CCACAAGGAG GTGCTATAAG  
 1561 GCAGTTTATG CACCTATGGT TTGGACACCA TCTTGCTGAT TGGTCTCCAG TGATGAAGAT  
 1621 CGCCTAAGCG AATTTCTTAT GATTTATGAT TTTTATTATT AAATAAGTTA TAAAAAAAAT  
 1681 AAGTGTATAC AAATTTTAAA GTGACTCTTA GGTTTTAAAA CGAAAATTCT TATTCTTGAG  
 1741 TAACTCTTTC CTGTAGGTCA GGTTGCTTTC TCAGGTATAG CATGAGGTCG CTCTTAGACA  
 1801 GGTCTTTGCC ATAAACCAGC AGGTCTTGGT GTAACTCTGG TTGTTTTGGC ACGAATGACT  
 1861 TGTCCTGGTG CAGCCATAAG CATCGCAATC TTCTCTCCTT TGCTAGTGTG TTGACGTCTA  
 1921 TCCCAAGCAG AACCACCTGC AGCTTTTACC TTGATGCCAA TCTCTCTGTA GACAGATCTT  
 1981 GCAGTAGCTA TAGCCCAAGC ACATCTAGGT GGTAGATCAT GCAATCCAGC TTGACTTGAG  
 2041 ATGTAATAGG GTTCAGCAGC GTCTATCAGC CTTTCAGCAA CTCTTGCTAA TGCAGCTCTG  
 2101 TTCTCTCTTG CAGCGTAATT CTCAGGAGTT AGACCAGCAT CTTGCAACCA TTCAGCAGGT  
 2161 AGATAGCATC TGTCAATAGC TGCATCGTCG ATAATATCTC TCGCGATGTT TGTCAGCTGA  
 2221 AAAGCCAAAC CTAGATCACA AGCTCTGTCC AAAACCCTTT CGTCTCTTAC ACCCATTACT  
 2281 CTTGCCATCA TCAAACCAAC TACTCCAGCA ACATGGTAGC AGTATCTCAA GGTGTCTTCA  
181 
 
 2341 AAGGTCACGT AACGAGTTTG AGCAACATCC ATTGCGAAAC CATCCAAGTG ATCAAGTGCC  
 2401 ATTCTTGGCG TAATACCGTG TGTTAGTGCA ACTTCTTGGA ATGCAGCAAA AGCAGGATCT  
 2461 TGCATCTCAG CACCTTCAAA AGCTGCAAGT GTAAGCGTTC TCAATCTAGC CAATCTCTGA  
 2521 GTAGCCTCTT CTTCTGCAGC AGCTTCAGAT GCGAAACCAT GTGTCTGGTC ATCTATAACG  
 2581 TCATCACAGT GTCTACACCA AGTGTACAGC ATAAGCACTG ATCTTCTAGT AGCTGGGTCA  
 2641 AACAGTTTAG CTGCTGTAGC AAAGGACTTG GAACCATTAG CCATCGTTTG AGTAGCATGA  
 2701 TCCAACAAAG GTGGTTGACT CATTGTTTTA TATTTGTTGT AAAAAGTAGA TAATTACTTC  
 2761 CTTGATGATC TGTAAAAAAG AGAAAAAGAA AGCATCTAAG AACTTGAAAA ACTACGAATT  
 2821 AGAAAAGACC AAATATGTAT TTCTTGCATT GACCAATTTA TGCAAGTTTA TATATATGTA  
 2881 AATGTAAGTT TCACGAGGTT CTACTAAACT AAACCACCCC CTTGGTTAGA AGAAAAGAGT  
 2941 GTGTGAGAAC AGGCTGTTGT TGTCACACGA TTCGGACAAT TCTGTTTGAA AGAGAGAGAG  
 3001 TAACAGTACG ATCGAACGAA CTTTGCTCTG GAGATCACAG TGGGCATCAT AGCATGTGGT  
 3061 ACTAAACCCT TTCCCGCCAT TCCAGAACCT TCGATTGCTT GTTACAAAAC CTGTGAGCCG  
 3121 TCGCTAGGAC CTTGTTGTGT GACGAAATTG GAAGCTGCAA TCAATAGGAA GACAGGAAGT  
 3181 CGAGCGTGTC TGGGTTTTTT CAGTTTTGTT CTTTTTGCAA ACAAATCACG AGCGACGGTA  
 3241 ATTTCTTTCT CGATAAGAGG CCACGTGCTT TATGAGGGTA ACATCAATTC AAGAAGGAGG  
 3301 GAAACACTTC CTTTTTCTGG CCCTGATAAT AGTATGAGGG TGAAGCCAAA ATAAAGGATT  
 3361 CGCGCCCAAA TCGGCATCTT TAAATGCAGG TATGCGATAG TTCCTCACTC TTTCCTTACT  
 3421 CACGAGTAAT TCTTGCAAAT GCCTATTATG CAGATGTTAT AATATCTGTG CGTCTTGAGT  
 3481 TGAAGTCAGG AATCTAAAAT AAAAATTAAG GTTAATAAAA AGAGGAAAGA AAAAAAAATT  
 3541 AATCGATTTA CAGAAACTTG CACACTAAAA ATACACAACT AAAAGCAATT ACAGTATGGG  
 3601 AAGTCATCGA CGTTATCTCT ACTATAGTAT ATTATCATTT CTATTATTAT CCTGCTCAGT  
 3661 GGTACTTGCA AAACAAGATA AGACCCCATT CTTTGAAGGT ACTTCTTCGA AAAATTCGCG  
 3721 TCTATAGCTT CAAAATGTTT CTACTCCTTT TTTACTCTTC CAGATTTTCT CGGACTCCGC  
 3781 GCATCGCCGT ACCACTTCAA AACACCCAAG CACAGCATAC TAAATTTCCC CTCTTTCTTC  
 3841 CTCTAGGGTG TCGTTAATTA CCCGTACTAA AGGTTTGGAA AAGAAAAAAG AGACCGCCTC  
 3901 GTTTCTTTTT CTTCGTCGAA AAAGGCAATA AAAATTTTTA TCACGTTTCT TTTTCTTGAA  
 3961 AATTTTTTTT TTTGATTTTT TTCTCTTTCG ATGACCTCCC ATTGATATTT AAGTTAATAA  
 4021 ACGGTCTTCA ATTTCTCAAG TTTCAGTTTC ATTTTTCTTG TTCTATTACA ACTTTTTTTA  
182 
 
 4081 CTTCTTGCTC ATTAGAAAGA AAGCATAGCA ATCTAATCTA AGTTTTAATT ACAAAATGAA  
 4141 GAAAACCGTA GTGATTGGTG CAGGTTTTGG TGGTTTAGCT TTGGCTATAC GTCTACAAGC  
 4201 TGCAGGTATT CCTACAGTGC TATTGGAGCA AAGAGACAAA CCAGGAGGAA GAGCTTATGT  
 4261 TTGGCACGAT CAAGGCTTTA CCTTTGATGC TGGTCCTACA GTCATCACTG ATCCTACTGC  
 4321 ATTGGAAGCT TTGTTCACCT TAGCTGGTAG AAGAATGGAA GATTATGTCC GTCTATTGCC  
 4381 TGTCAAGCCG TTTTACAGAT TGTGTTGGGA ATCTGGTAAA ACCCTAGATT ACGCCAATGA  
 4441 CAGTGCTGAA CTAGAAGCTC AGATTACGCA GTTTAATCCC AGAGATGTCG AAGGTTACAG  
 4501 GAGATTCCTT GCCTATTCCC AAGCTGTTTT CCAAGAGGGT TATCTTCGTT TGGGTTCAGT  
 4561 TCCATTCCTG TCCTTTAGGG ATATGCTTAG AGCAGGTCCT CAGTTGTTGA AGCTACAAGC  
 4621 ATGGCAAAGT GTGTATCAGT CTGTTTCGAG ATTTATCGAG GATGAACATC TGAGACAAGC  
 4681 ATTCTCATTC CACAGTCTTC TAGTTGGAGG TAATCCCTTT ACCACATCGA GCATATATAC  
 4741 GTTGATTCAC GCTTTGGAAA GAGAATGGGG AGTTTGGTTT CCTGAAGGTG GAACAGGTGC  
 4801 TTTGGTTAAT GGTATGGTGA AGCTATTCAC GGATTTGGGT GGAGAAATAG AGCTGAATGC  
 4861 AAGAGTGGAA GAACTTGTTG TAGCAGACAA CAGAGTCTCA CAAGTTAGAC TTGCTGATGG  
 4921 TAGGATCTTC GATACAGATG CTGTAGCTTC AAACGCAGAT GTAGTGAACA CTTATAAAAA  
 4981 GTTGTTGGGA CATCATCCTG TTGGACAAAA GAGAGCAGCT GCTTTGGAGA GGAAATCTAT  
 5041 GAGCAACTCG TTGTTTGTCC TTTACTTTGG GCTGAATCAA CCACACTCAC AACTAGCTCA  
 5101 TCACACAATC TGCTTTGGTC CTAGATACAG AGAGCTGATA GATGAAATTT TCACTGGATC  
 5161 TGCTTTAGCA GACGATTTTT CCCTGTACTT GCATTCACCA TGTGTTACTG ATCCCTCTTT  
 5221 AGCACCACCT GGTTGTGCTA GCTTCTATGT ACTAGCACCT GTACCACATT TGGGTAATGC  
 5281 TCCATTAGAT TGGGCACAAG AAGGACCGAA ATTGAGGGAT AGGATCTTCG ACTATTTGGA  
 5341 AGAACGTTAC ATGCCAGGTT TGAGATCTCA GTTGGTTACA CAGAGGATAT TCACACCAGC  
 5401 TGATTTTCAT GATACTCTAG ATGCGCATTT AGGTAGCGCT TTTTCCATTG AGCCACTTTT  
 5461 GACGCAAAGT GCTTGGTTTA GACCACACAA CAGAGATTCT GACATTGCCA ATCTGTACCT  
 5521 AGTAGGTGCA GGAACTCATC CAGGAGCTGG TATTCCTGGA GTTGTAGCTT CTGCTAAAGC  
 5581 TACTGCTAGT CTGATGATCG AGGATTTGCA GTAATCTCTG CTTTTGTGCG CGTATGTTTA  
 5641 TGTATGTACC TCTCTCTCTA TTTCTATTTT TAAACCACCC TCTCAATAAA ATAAAAATAA  
 5701 TAAAGTATTT TTAAGGAAAA GACGTGTTTA AGCACTGACT TTATCTACTT TTTGTACGTT  
 5761 TTCATTGATA TAATGTGTTT TGTCTCTCCC TTTTCTACGA AAATTTCAAA AATTGACCAA  
183 
 
 5821 AAAAAGGAAT ATATATACGA AAAACTATTA TATTTATATA TCATAGTGTA ACGACATTAC  
 5881 TATATATATA ATATAGGAAG CATTTAATAG ACAGCATCGT AATATATGTG TACTTTGCAG  
 5941 TTATGACGCC AGATGGCAGT AGTGGAAGAT ATTCTTTATT GAAAAATAGC TTGTCACCTT  
 6001 ACGTACAATC TTGATCCGGA GCTTTTCTTT TTTTGCCGAT TAAGAATTAA TTCGGTCGAA  
 6061 AAAAGAAAAG GAGAGGGCCA AGAGGGAGGG CATTGGTGAC TATTGAGCAC GTGAGTATAC  
 6121 GTGATTAAGC ACACAAAGGC AGCTTGGAGT ATGTCTGTTA TTAATTTCAC AGGTAGTTCT  
 6181 GGTCCATTGG TGAAAGTTTG CGGCTTGCAG AGCACAGAGG CCGCAGAATG TGCTCTAGAT  
 6241 TCCGATGCTG ACTTGCTGGG TATTATATGT GTGCCCAATA GAAAGAGAAC AATTGACCCG  
 6301 GTTATTGCAA GGAAAATTTC AAGTCTTGTA AAAGCATATA AAAATAGTTC AGGCACTCCG  
 6361 AAATACTTGG TTGGCGTGTT TCGTAATCAA CCTAAGGAGG ATGTTTTGGC TCTGGTCAAT  
 6421 GATTACGGCA TTGATATCGT CCAACTGCAT GGAGATGAGT CGTGGCAAGA ATACCAAGAG  
 6481 TTCCTCGGTT TGCCAGTTAT TAAAAGACTC GTATTTCCAA AAGACTGCAA CATACTACTC  
 6541 AGTGCAGCTT CACAGAAACC TCATTCGTTT ATTCCCTTGT TTGATTCAGA AGCAGGTGGG  
 6601 ACAGGTGAAC TTTTGGATTG GAACTCGATT TCTGACTGGG TTGGAAGGCA AGAGAGCCCC  
 6661 GAAAGCTTAC ATTTTATGTT AGCTGGTGGA CTGACGCCAG AAAATGTTGG TGATGCGCTT  
 6721 AGATTAAATG GCGTTATTGG TGTTGATGTA AGCGGAGGTG TGGAGACAAA TGGTGTAAAA  
 6781 GACTCTAACA AAATAGCAAA TTTCGTCAAA AATGCTAAGA AATAGGTTAT TACTGAGTAG  
 6841 TATTTATTTA AGTATTGTTT GTGCACTTGC CTAGTTTATC ATTATCAATA CTCGCCATTT  
 6901 CAAAGAATAC GTAAATAATT AATAGTAGTG ATTTTCCTAA CTTTATTTAG TCAAAAAATT  
 6961 AGCCTTTTAA TTCTGCTGTA ACCCGTACAT GCCCAAAATA GGGGGCGGGT TACACAGAAT  
 7021 ATATAACATC GTAGGTGTCT GGGTGAACAG TTTATTCCTG GCATCCACTA AATATAATGG  
 7081 AGCCCGCTTT TTAAGCTGGC ATCCAGAAAA AAAAAGAATC CCAGCACCAA AATATTGTTT  
 7141 TCTTCACCAA CCATCAGTTC ATAGGTCCAT TCTCTTAGCG CAACTACAGA GAACAGGGGC  
 7201 ACAAACAGGC AAAAAACGGG CACAACCTCA ATGGAGTGAT GCAACCTGCC TGGAGTAAAT  
 7261 GATGACACAA GGCAATTGAC CCACGCATGT ATCTATCTCA TTTTCTTACA CCTTCTATTA  
 7321 CCTTCTGCTC TCTCTGATTT GGAAAAAGCT GAAAAAAAAG GTTGAAACCA GTTCCCTGAA  
 7381 ATTATTCCCC TACTTGACTA ATAAGTATAT AAAGACGGTA GGTATTGATT GTAATTCTGT  
 7441 AAATCTATTT CTTAAACTTC TTAAATTCTA CTTTTATAGT TAGTCTTTTT TTTAGTTTTA  
 7501 AAACACCAGA ACTTAGTTTC GAATAAACAC ACATAAACAA ACAAAATGGA CCAATTGGTG  
184 
 
 7561 AAAACTGAAG TCACCAAGAA GTCTTTTACT GCTCCTGTAC AAAAGGCTTC TACACCAGTT  
 7621 TTAACCAATA AAACAGTCAT TTCTGGATCG AAAGTCAAAA GTTTATCATC TGCGCAATCG  
 7681 AGCTCATCAG GACCTTCATC ATCTAGTGAG GAAGATGATT CCCGCGATAT TGAAAGCTTG  
 7741 GATAAGAAAA TACGTCCTTT AGAAGAATTA GAAGCATTAT TAAGTAGTGG AAATACAAAA  
 7801 CAATTGAAGA ACAAAGAGGT CGCTGCCTTG GTTATTCACG GTAAGTTACC TTTGTACGCT  
 7861 TTGGAGAAAA AATTAGGTGA TACTACGAGA GCGGTTGCGG TACGTAGGAA GGCTCTTTCA  
 7921 ATTTTGGCAG AAGCTCCTGT ATTAGCATCT GATCGTTTAC CATATAAAAA TTATGACTAC  
 7981 GACCGCGTAT TTGGCGCTTG TTGTGAAAAT GTTATAGGTT ACATGCCTTT GCCCGTTGGT  
 8041 GTTATAGGCC CCTTGGTTAT CGATGGTACA TCTTATCATA TACCAATGGC AACTACAGAG  
 8101 GGTTGTTTGG TAGCTTCTGC CATGCGTGGC TGTAAGGCAA TCAATGCTGG CGGTGGTGCA  
 8161 ACAACTGTTT TAACTAAGGA TGGTATGACA AGAGGCCCAG TAGTCCGTTT CCCAACTTTG  
 8221 AAAAGATCTG GTGCCTGTAA GATATGGTTA GACTCAGAAG AGGGACAAAA CGCAATTAAA  
 8281 AAAGCTTTTA ACTCTACATC AAGATTTGCA CGTCTGCAAC ATATTCAAAC TTGTCTAGCA  
 8341 GGAGATTTAC TCTTCATGAG ATTTAGAACA ACTACTGGTG ACGCAATGGG TATGAATATG  
 8401 ATTTCTAAAG GTGTCGAATA CTCATTAAAG CAAATGGTAG AAGAGTATGG CTGGGAAGAT  
 8461 ATGGAGGTTG TCTCCGTTTC TGGTAACTAC TGTACCGACA AAAAACCAGC TGCCATCAAC  
 8521 TGGATCGAAG GTCGTGGTAA GAGTGTCGTC GCAGAAGCTA CTATTCCTGG TGATGTTGTC  
 8581 AGAAAAGTGT TAAAAAGTGA TGTTTCCGCA TTGGTTGAGT TGAACATTGC TAAGAATTTG  
 8641 GTTGGATCTG CAATGGCTGG GTCTGTTGGT GGATTTAACG CACATGCAGC TAATTTAGTG  
 8701 ACAGCTGTTT TCTTGGCATT AGGACAAGAT CCTGCACAAA ATGTTGAAAG TTCCAACTGT  
 8761 ATAACATTGA TGAAAGAAGT GGACGGTGAT TTGAGAATTT CCGTATCCAT GCCATCCATC  
 8821 GAAGTAGGTA CCATCGGTGG TGGTACTGTT CTAGAACCCC AAGGTGCCAT GTTGGACTTA  
 8881 TTAGGTGTAA GAGGCCCGCA TGCTACCGCT CCTGGTACCA ACGCACGTCA ATTAGCAAGA  
 8941 ATAGTTGCCT GTGCCGTCTT GGCAGGTGAA TTATCCTTAT GTGCTGCCCT AGCAGCCGGC  
 9001 CATTTGGTTC AAAGTCATAT GACCCACAAC AGGAAACCTG CTGAACCAAC AAAACCTAAC  
 9061 AATTTGGACG CCACTGATAT AAATCGTTTG AAAGATGGGT CCGTCACCTG CATTAAATCC  
 9121 TAAGCGAATT TCTTATGATT TATGATTTTT ATTATTAAAT AAGTTATAAA AAAAATAAGT  
 9181 GTATACAAAT TTTAAAGTGA CTCTTAGGTT TTAAAACGAA AATTCTTATT CTTGAGTAAC  
 9241 TCTTTCCTGT AGGTCAGGTT GCTTTCTCAG GTATAGCATG AGGTCGCTCC TATTTGCTTC  
185 
 
 9301 TCTTGTAAAC TTTGTTCAAG AACGCAGTTA AGACATCAGC TTTGAAGCCA CGAGACTCAT  
 9361 CGACCTGAGA AATTTTGGCC TTCAAATCCT TGGCAATAGA CTCTTCATAT TCGTGGTATA  
 9421 GCTGTTCAAT TTTCAAGTCA TTGAAAATCT TTTTGCATTT GGCTTCTGCG ACTGAGTCCT  
 9481 TCTTACCGTA ATTTTCGTCT AAAGTCTTTC TTTGTTCTGC GGAAGCAAGT TCCAATGCCT  
 9541 TGTTGATTAC CCAAGAACAT TTGTTATCTT GGATATCTGT ACCGATCTTA CCGATCTGTT  
 9601 CTGGGGTACC GAAGCAGTCT AAGTAGTCAT CTTGAATTTG GAAGTATTCA CCCAATGGAA  
 9661 TCAAGACATC TCTGGCTTGT TTCAAATCCT TTTCATCCGT GATACCGGCA ACGTACATGG  
 9721 CCAATGCGAC AGGCAAGTAG AAAGAATAGT AAGCAGTCTT GAAAGTAACT ATGAAGGAGT  
 9781 GCTTCTTTAG GGAGAACTTA CTCAAGTCGA CTTTGTCTTC AGGTGCAGTG ATTAAGTCCA  
 9841 TCAATTGGCC CAATTCGGTT TGGAAGGTGA CCTCATGGAA CAATTCGGTG ATATCTATGT  
 9901 AGTATTTTTC GTTTCTGAAG TGAGATTTCA AAAGCTTGTA GATAGCAGCC TCTAACATGA  
 9961 ATGCGTCATT GATGGCAATT TCCCCAACTT CAGGAACCTT GTACCAACAT GGTTGGCCTC  
10021 TTCTGGTAAT GGACTTGTCC ATCATATCAT CGGCGACCAA GAAGTAAGCC TGCAACAACT  
10081 CAATGCACCA ACCTAGAATG GCAACCTTTT CGTATTCTTC TTGCCCCAAT TGTTCAACGG  
10141 TCTTGTTGGA GAGAATAGCA TACGTGTCCA CAACGGACAA ACCTCTATTT AGCTTACCGC  
10201 CTGGAGTGTT GTAGTTCAAT GAGTGGGCAT ACCAGTCACA TGCTTCCTTA GGCATACCGT  
10261 AAGCCAAAAG CGATGCGTTC AATTCCTCTA CTAATTTAGG GAAAACGTTC AAGAATCTCT  
10321 CTCTCCTAAT TTCTTTTTCT GAAGCCATTT TGTAATTAAA ACTTAGATTA GATTGCTATG  
10381 CTTTCTTTCT AATGAGCAAG AAGTAAAAAA AGTTGTAATA GAACAAGAAA AATGAAACTG  
10441 AAACTTGAGA AATTGAAGAC CGTTTATTAA CTTAAATATC AATGGGAGGT CATCGAAAGA  
10501 GAAAAAAATC AAAAAAAAAA ATTTTCAAGA AAAAGAAACG TGATAAAAAT TTTTATTGCC  
10561 TTTTTCGACG AAGAAAAAGA AACGAGGCGG TCTCTTTTTT CTTTTCCAAA CCTTTAGTAC  
10621 GGGTAATTAA CGACACCCTA GAGGAAGAAA GAGGGGAAAT TTAGTATGCT GTGCTTGGGT  
10681 GTTTTGAAGT GGTACGGCGA TGCGCGGAGT CCGAGAAAAT CTGGAAGAGT AAAAAAGGAG  
10741 TAGAAACATT TTGAAGCTAT TGTTTTGCAA GTACCACTGA GCAGGATAAT AATAGAAATG  
10801 ATAATATACT ATAGTAGAGA TAACGTCGAT GACTTCCCAT ACTGTAATTG CTTTTAGTTG  
10861 TGTATTTTTA GTGTGCAAGT TTCTGTAAAT CGATTAATTT TTTTTTCTTT CCTCTTTTTA  
10921 TTAACCTTAA TTTTTATTTT AGATTCCTGA CTTCAACTCA AGACGCACAG ATATTATAAC  
10981 ATCTGCATAA TAGGCATTTG CAAGAATTAC TCGTGAGTAA GGAAAGAGTG AGGAACTATC  
186 
 
11041 GCATACCTGC ATTTAAAGAT GCCGATTTGG GCGCGAATCC TTTATTTTGG CTTCACCCTC  
11101 ATACTATTAT CAGGGCCAGA AAAAGGAAGT GTTTCCCTCC TTCTTGAATT GATGTTACCC  
11161 TCATAAAGCA CGTGGCCTCT TATCGAGAAA GAAATTACCG TCGCTCGTGA TTTGTTTGCA  
11221 AAAAGAACAA AACTGAAAAA ACCCAGACAC GCTCGACTTC CTGTCTTCCT ATTGATTGCA  
11281 GCTTCCAATT TCGTCACACA ACAAGGTCCT AGCGACGGCT CACAGGTTTT GTAACAAGCA  
11341 ATCGAAGGTT CTGGAATGGC GGGAAAGGGT TTAGTACCAC ATGCTATGAT GCCCACTGTG  
11401 ATCTCCAGAG CAAAGTTCGT TCGATCGTAC TGTTACTCTC TCTCTTTCAA ACAGAATTGT  
11461 CCGAATCGTG TGACAACAAC AGCCTGTTCT CACACACTCT TTTCTTCTAA CCAAGGGGGT  
11521 GGTTTAGTTT AGTAGAACCT CGTGAAACTT ACATTTACAT ATATATAAAC TTGCATAAAT  
11581 TGGTCAATGC AAGAAATACA TATTTGGTCT TTTCTAATTC GTAGTTTTTC AAGTTCTTAG  
11641 ATGCTTTCTT TTTCTCTTTT TTACAGATCA TCAAGGAAGT AATTATCTAC TTTTTACAAC  
11701 AAATATAAAA CAATGACTAA GCTACACTTT GACACTGCTG AACCAGTCAA GATCACACTT  
11761 CCAAATGGTT TGACATACGA GCAACCAACC GGTCTATTCA TTAACAACAA GTTTATGAAA  
11821 GCTCAAGACG GTAAGACCTA TCCCGTCGAA GATCCTTCCA CTGAAAACAC CGTTTGTGAG  
11881 GTCTCTTCTG CCACCACTGA AGATGTTGAA TATGCTATCG AATGTGCCGA CCGTGCTTTC  
11941 CACGACACTG AATGGGCTAC CCAAGACCCA AGAGAAAGAG GCCGTCTACT AAGTAAGTTG  
12001 GCTGACGAAT TGGAAAGCCA AATTGACTTG GTTTCTTCCA TTGAAGCTTT GGACAATGGT  
12061 AAAACTTTGG CCTTAGCCCG TGGGGATGTT ACCATTGCAA TCAACTGTCT AAGAGATGCT  
12121 GCTGCCTATG CCGACAAAGT CAACGGTAGA ACAATCAACA CCGGTGACGG CTACATGAAC  
12181 TTCACCACCT TAGAGCCAAT CGGTGTCTGT GGTCAAATTA TTCCATGGAA CTTTCCAATA  
12241 ATGATGTTGG CTTGGAAGAT CGCCCCAGCA TTGGCCATGG GTAACGTCTG TATCTTGAAA  
12301 CCCGCTGCTG TCACACCTTT AAATGCCCTA TACTTTGCTT CTTTATGTAA GAAGGTTGGT  
12361 ATTCCAGCTG GTGTCGTCAA CATCGTTCCA GGTCCTGGTA GAACTGTTGG TGCTGCTTTG  
12421 ACCAACGACC CAAGAATCAG AAAGCTGGCT TTTACCGGTT CTACAGAAGT CGGTAAGAGT  
12481 GTTGCTGTCG ACTCTTCTGA ATCTAACTTG AAGAAAATCA CTTTGGAACT AGGTGGTAAG  
12541 TCCGCCCATT TGGTCTTTGA CGATGCTAAC ATTAAGAAGA CTTTACCAAA TCTAGTAAAC  
12601 GGTATTTTCA AGAACGCTGG TCAAATTTGT TCCTCTGGTT CTAGAATTTA CGTTCAAGAA  
12661 GGTATTTACG ACGAACTATT GGCTGCTTTC AAGGCTTACT TGGAAACCGA AATCAAAGTT  
12721 GGTAATCCAT TTGACAAGGC TAACTTCCAA GGTGCTATCA CTAACCGTCA ACAATTCGAC  
187 
 
12781 ACAATTATGA ACTACATCGA TATCGGTAAG AAAGAAGGCG CCAAGATCTT AACTGGTGGC  
12841 GAAAAAGTTG GTGACAAGGG TTACTTCATC AGACCAACCG TTTTCTACGA TGTTAATGAA  
12901 GACATGAGAA TTGTTAAGGA AGAAATTTTT GGACCAGTTG TCACTGTCGC AAAGTTCAAG  
12961 ACTTTAGAAG AAGGTGTCGA AATGGCTAAC AGCTCTGAAT TCGGTCTAGG TTCTGGTATC  
13021 GAAACAGAAT CTTTGAGCAC AGGTTTGAAG GTGGCCAAGA TGTTGAAGGC CGGTACCGTC  
13081 TGGATCAACA CATACAACGA TTTTGACTCC AGAGTTCCAT TCGGTGGTGT TAAGCAATCT  
13141 GGTTACGGTA GAGAAATGGG TGAAGAAGTC TACCATGCAT ACACTGAAGT AAAAGCTGTC  
13201 AGAATTAAGT TGTAATCTCT GCTTTTGTGC GCGTATGTTT ATGTATGTAC CTCTCTCTCT  
13261 ATTTCTATTT TTAAACCACC CTCTCAATAA AATAAAAATA ATAAAGTATT TTTAAGGAAA  
13321 AGACGTGTTT AAGCACTGAC TTTATCTACT TTTTGTACGT TTTCATTGAT ATAATGTGTT  
13381 TTGTCTCTCC CTTTTCTACG AAAATTTCAA AAATTGACCA AAAAAAGGAA TATATATACG  
13441 AAAAACTATT ATATTTATAT ATCATAGTGT CGGATGCAAG GGTTCGAATC CCTTAGCTCT  
13501 CATTATTTTT TGCTTTTTCT CTTGAGGTCA CATGATCGCA AAATGGCAAA TGGCACGTGA  
13561 AGCTGTCGAT ATTGGGGAAC TGTGGTGGTT GGCAAATGAC TAATTAAGTT AGTCAAGGCG  
13621 CCATCCTCAT GAAAACTGTG TAACATAATA ACCGAAGTGT CGAAAAGGTG GCACCTTGTC  
13681 CAATTGAACA CGCTCGATGA AAAAAATAAG ATATATATAA GGTTAAGTAA AGCGTCTGTT  
13741 AGAAAGGAAG TTTTTCCTTT TTCTTGCTCT CTTGTCTTTT CATCTACTAT TTCCTTCGTG  
13801 TAATACAGGG TCGTCAGATA CATAGATACA ATTCTATTAC CCCCATCCAT ACAATGCCAT  
13861 CTCATTTCGA TACTGTTCAA CTACACGCCG GCCAAGAGAA CCCTGGTGAC AATGCTCACA  
13921 GATCCAGAGC TGTACCAATT TACGCCACCA CTTCTTATGT TTTCGAAAAC TCTAAGCATG  
13981 GTTCGCAATT GTTTGGTCTA GAAGTTCCAG GTTACGTCTA TTCCCGTTTC CAAAACCCAA  
14041 CCAGTAATGT TTTGGAAGAA AGAATTGCTG CTTTAGAAGG TGGTGCTGCT GCTTTGGCTG  
14101 TTTCCTCCGG TCAAGCCGCT CAAACCCTTG CCATCCAAGG TTTGGCACAC ACTGGTGACA  
14161 ACATCGTTTC CACTTCTTAC TTATACGGTG GTACTTATAA CCAGTTCAAA ATCTCGTTCA  
14221 AAAGATTTGG TATCGAGGCT AGATTTGTTG AAGGTGACAA TCCAGAAGAA TTCGAAAAGG  
14281 TCTTTGATGA AAGAACCAAG GCTGTTTATT TGGAAACCAT TGGTAATCCA AAGTACAATG  
14341 TTCCGGATTT TGAAAAAATT GTTGCAATTG CTCACAAACA CGGTATTCCA GTTGTCGTTG  
14401 ACAACACATT TGGTGCCGGT GGTTACTTCT GTCAGCCAAT TAAATACGGT GCTGATATTG  
14461 TAACACATTC TGCTACCAAA TGGATTGGTG GTCATGGTAC TACTATCGGT GGTATTATTG  
188 
 
14521 TTGACTCTGG TAAGTTCCCA TGGAAGGACT ACCCAGAAAA GTTCCCTCAA TTCTCTCAAC  
14581 CTGCCGAAGG ATATCACGGT ACTATCTACA ATGAAGCCTA CGGTAACTTG GCATACATCG  
14641 TTCATGTTAG AACTGAACTA TTAAGAGATT TGGGTCCATT GATGAACCCA TTTGCCTCTT  
14701 TCTTGCTACT ACAAGGTGTT GAAACATTAT CTTTGAGAGC TGAAAGACAC GGTGAAAATG  
14761 CATTGAAGTT AGCCAAATGG TTAGAACAAT CCCCATACGT ATCTTGGGTT TCATACCCTG  
14821 GTTTAGCATC TCATTCTCAT CATGAAAATG CTAAGAAGTA TCTATCTAAC GGTTTCGGTG  
14881 GTGTCTTATC TTTCGGTGTA AAAGACTTAC CAAATGCCGA CAAGGAAACT GACCCATTCA  
14941 AACTTTCTGG TGCTCAAGTT GTTGACAATT TAAAGCTTGC CTCTAACTTG GCCAATGTTG  
15001 GTGATGCCAA GACCTTAGTC ATTGCTCCAT ACTTCACTAC CCACAAACAA TTAAATGACA  
15061 AAGAAAAGTT GGCATCTGGT GTTACCAAGG ACTTAATTCG TGTCTCTGTT GGTATCGAAT  
15121 TTATTGATGA CATTATTGCA GACTTCCAGC AATCTTTTGA AACTGTTTTC GCTGGCCAAA  
15181 AACCATGAGT GTGCGTAATG AGTTGTAAAA TTATGTATAA ACCTACTTTC TCTCACAAGT  
15241 ACTATACTTT TATAAAACGA ACTTTATTGA AATGAATATC CTTTTTTTCC CTTGTTACAT  
15301 GTCGTGACTC GTACTTTGAA CCTAAATTGT TCTAACATCA AAGAACAGTG TTAATTCGCA  
15361 GTCGAGAAGA AAAATATGGT GAACAAGACT CATCTAATAG CTTCAAAATG TTTCTACTCC  
15421 TTTTTTACTC TTCCAGATTT TCTCGGACTC CGCGCATCGC CGTACCACTT CAAAACACCC  
15481 AAGCACAGCA TACTAAATTT CCCCTCTTTC TTCCTCTAGG GTGTCGTTAA TTACCCGTAC  
15541 TAAAGGTTTG GAAAAGAAAA AAGAGACCGC CTCGTTTCTT TTTCTTCGTC GAAAAAGGCA  
15601 ATAAAAATTT TTATCACGTT TCTTTTTCTT GAAAATTTTT TTTTTTGATT TTTTTCTCTT  
15661 TCGATGACCT CCCATTGATA TTTAAGTTAA TAAACGGTCT TCAATTTCTC AAGTTTCAGT  
15721 TTCATTTTTC TTGTTCTATT ACAACTTTTT TTACTTCTTG CTCATTAGAA AGAAAGCATA  
15781 GCAATCTAAT CTAAGTTTTA ATTACAAAAT GAGCCAAACA CATAAACACG CCATTCCCGC  
15841 CAACATTGCG GATCGTTGCC TGATAAATCC AGAGCAGTAT GAGACTAAAT ATAAACAGTC  
15901 TATTAACGAC CCCGATACGT TTTGGGGCGA ACAGGGAAAA ATTCTCGATT GGATCACGCC  
15961 GTACCAAAAA GTGAAAAACA CCTCCTTTGC GCCAGGCAAT GTGTCGATTA AATGGTACGA  
16021 GGACGGCACG CTGAATCTGG CGGCGAACTG TCTTGACCGC CATTTGCAGG AAAATGGCGA  
16081 TCGCACCGCC ATTATCTGGG AAGGCGATGA CACGTCGCAG AGTAAACATA TCTCTTATCG  
16141 CGAACTGCAT CGCGATGTCT GCCGTTTCGC GAATACGCTG CTGGATCTGG GCATTAAAAA  
16201 AGGCGATGTG GTAGCGATTT ATATGCCGAT GGTGCCGGAA GCGGCGGTGG CAATGTTGGC  
189 
 
16261 CTGCGCCCGC ATCGGTGCGG TGCATTCGGT GATCTTCGGG GGCTTCTCGC CGGAAGCCGT  
16321 CGCCGGACGC ATTATCGACT CCAGCTCGCG GCTGGTGATC ACCGCTGACG AAGGTGTACG  
16381 TGCCGGACGC AGTATCCCGC TGAAAAAGAA TGTCGATGAC GCGCTGAAAA ACCCGAATGT  
16441 CACTAGCGTT GAGCATGTGA TCGTCCTGAA GCGCACCGGC AGCGACATTG ACTGGCAAGA  
16501 AGGCCGCGAC CTGTGGTGGC GCGATTTGAT TGAAAAAGCC AGCCCTGAGC ACCAGCCTGA  
16561 AGCGATGAAT GCCGAAGATC CGCTGTTTAT CCTTTATACC TCCGGCTCCA CCGGCAAGCC  
16621 GAAAGGCGTG CTGCACACCA CCGGCGGCTA TCTGGTCTAC GCCGCGACCA CCTTTAAGTA  
16681 TGTCTTTGAT TATCACCCTG GCGATATTTA CTGGTGTACC GCCGATGTGG GTTGGGTGAC  
16741 GGGGCACAGC TATCTGTTGT ATGGCCCGCT GGCCTGCGGC GCGACCACCT TAATGTTTGA  
16801 AGGCGTGCCG AATTGGCCAA CGCCCGCTCG CATGTGCCAG GTGGTCGACA AACACCAGGT  
16861 CAACATTCTC TATACCGCCC CGACGGCCAT CCGCGCGCTG ATGGCGGAAG GCGATAAAGC  
16921 CATTGAAGGC ACCGACCGTT CTTCACTGCG CATTCTGGGT TCCGTCGGCG AGCCGATCAA  
16981 TCCCGAAGCG TGGGAATGGT ACTGGAAGAA GATCGGCAAG GAAAAATGTC CGGTCGTCGA  
17041 CACCTGGTGG CAGACTGAAA CAGGCGGTTT TATGATCACG CCGCTACCAG GCGCTATCGA  
17101 ACTGAAAGCC GGTTCCGCCA CCCGTCCTTT CTTTGGCGTA CAGCCTGCGC TGGTGGATAA  
17161 CGAAGGCCAT CCGCAAGAAG GCGCGACGGA AGGCAATCTG GTCATCACCG ATTCCTGGCC  
17221 GGGCCAGGCG CGCACTCTGT TCGGCGATCA TGAACGTTTT GAGCAGACCT ATTTCTCTAC  
17281 CTTTAAGAAT ATGTATTTCA GCGGCGACGG CGCGCGTCGC GATGAGGACG GCTATTACTG  
17341 GATCACCGGT CGCGTGGACG ACGTGTTAAA CGTCTCCGGC CACCGTCTGG GTACGGCGGA  
17401 AATCGAGTCA GCGCTGGTGG CGCATCCGAA GATCGCCGAA GCGGCGGTGG TGGGTATTCC  
17461 ACACGCTATC AAAGGCCAGG CGATTTACGC TTATGTGACG CTCAACCACG GCGAGGAGCC  
17521 GTCGCCAGAA CTGTACGCGG AGGTGCGCAA CTGGGTACGT AAAGAGATTG GCCCACTGGC  
17581 GACGCCGGAC GTGCTGCACT GGACCGACTC ACTGCCAAAA ACCCGTTCCG GCAAAATTAT  
17641 GCGCCGCATT TTGCGCAAAA TCGCGGCGGG CGATACCAGC AATCTGGGCG ATACCTCGAC  
17701 TCTCGCCGAT CCTGGCGTGG TGGAGAAACC GCTCGAAGAG AAGCAGGCCA TCGCGATGCC  
17761 GTCATAAGCG AATTTCTTAT GATTTATGAT TTTTATTATT AAATAAGTTA TAAAAAAAAT  
17821 AAGTGTATAC AAATTTTAAA GTGACTCTTA GGTTTTAAAA CGAAAATTCT TATTCTTGAG  
17881 TAACTCTTTC CTGTAGGTCA GGTTGCTTTC TCAGGTATAG CATGAGGTCG CTCTCATAAC  
17941 GAAAAATCAG AGAAATTTGT TGTTGTCATC GATGGTAATC CGCCACCGAG GAAATCTAGC  
190 
 
18001 ATCATATGCA TATCACCACC TCCACTGTAT TCGTCAACAT CTTGAGGCAG CACCTGCGTG  
18061 ACTCCTTCGA GAAACCAGAC TTTATCCTTG ACCTCTGTGG CAAATCCTCG AAGTAGTTTA  
18121 TAATATGATC TCATAATTCT CATTGCACCT AAATCACCTG TCATCAGTAA TGCCAGGAAT  
18181 GTCTTGTCTA GCAATGCTGG AAATGTAAAT ACCCGCAGAA TAAAATCACC CTGGTTTTTT  
18241 TCACGGTGCA ATTTATCTAA ATAAGCTAGT GTTATCAAAT ATGGCGAATC TAAGCCGACA  
18301 GGATACAAAT CGGCAATACT TTCATCAAAA CATACCAATT CAGTAATTGT TCCAACATCA  
18361 GGGTTAATGA CATCGCCTAA ATCGCTAAGA TCAACAGATA TAATGTTATG AAATTTAGAT  
18421 CTTTCACTCA AAGGCCACAC AGCGGTTAAA ATTGTTGCAG CACCTTTGAC ATGAAAGATC  
18481 CAAGCGCTTG GTGACATGCT ATTCAAACTT TGGTTTCCTA CAGTGCCGTT ACCACTAGCA  
18541 TTTGCTAACG AGTCCATGAT TAGTATCAGG GCGCTGGCAA CTAGCGCATC GGTGTTATTC  
18601 TCAGATATTT CTAAAACAGC TTCTCTTAAT AATCTCAGAG CGTCTAGGCG GTGAGATGAA  
18661 ACGTATTGCT CCAGTCCAGT TTCAGTCCTC GAAAGATGGG TGGCACTGAA TGCCAACAAA  
18721 GCGTGCATTA AAAATGGATA GTCAAATGCT AACTCCGGTA TGTAGTCCCT CCATATTTCA  
18781 GGCCCAGAAA CTTTGGCCGC TGTAATCGTA GGCCAGACCT TTGTGCAATA ATGATGAAAC  
18841 AGTTTCATGT CTATCAGGTT CAGATTGCCT TTGGTAGAAA GATCTAAAAG CTTAGCGATG  
18901 TTACTGGTAC CAGCAGAAAC AGAACTTCGG TCAGCTTCGT TATTAATTTT TGAGGTCATG  
18961 TCTTGCCGCG ATGCATCGTC TTCATTCTCT GTCTGTGATG TTTGTAAACT TATCGTTGGT  
19021 TCGTTGTTCT CCAAGGCTGC TTTTGTCAGA TTTCCTAGAG AACTTATAGA ATCTTGCATC  
19081 TCTTGCCTAT CATTCAACAC TGCAGAGGGC GTTGATGGAG AAATGTTGCT GTTTCTGTTC  
19141 ATGTTTCTTT CAATCATTGA TATAGGCGCC ATTGTCGAAA CCGCATCAGC CGCCTGAGGT  
19201 TCCATAATAC TAGCACTTCC CCCTTGGGCG TTATTCGATG GCGCTGGACT CTTCGTATCA  
19261 GAGAGCTGAC CATCATTCTC CTTTACAGAA GCAGCTGCAC GTTCATGATG CTCTTGCATA  
19321 TTGGCCAAAG CTTCCTCTGC GTTGCTGGCC TTAGTAGCTC TTGAATTGCC GTTATTTATT  
19381 GGAAACTTAA TACCTAACAG TTCCTGAAAG TCATAGGAAA CACCACCAAT ACCAGCTGTT  
19441 GGAAAGGTAC TTAACGACTT TAGGCTTAGC CCCATCTTAC TTAACTGAGA TAATGCATCA  
19501 GCTTGTAATG TAGCAGCATC GCTGTTTAAA GTAGTTTCGC TTGTTTGTGA TTGTAAAGGC  
19561 CCTTCCTTTA CCTTTTTGCT GTTTTCTTCC TGAACGCCAC CTTCCTCATC GTTAGGTTGT  
19621 TGCTCTTGCT GAAGCAGTAC TTGTTGCTGC TGTTGCAAAA AATGTTGTTG GTATTGCTGG  
19681 AGTTGTTCCT GTTGTTGTTG CTGAACTTGT TGGTGTTGTT CCTGACGTAA TTGTTGATAC  
191 
 
19741 TGCTGCAGCT GAACTTGCTG ATGCTGTTGC AATTGCAGCT GCTGGTGTAA TTGATATTGT  
19801 AATTGTTGTT GAGTGTAGTT TTGGCCGGAA GGAATCCTGT TACATAGTAA CATCCCGCTT  
19861 AGACTATTTG ATAAGCTCAT TCCCGTGGAT TGCAATGCAG GACTACCCGC AAGATCGAAT  
19921 GAACCATATC TCTCGTTTGG AGTTCCACTT GCTTGCTGCG CTTGGGTCTG TGGTTGAGAT  
19981 TGCTGCTGCA CTTGCTGCTG TTGCTGAAGT TGGAACGCAC CCATATTTCC AGAAGGCAAT  
20041 GGCGGTAATA GTAAGCCATC GATACCTGAA TTCAATCTTT CAGGAGAACC AAAACCAATA  
20101 GTGCCATTTT GAGAGAAAAA GTTATTCATC ATATCTTTCT TATTGATGGT ACCCTGGAGG  
20161 CCCATACTTA GAGGAGTCAT ATTGTTTTTG TCCTCTATAG GGGCCGATGA CTTTTCCTCG  
20221 CTCTCACTCT TAGTTGTAGA GGCGCTTGAT GGAAAGGAAT CATTGGATGA GCCTGAAGCT  
20281 TTTACCGCTG ATTGGATATC ATTGAACGGT GTCTGCTCCT TCTTGATCGT AGGAGGTAAA  
20341 TCTACCGATG AATCAGACTC CACGCTACCG TCTGCCTTTC TCGTGACATA CTTCACTACT  
20401 GTTGCTCCTC TACCTTTCCT TAAATGGATT GGTGTATACT GACATTCCAA CTTCATATTT  
20461 GTGCACTTCC TACAGGCTGG CTTCCCTTCA TCACACTTAA CTCTTCTTCT TTTACAGTTA  
20521 TCGCACCCAT TCTTTGATTT GTTATGGAAT TTACGTTTAC CGGTTGAAGT CGTACTCACC  
20581 TTTTTGCCGT CCACTTCAAT TAGCTCGATG ACTTTTTCTC TTCTTCTGGG TTTTGTCACC  
20641 GCTTTCTTGT GATTCTGTAT ACCGACTTCG CTCATTGTTT TATATTTGTT GTAAAAAGTA  
20701 GATAATTACT TCCTTGATGA TCTGTAAAAA AGAGAAAAAG AAAGCATCTA AGAACTTGAA  
20761 AAACTACGAA TTAGAAAAGA CCAAATATGT ATTTCTTGCA TTGACCAATT TATGCAAGTT  
20821 TATATATATG TAAATGTAAG TTTCACGAGG TTCTACTAAA CTAAACCACC CCCTTGGTTA  
20881 GAAGAAAAGA GTGTGTGAGA ACAGGCTGTT GTTGTCACAC GATTCGGACA ATTCTGTTTG  
20941 AAAGAGAGAG AGTAACAGTA CGATCGAACG AACTTTGCTC TGGAGATCAC AGTGGGCATC  
21001 ATAGCATGTG GTACTAAACC CTTTCCCGCC ATTCCAGAAC CTTCGATTGC TTGTTACAAA  
21061 ACCTGTGAGC CGTCGCTAGG ACCTTGTTGT GTGACGAAAT TGGAAGCTGC AATCAATAGG  
21121 AAGACAGGAA GTCGAGCGTG TCTGGGTTTT TTCAGTTTTG TTCTTTTTGC AAACAAATCA  
21181 CGAGCGACGG TAATTTCTTT CTCGATAAGA GGCCACGTGC TTTATGAGGG TAACATCAAT  
21241 TCAAGAAGGA GGGAAACACT TCCTTTTTCT GGCCCTGATA ATAGTATGAG GGTGAAGCCA  
21301 AAATAAAGGA TTCGCGCCCA AATCGGCATC TTTAAATGCA GGTATGCGAT AGTTCCTCAC  
21361 TCTTTCCTTA CTCACGAGTA ATTCTTGCAA ATGCCTATTA TGCAGATGTT ATAATATCTG  
21421 TGCGTCTTGA GTTGAAGTCA GGAATCTAAA ATAAAAATTA AGGTTAATAA AAAGAGGAAA  
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21481 GAAAAAAAAA TTAATCGATT TACAGAAACT TGCACACTAA AAATACACAA CTAAAAGCAA  
21541 TTACAGTATG GGAAGTCATC GACGTTATCT CTACTATAGT ATATTATCAT TTCTATTATT  
21601 ATCCTGCTCA GTGGTACTTG CAAAACAAGA TAAGACCCCA TTCTTTGAAG GTACTTCTTC  
21661 GAAAAATTCG CGTCTTTTCA GCTTTCCGCA ACAGTATAAC TGTGC 
 
A.3  Sequence of the E. coli carotenoid biosynthetic pathway 
 Sequence of the completed pathway for the biosynthesis of tetradehydrolycopene 
in E. coli, which is shown schematically in Figure 5-6.    To show the context of the 
sequence in the chromosome, the last 30 bp of the HO(L) region on the 5’ end and the 
first 30 bp of the acceptor module (containing the HO cleavage site and the HIS3 
terminator) on the 3’ end are shown. 
   1 . . 30   HO(L) 
  31 . . 167  Subfragment 1a (pLac) 
 168 . . 1082 Subfragment 1b (crtE) 
1083 . . 1993 Fragment 2 (crtB) 
1994 . . 3491 Fragment 3 (crtI14) 
3492 . . 4920 Fragment 4 (KanMX) 
4921 . . 4950 Acceptor module 
 
   1 aaaattgtgc ctttggactt aaaatggcgt ccgactggaa agcgggcagt gagcgcaacg  
  61 caattaatgt gagttagctc actcattagg caccccaggc tttacacttt atgcttccgg  
 121 ctcgtatgtt gtgtggaatt gtgagcgtct agaaggagga ttacaaaatg acggtctgcg  
 181 caaaaaaaca cgttcatctc actcgcgatg ctgcggagca gttactggct gatattgatc  
 241 gacgccttga tcagttattg cccgtggagg gagaacggga tgttgtgggt gccgcgatgc  
 301 gtgaaggtgc gctggcaccg ggaaaacgta ttcgccccat gttgctgttg ctgaccgccc  
 361 gcgatctggg ttgcgctgtc agccatgacg gattactgga tttggcctgt gcggtggaaa  
 421 tggtccacgc ggcttcgctg atccttgacg atatgccctg catggacgat gcgaagctgc  
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 481 ggcgcggacg ccctaccatt cattctcatt acggagagca tgtggcaata ctggcggcgg  
 541 ttgccttgct gagtaaagcc tttggcgtaa ttgccgatgc agatggcctc acgccgctgg  
 601 caaaaaatcg ggcggtttct gaactgtcaa acgccatcgg catgcaagga ttggttcagg  
 661 gtcagttcaa ggatctgtct gaaggggata agccgcgcag cgctgaagct attttgatga  
 721 cgaatcactt taaaaccagc acgctgtttt gtgcctccat gcagatggcc tcgattgttg  
 781 cgaatgcctc cagcgaagcg cgtgattgcc tgcatcgttt ttcacttgat cttggtcagg  
 841 catttcaact gctggacgat ttgaccgatg gcatgaccga caccggtaag gatagcaatc  
 901 aggacgccgg taaatcgacg ctggtcaatc tgttaggccc gagggcggtt gaagaacgtc  
 961 tgagacaaca tcttcagctt gccagtgagc atctctctgc ggcctgccaa cacgggcacg  
1021 ccactcaaca ttttattcag gcctggtttg acaaaaaact cgctgccgtc agttaaggat  
1081 gcaggaggat tacaaaatgg cagttggctc gaaaagtttt gcgacagcct caaagttatt  
1141 tgatgcaaaa acccggcgca gcgtactgat gctctacgcc tggtgccgcc attgtgacga  
1201 tgttattgac gatcagacgc tgggctttca ggcccggcag cctgccttac aaacgcccga  
1261 acaacgtctg atgcaacttg agatgaaaac gcgccaggcc tatgcaggat cgcagatgca  
1321 cgaaccggcg tttgcggctt ttcaggaagt ggctatggct catgatatcg ccccggctta  
1381 cgcgtttgat catctggaag gcttcgccat ggatgtacgc gaagcgcaat acagccaact  
1441 ggatgatacg ctgcgctatt gctatcacgt tgcaggcgtt gtcggcttga tgatggcgca  
1501 aatcatgggc gtgcgggata acgccacgct ggaccgcgcc tgtgaccttg ggctggcatt  
1561 tcagttgacc aatattgctc gcgatattgt ggacgatgcg catgcgggcc gctgttatct  
1621 gccggcaagc tggctggagc atgaaggtct gaacaaagag aattatgcgg cacctgaaaa  
1681 ccgtcaggcg ctgagccgta tcgcccgtcg tttggtgcag gaagcagaac cttactattt  
1741 gtctgccaca gccggcctgg cagggttgcc cctgcgttcc gcctgggcaa tcgctacggc  
1801 gaagcaggtt taccggaaaa taggtgtcaa agttgaacag gccggtcagc aagcctggga  
1861 tcagcggcag tcaacgacca cgcccgaaaa attaacgctg ctgctggccg cctctggtca  
1921 ggcccttact tcccggatgc gggctcatcc tccccgccct gcgcatctct ggcagcgccc  
1981 gctctagctc gagaggagga ttacaaaatg aaaccaacta cggtaattgg tgcaggcttc  
2041 ggtggcctgg cactggcaat tcgtctacaa gctgcgggga tccccgtctt actgcttgaa  
2101 caacgtgata aacccggcgg tcgggcttat gtctacgagg atcaggggtt tacctttgat  
2161 gcaggcccga cggttatcac cgatcccagt gccattgaag aactgtttgc actggcagga  
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2221 aaacagttaa aagagtatgt cgaactgctg ccggttacgc cgttttaccg cctgtgttgg  
2281 gagtcaggga aggtctttaa ttacgataac gatcaaaccc ggctcgaagc gcagattcag  
2341 cagtttaatc cccgcgatgt cgaaggttat cgtcagtttc tggactattc acgcgcggtg  
2401 tttaaagaag gctatctaaa gctcggtact gtcccttttt tatcgttcag agacatgctt  
2461 cgcgccgcac ctcaactggc gaaactgcag gcatggagaa gcgtttacag taaggttgcc  
2521 agttacatcg aagatgaaca tctgcgccag gcgttttctt tccactcgct gttggtgggc  
2581 ggcaatccct tcgccacctc atccatttat acgttgatac acgcgctgga gcgtgagtgg  
2641 ggcgtctggt ttccgcgtgg cggcaccggc gcattagttc aggggatgat aaagctgttt  
2701 caggatctgg gtggcgaagt cgtgttaaac gccagagtca gccatatgga aacgacagga  
2761 aacaagattg aagccgtgca tttagaggac ggtcgcaggt tcctgacgca agccgtcgcg  
2821 tcaaatgcag atgtggttca tacctatcgc gacctgttaa gccagcaccc tgccgcggtt  
2881 aagcagtcca acaaactgca gactaagcgc atgagtaact ctctgtttgt gctctatttt  
2941 ggtttgaatc accatcatga tcagctcgcg catcacacgg tttgtttcgg cccgcgttac  
3001 cgcgagctga ttgacgaaat ttttaatcat gatggcctcg cagaggactt ctcactttat  
3061 ctgcacgcgc cctgtgtcac ggattcgtca ctggcgcctg aaggttgcgg cagttactat  
3121 gtgttggcgc cggtgccaca tttaggcacc gcgaacctcg actggacggt tgaggggcca  
3181 aaactacgcg accgtatttt tgcgtacctt gagcagcatt acatgcctgg cttacggagt  
3241 cagctggtca cgcaccggat gtttacgccg tttgattttc gcgaccagct taatgcctat  
3301 catggctcag ccttttctgt ggagcccgtt cttacccaga gcgcctggtt tcggccgcat  
3361 aaccgcgata aaaccattac taatctctac ctggtcggcg caggcacgca tcccggcgca  
3421 ggcattcctg gcgtcatcgg ctcggcaaaa gcgacagcag gtttgatgct ggaggatctg  
3481 atttgagaat tagcttgcct cgtccccgcc gggtcacccg gccagcgaca tggaggccca  
3541 gaataccctc cttgacagtc ttgacgtgcg cagctcaggg gcatgatgtg actgtcgccc  
3601 gtacatttag cccatacatc cccatgtata atcatttgca tccatacatt ttgatggccg  
3661 cacggcgcga agcaaaaatt acggctcctc gctgcagacc tgcgagcagg gaaacgctcc  
3721 cctcacagac gcgttgaatt gtccccacgc cgcgcccctg tagagaaata taaaaggtta  
3781 ggatttgcca ctgaggttct tctttcatat acttcctttt aaaatcttgc taggatacag  
3841 ttctcacatc acatccgaac ataaacaacc atgggtaagg aaaagactca cgtttcgagg  
3901 ccgcgattaa attccaacat ggatgctgat ttatatgggt ataaatgggc tcgcgataat  
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3961 gtcgggcaat caggtgcgac aatctatcga ttgtatggga agcccgatgc gccagagttg  
4021 tttctgaaac atggcaaagg tagcgttgcc aatgatgtta cagatgagat ggtcagacta  
4081 aactggctga cggaatttat gcctcttccg accatcaagc attttatccg tactcctgat  
4141 gatgcatggt tactcaccac tgcgatcccc ggcaaaacag cattccaggt attagaagaa  
4201 tatcctgatt caggtgaaaa tattgttgat gcgctggcag tgttcctgcg ccggttgcat  
4261 tcgattcctg tttgtaattg tccttttaac agcgatcgcg tatttcgtct cgctcaggcg  
4321 caatcacgaa tgaataacgg tttggttgat gcgagtgatt ttgatgacga gcgtaatggc  
4381 tggcctgttg aacaagtctg gaaagaaatg cataagcttt tgccattctc accggattca  
4441 gtcgtcactc atggtgattt ctcacttgat aaccttattt ttgacgaggg gaaattaata  
4501 ggttgtattg atgttggacg agtcggaatc gcagaccgat accaggatct tgccatccta  
4561 tggaactgcc tcggtgagtt ttctccttca ttacagaaac ggctttttca aaaatatggt  
4621 attgataatc ctgatatgaa taaattgcag tttcatttga tgctcgatga gtttttctaa  
4681 tcagtactga caataaaaag attcttgttt tcaagaactt gtcatttgta tagttttttt  
4741 atattgtagt tgttctattt taatcaaatg ttagcgtgat ttatattttt tttcgcctcg  
4801 acatcatctg cccagatgcg aagttaagtg cgcagaaagt aatatcatgc gtcaatcgta  
4861 tgtgaatgct ggtcgctata ctgctgtcga ttcgatacta acgccgccat ccagtgtcga  
4921 tttcagcttt ccgcaacagt ataactgtgc 
